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1 Introduction
Nanoscience, the investigation of objects in the nanometer regime, has greatly emerged
within the last decades, due to new synthesis routes to nanomaterials and also further
developed analytical tools to characterize them. Along with this, the ﬁeld of nanotechno-
logy where nanomaterials with new, size-dependent properties are brought to application is
growing steadily.[1]
Among these, diverse applications in the biomedical ﬁeld are envisioned.[2, 3] Nanomaterials
might help to answer fundamental questions in cell biology to understand molecular mecha-
nisms of natural nanostructures.[4] They might also ﬁnd their way to applications in medi-
cinal diagnosis, imaging and therapy techniques, the latter both in the form of drug carrier
systems or as active compounds in magnetically or photometrically based thermotherapy.
Furthermore, the enhanced production and use of nanomaterials in other than biomedical
applications such as electronic devices and in materials science leads to increased poten-
tial exposition to public and the environment during production, usage and even after
disposal.[5]
For these reasons, the investigation of biological eﬀects of nanomaterials is of great impor-
tance. There is already a huge number of nanomaterials of diﬀerent materials, sizes and
shapes available, and this number is still growing, yet data of biological eﬀects are sparse
and far from being fully understood.[6]
Based on the information gained so far, there are some ﬁrst general assumptions. Firstly,
there are size-dependent eﬀects, i. e. a non-toxic bulk material might be toxic in the nano-
meter size range. Nanomaterials with dimensions of smaller than approximately 2 nm are
in the same size regime as cellular structures and can thus potentially mimic biologically
active compounds, such as peptide hormones, cytokines or antigens, thereby causing adverse
1
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eﬀects to living organisms. Secondly, these phenomena are not only determined by size, but
the chemical composition, which might be crucial as well.[7] It would therefore be important
to conduct systematic investigations concerning these parameters to potentially ﬁnd some
fundamental mechanisms and conclusions about the manifold interactions of nanomaterials
with biological entities.
Exemplary for unexpected toxic behavior are gold nanoparticles (AuNPs) for which conﬂict-
ing data were presented. While in its bulk form being biologically inert, small phosphine-
stabilized AuNPs of the chemical formula Au55[(C6H5)2P(C6H4SO3Na)]12Cl6 were found to
be highly cytotoxic in diﬀerent cell lines. A potential mechanism based on an interaction of
these AuNPs with the major groove of DNA was proposed, supported by molecular dynamics
simulations.[8, 9]
Pernodet et al. reported of 14 nm sized citrate-stabilized AuNPs that induced a disturbed
actin structure in human dermal ﬁbroblasts, accompanied by a decrease in cell prolifera-
tion, adhesion, and motility.[10] On the other hand it was found that 18 nm sized AuNPs,
stabilized by either citrate or biotin, do not cause acute cytotoxicity in K562 leukemia cells
despite being taken up in cells.[11]
Against this background, a DFG funded cooperation project of the groups Simon and
Jahnen-Dechent (Aachen), Schmid and Brandau (Duisburg-Essen) and, in a second funding
phase, Wenzel (Karlsruhe), was initiated concerning the Control of the physiological impact
of noble metal nanoparticles by size and chemical modiﬁcation, including a project part for
Size-selective synthesis of new, water-soluble noble metal nanoparticles that was the basis
for this work.
In this, the synthesis and characterization of a series of ligand-stabilized water-soluble spher-
ical AuNPs was sought by modifying known synthesis routes as well as generating new ones
for systematic cytotoxicity studies. The parameters of variation include AuNP size as well
as the gold-ligand stability and the outer functional groups of ligands, thus the introduction
of new, AuNP-stabilizing ligands (see ﬁg. 1.1). While this work focuses on synthesis and
chemical characterization of the AuNPs, the cell experiments were conducted by Dr. Yu
Pan-Bartneck and are described in detail in the respective dissertation.[12]
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Figure 1.1: Control parameters for the cytotoxicity evaluation of AuNPs.
Further, the subjacent mechanisms of biological activity of AuNPs were investigated by a
variety of methods. The generation of reactive oxygen species (ROS) and resulting oxidative
stress has been related to nanomaterial toxicity before[13] and was therefore investigated in
detail. This was, amongst other tests, done by EPR spectroscopy.
Besides cytotoxicity evaluation, genotoxicity was also examined by sophisticated GC/MS
measurements in cooperation with Dr. Bryant Nelson at the National Institute of Standards
and Technology (NIST, Gaithersburg, MD, USA).
An approach to identify the toxicity mechanism of AuNPs was an investigation concerning
possibly released Au(I) species, and the analysis of the equilibrium between AuNPs, a Au(I)
complex and the phosphine ligand 3-(diphenylphosphino)benzenesulfonic acid sodium salt
(TPPMS) by 31P-NMR spectroscopy.
As another potential biological eﬀect, the interaction of AuNPs with ion channel expressing
cells was determined by electrophysiological patch clamp experiments. This was done at
Cytocentrics AG in Rostock. Parts of these results are already described in the dissertation
of Dr. Yu Pan-Bartneck.[12]
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Besides these mechanistic investigations, a species with application potential in cancer ther-
apy was synthesized. This was sought by functionalization of toxic AuNPs with (Lys3)-
bombesin, an oligopeptide, to induce cancer cell speciﬁcity for a conceivable application as
an anticancer drug. By a similar route it was also attempted to functionalize AuNPs with
a ﬂuorophore as a probe for potential ligand release in contact to cells.
4
2 Basic Knowledge
2.1 Gold Nanoparticles
2.1.1 Deﬁnitions and Nomenclature
The term nanotechnology describes the ﬁeld of developments in which size-dependent
properties of materials in the nanometer regime play a dominant role, and where these
properties can be used to generate new techniques and devices.[14] The materials can
include nanoparticles with dimensions of less than 100 nm as well as patterned surfaces
and more sophisticated assemblies. Nanotechnology is an interdisciplinary ﬁeld with
contributions from physics, chemistry, biology, materials science, medicine and other
disciplines. A typical example of a nanomaterial with distinct properties and a broad
variety of potential and already realized applications are gold nanoparticles.[15]
Gold nanoparticles (AuNPs) are spherical particles with a diameter of less than 100 nm
and, in solution, typically consist of a gold metal core and a stabilizing ligand shell that
prevents the particles either sterically or electrostatically from aggregation.[16] The term
nanoparticles (NPs) includes clusters as well as colloids. The term cluster is used for
very small NPs with a well deﬁned number of metal atoms, i. e. molecular species. The
term colloid describes larger particles. Hence, colloidal materials do not have a precise
molecular formula any more and are not monodisperse. However, particles with a size
distribution of less than 10% deviation are typically regarded as systems with suﬃciently
low polydispersity, and it is reasonable to describe such samples by their mean diameter.
In this work, the term ligand is used for organic molecules that have the ability to bind
to NPs via electron donating functional groups. For AuNPs, the most commonly used
5
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molecules for this purpose are thiols that form a thiolate bond on the gold surface. Other
molecules are for example phosphines, amines, carboxylates and polymers. For a more
detailed discussion about ligands for AuNPs, see chapter 2.1.4.
The nomenclature for the AuNPs used in this work includes the element, the mean diameter
of the particles in nm and an abbreviation for the ligand. For example, Au1.4MS is a NP
of gold with a mean diameter of 1.4 nm and a ligand shell of TPPMS (MS).
2.1.2 Physical Properties
This work focuses on biological eﬀects of AuNPs. However, to fully understand the discussion
of the observed eﬀects and the proposed mechanisms, an introduction into the main size-
related physical properties of AuNPs is requisite.
2.1.2.1 Electronic Structure of AuNPs
As metal NPs have atom numbers between molecular species and the bulk material, their
electronic structure diﬀers from these both boundary states and thus they have several
unique size-dependent properties.[16] Small gold clusters exhibit distinct energy gaps in
their electronic structure, whereas for larger colloids no energy gaps exist in the 6sp band.
A cluster can be described as a zero-dimensional entity in which the electrons occupy dis-
crete energy levels and quantum mechanical properties become dominant.[17] The valence
electrons in clusters are therefore in quantized states, but also highly delocalized within
the cluster.[18] With increasing NP size, the orbital density increases and quasi-continuous
electron bands as in the bulk state arise. These size-dependent electronic states have an im-
pact on intrinsic features such as optical or electronic properties and on application relevant
characteristics, for example in metal NP catalysis (see chapter 2.1.2.3).
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2.1.2.2 Optical Properties
In small gold clusters with energetically separated orbitals, discrete electron excitations
occur. UV/Vis spectra show narrow peaks in the short-wave length range, reﬂecting such
single electron excitations, as for example shown for the cluster [Au9[(C6H5)3P]8](NO3)3.[19]
AuNPs above a size of approximately 3 nm show a plasmon resonance peak in their UV/Vis
spectra. This phenomenon arises from the electron gas of delocalized 6s electrons of the
individual particles. The plasmons of the electron gas are excited with energies in the range
of visible light. In the case of resonance of the electromagnetic wave of light and the plasmon
frequency, the latter is stimulated to oscillate and the light is absorbed. A full theoretical
description of this was already given by Mie in 1908.[20]
The plasmon oscillation frequency depends on the restoring force between electrons and
nuclei. The UV/Vis spectrum of a certain AuNP species therefore depends e. g. on the size
and shape of the particles and on the environment (i. e. the ligand shell and the solvent).
This can be used for AuNP analysis (see 2.2.1).[21]
AuNPs can also display ﬂuorescence. This phenomenon is clearly dependent from size and
ligand functionalization. Huang and Murray investigated tiopronin-stabilized AuNPs with
a diameter of 1.8 nm and found ﬂuorescence at 700-800 nm. They hypothesize a mechanism
of interband transitions between the ﬁlled 5d10 band and 6(sp)1 conduction band.[22]
2.1.2.3 Catalytic Activity of AuNPs
The electronic structure also has an impact on the catalytic activity of AuNPs. In general,
NPs often have high catalytic activity due to their large number of surface atoms relative to
their mass. Surface atoms are energetically in an activated state and can catalyze reactions
of molecules that adsorb on the surface. For example, O2 can be activated by AuNPs
through partial electron transfer from the gold clusters to the antibonding pi∗ orbital of
O2 and generation of highly active peroxo-like species.[23] Thus, the catalysis of oxidation
reactions by AuNPs has recently been investigated by diﬀerent groups.[24, 25]
For small gold clusters, it was found that the activity varies with changes in the gold
atom number, already with the alteration of single atoms.[26] The observed size dependence
7
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is, on the one hand, related to the surface to volume ratio and the enlarged number of
energetically activated surface atoms. The energy levels of gold clusters, which are very
sensitive to changes in single atom numbers, are on the other hand of great importance as
well, as they inﬂuence the ability to activate adsorbed molecules. The activation of adsorbed
substrates is a key issue in NP catalysis.
AuNPs on supporting metal oxides such as TiO2 or MgO show signiﬁcantly enhanced activity
and selectivity.[27] This is explained by charge transfer between gold clusters and metal oxide
support. Ligands on the other hand may hinder catalytic reactivity of AuNPs as they shield
the surface against adsorption of the substrate. In some examples however, certain ligands
such as poly(vinylpyrrolidone) (PVP) can enhance catalytic activity. A mechanism similar
to the one proposed for support materials is expected.[28]
Turner et al. reported high activity and selectivity for the oxidation of styrene to benzal-
dehyde by Au55[(C6H5)3P]12Cl6 on diﬀerent support materials at relatively mild conditions
of 100 ◦C in toluene. AuNPs of larger sizes were less active to completely inactive.[29] The
ability of AuNPs to catalyze oxidation reactions will be relevant in the following discussion
of AuNP cytotoxicity.
AuNPs can also catalyze other reactions. For example, the hydrogenation of α, β-
unsaturated ketones and aldehydes by a Au25(SR)18 cluster was published. Here, a cat-
alytic cycle was proposed, in which the active sites on the Au25 structure could be spatially
located.[30]
2.1.3 Syntheses
Metal NPs can generally be synthesized either in gas or in solution phase. In this work, only
wet chemical synthesis routes are discussed. Gas phase syntheses are described elsewhere.[31]
Due to the great interest of AuNPs for applications in diﬀerent ﬁelds, there is a huge and still
increasing number of diﬀerent synthesis routes.[15] Some of these are exemplary described
here in more detail.
The bottom-up synthesis of AuNPs is typically conducted by the reduction of a dissolved
Au(III) salt or Au(I) complex to Au(0) in presence of a ligand. Typical reducing agents
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are for example trisodium citrate, Na3C6H5O7, sodium borohydride, NaBH4, and diborane,
B2H6.
One of the most commonly used synthesis routes is the one of Turkevitch et al. from
1951.[32] Here, [AuCl4]
 is reduced by trisodium citrate in boiling water. The citrate which
is added in excess also acts as ligand for the formed AuNPs. Depending on the synthesis
conditions, i. e. the concentrations of the components as well as temperature and reaction
time, diﬀerent AuNP sizes in the range from 15 nm up to 150 nm can be generated.
Very small clusters with the chemical formula Au55[(C6H5)3P]12Cl6 and a gold core diame-
ter of 1.4 nm can be synthesized by the method developed by Schmid et al. in 1981.[33]
The Au(I) complex [(C6H5)3P]AuCl is dissolved in benzene and reduced with diborane at
moderate heat.
Schmid et al. also developed a method to transfer these AuNPs into the aqueous phase.[34]
For this purpose, a dichloromethane dispersion of the clusters is covered with an aqueous so-
lution of TPPMS and stirred at room temperature for three days. An equilibrium of AuNPs
in both phases is reached after this time. To improve the yield of water soluble clusters,
the volume of the water phase is larger and TPPMS is added in excess. Furthermore, the
ability to stabilize AuNPs is slightly higher for TPPMS compared to triphenylphosphine.
They are not only stabilized by steric repulsion but also by an electrostatic stabilization
of the charged TPPMS which has a negative sulfonate group when it is in solution. This
further shifts the equilibrium.
Another break-through in AuNP synthesis was achieved in 1994 when Brust et al. developed
the so-called Brust-Schiﬀrin synthesis.[35] In this two-phase system, HAuCl4 is dissolved in
H2O, covered with an organic solvent (e. g. toluene) containing an alkylthiol, and reduced
with an aqueous solution of sodium borohydride. AuNPs with sizes between 1.5 and 5.2 nm
with diﬀerent alkylthiol ligands were obtained. One year later, they expanded this route to
a one-phase method by using methanol as solvent for all compounds.[36]
Leﬀ et al. described a synthesis route to amine-stabilized AuNPs in a size range from 2.5
to 7.0 nm, depending on the synthesis conditions.[37] As amines are weakly binding ligands,
these AuNPs are of special interest for subsequent ligand exchange reactions with more
strongly binding ligands.
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An approach to thiol-stabilized, water soluble AuNPs was performed by Whetten et al. and
reﬁned by Negishi et al..[38, 39] HAuCl4 is reduced by sodium borohydride in the presence
of glutathione, a biogenic tripeptide consisting of L-cysteine, L-glutamic acid and glycine.
The resulting AuNPs have a mean diameter of approximately 1 nm.
2.1.4 Ligands and Functionalization
AuNPs need a stabilizing surfactant shell to prevent them from aggregation.[40] Molecules
which are electron donors can act as ligands for AuNPs. The interaction between ligand and
AuNP surface depends on the functional group which binds to the particle and ranges from
coordinative chemisorption of strong ligands to electrostatic attraction of weaker ones. The
binding strength has inﬂuence on several properties of the particles, the most prominent
one being the AuNP stability.
AuNP stability in media further depends on the character of the end group (the part of the
ligand molecule that points away from the particle surface). The stabilization is achieved
either by steric (e. g. alkylthiols) or by electrostatic repulsion (e. g. phosphine sulfonates).
The nature of the ligand not only determines the AuNP stabilization, but also inﬂuences
their properties, such as solubility in apolar or polar solvents and the ζ potential. With
respect to biological eﬀects of AuNPs, it is reasonable to expect the ligand shell to play a
crucial role, as this is the ﬁrst entity the cell gets in contact with.
Thiols have the highest aﬃnity to gold and are therefore the most frequently used class of
ligands. For self-assembled monolayers (SAM) consisting of thiols on a ﬂat gold surface, a
binding energy of approximately 200 kJ/mol (=̂ 2.07 eV) was determined.[41] However, this
value may be diﬀerent for AuNPs as the surface of NPs diﬀers from a plain surface because of
its curvature and the resulting edge and vertex atoms. Other sulfur containing molecules are
e. g. disulﬁdes and thioethers, both forming considerably weaker bonds towards AuNPs.[42,
43]
Phosphines are another class of widely used AuNP ligands. Compared to thiols, the binding
energy is lower, as DFT calculations on Au38 and Au39 clusters showed. Here, binding
energies of 0.93 eV for the Au−PH3 bond compared to 2.45 eV for Au−SCH3 were found.[44]
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Typically, aryl phosphines like triphenyl phosphine (TPP) and its derivatives are used, as
their phenyl rings provide high AuNP stability due to sterical bulkiness as well as oxidation
resistance of the phosphine itself.
Amines, such as alkylamines or the amino acid lysine, have also been used as ligands.[45]
Compared to thiols and phosphines, their aﬃnity is only moderate, but stable AuNP dis-
persions can be obtained.
Carboxylates like trisodium citrate can also act as AuNP ligands. As they are mainly
electrostatically bound to the surface, the stability strongly depends on factors such as salt
concentration and pH of the solution. It is not possible to dry and redisperse such AuNPs.
Dendrimers and polymers such as PVP and PEG are also used as ligands to stabilize AuNPs.
Such AuNPs are often synthesized by reducing a gold salt in presence of the respective
polymer, so that the polymer matrix determines the particle growth.[15]
Furthermore, a chelate eﬀect can play a role in ligand binding. Multivalent ligands show
higher aﬃnity to NP surfaces. This is based on a higher probability of recombination if one
functional group desorbed from the nanoparticle surface. A multivalent molecule remains in
the proximity of the particle, as opposed to monovalent ligands which will desorb completely.
Also, entropic eﬀects play a role.
Perumal et al. investigated binding kinetics of mono-, di- and trithiols on diﬀerently sized
AuNPs (2.2, 3.2 and 4.4 nm) via time resolved ﬂuorescence spectroscopy of the leaving ligand
(a pyrene).[46] They found that divalent ligands show highest exchange velocity and explain
this by a cooperative activation model of vicinal atoms. The lower velocity of trithiols is
explained by enhanced sterical hindrance. They also ﬁnd a particle size dependence, as the
ligand exchange rate increases with increasing particle size.
The chemical stability of mono-, di- and trithiol-stabilized AuNPs (2 nm diameter) was
also investigated by Srisombat et al. by UV/Vis spectroscopic monitoring of cyanide
degradation.[47] They found the same trend that dithiols stabilize AuNPs best.
Diphosphines can also act as AuNP ligands. An example are 2,2'-bis(diphenylphosphino)-
1,1'-binaphthyl (BINAP)-stabilized AuNPs with an mean diameter of 1.7 nm that could
be synthesized via a direct route.[48] Ligand characterization was performed by XPS, also
showing that the gold atoms are present as Au0.
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Furthermore, Au11 clusters, stabilized by four BINAP molecules per particle, were
reported.[49]
The formation mechanism of diphosphine-stabilized undecagold was investigated in detail
by electrospray ionization−mass spectrometry (ESI-MS).[50] It was found that ligand
lability is an important factor in the equilibria of relevant gold complex intermediates
and that the direct formation of diphosphine-stabilized clusters from diphosphine-gold
complexes may be hindered due to high stability of such complexes. A problem in AuNP
stabilization with polyfunctional ligands may occur by possible network formation of
numerous AuNPs and a resulting aggregation.
Ligands undergo dynamic binding and unbinding processes.[40] The phenomenon of
ligand mobility was described in detail for thiols.[51] Kinetics of the exchange rate of
ligands depend on the ligand concentration and the character of the competing ligand.
Furthermore, some atoms in a cluster are more prone to ligand exchange than others.
Functionalization of AuNPs can be realized either by a ligand exchange or by further chem-
ical modiﬁcation of the existing ligand shell. The mechanistic aspects of ligand exchange
reactions are quite complex and depend on several factors such as the leaving ligand, the
incoming ligand, the AuNP size and of course the reaction conditions under which the ligand
exchange is performed.[52] In general it is possible to exchange weak binding ligands against
stronger ones. This can be done either in one phase or in a two phase system. In a one
phase system, AuNPs and incoming ligands can easily interact. A disadvantage is the more
elaborate puriﬁcation. The main drawback of a two phase ligand exchange is the possibly
impaired NP stability at the phase boundary, as the AuNPs lose their primary ligands and
are partly unprotected during phase crossing.
The aspect of chemical modiﬁcation of the ligand shell is further discussed in chapter 2.4.
2.1.5 Separation from Possible Impurities
Three key issues are important concerning the purity of AuNPs: Polydispersity of a sample,
excess ligand, and metal ion or complex impurities. These factors depend on the synthesis
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conditions, and ideally those are adjusted in such a way that sophisticated puriﬁcation
steps are not necessary. Nevertheless, even for well optimized synthesis routes the degree of
purity from the raw product might not be suﬃcient for the envisioned further experiments
or applications. Several methods can then be applied to purify the material.
The most frequently used methods for size selectivity include ﬁltration, selective centrifu-
gation, selective precipitation, and column chromatography.
Filtration is useful if considerably larger aggregates have to be removed, but not for samples
with a broad size distribution. Filters with diﬀerent membrane pores down to 20 nm are
commercially available, fabricated from diﬀerent materials such as alumina and various
polymers. It is important to choose a suitable material to exclude any interaction of the
particles with the membrane material.
Quantitative centrifugation, relying on the sedimentation principle, can also be used to
separate particles with a bimodal distribution of diﬀerent masses.[53] Both the centrifugate
or the supernatant may content the desired product. Sample volumes range from µL to
hundreds of mL which makes centrifugation especially interesting for large batches.
Size selective precipitation is based on diﬀerent solubility of diﬀerently sized NPs due to
varying numbers of ligands on the particle surface and therefore diﬀering stabilization. NPs
are dispersed in a solvent, and a nonsolvent or a salt is added stepwise, enabling the suc-
cessive precipitation and removal of NP fractions.[54]
Column chromatography or size exclusion chromatography relies on the same principle,
as the retention time of NPs depends on the particle size and therefore solubility and
polarity.[55] Diﬀerent materials for the stationary phase are useful for puriﬁcation of AuNPs,
such as cellulose or sephadex (a cross-linked dextran gel). However, not all AuNPs are suit-
able for column chromatography, as especially larger particles or weakly stabilized ones tend
to aggregate on the adsorbent.
Puriﬁcation methods to eliminate excess of ligand, synthesis by-products, and ionic im-
purities include centrifugation, washing or precipitation, and column chromatography, but
also dialysis. Here, diﬀerent membranes are commercially available with diﬀerent molecular
weight cut oﬀ (MWCO) radii and made of diﬀerent materials. Although dialysis may be a
quite time consuming method when performed over several days, it is easy to perform.
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Depending on particle size and ligand stabilization, AuNPs sometimes show problems of sta-
bility when kept in solution over longer periods of time. The particle size might change due
to ripening eﬀects, and partial decomposition and therefore slow enrichment of impurities
is possible. Because of their large surface area and therefore activated state, NPs are ther-
modynamically metastable. Energy input by elevated temperature or light might enhance
further reactions. Also, the medium plays a role, as for example high salt concentrations
may impair NP stability.
These facts need to be considered for the preparation, storage and handling of AuNPs.
Regularly repeated analysis of the NP quality is essential to ensure that the investigated
material has the expected structure.
2.2 Characterization
Two aspects have to be considered in NP analysis: size and polydispersity determination of
a sample, and characterization of the ligand shell. Diﬀerent methods to address these two
issues will be brieﬂy explained, together with recent examples of nanomaterial applications.
Typically, only a few selected of the presented analysis methods are used and presented
by diﬀerent groups reporting about AuNP synthesis and characterization. One must be
aware of the detection limits and the advantages and disadvantages of diﬀerent techniques
when applied to AuNPs. The comparability between diﬀerent methods is sometimes not
directly given and must carefully taken into account. One example of extensive AuNP
characterization with various diﬀerent techniques was given by Leﬀ et al. by the investigation
of diﬀerently sized alkylamine-stabilized AuNPs.[37]
2.2.1 UV/Vis Spectroscopy
The optical properties of a AuNP sample can easily be investigated by UV/Vis spectroscopy.
AuNPs above a certain size (∼ 3 nm) exhibit a plasmon resonance peak (2.1.2.2). As this de-
pends on size and NP surrounding, UV/Vis spectroscopy is used for qualitative NP analysis
for dispersions of spherical AuNPs. When parameters such as solvent and ligand shell are
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equal for two samples, the wavelength of the absorption maximum depends on the particle
size and the width of the peak is a measure for the polydispersity of the sample.
Furthermore, assemblies of AuNPs can be investigated. If AuNPs are in close proximity,
their valence electrons interact. The excited plasmon of one AuNP induces an alteration
of the polarizability of the neighboring AuNPs. The resonance frequency is aﬀected, which
leads to a redshift of the plasmon resonance peak maximum.
This is for example used in enzyme sensors. In a recent example, peptide- as well as
antibody-functionalized AuNPs were synthesized and mixed.[56] In presence of a kinase,
the peptide was phosphorylated and thus compatible for antibody interaction, leading to
AuNP aggregation. This colorimetric assay enables the quantiﬁcation of enzyme and also
the determination of kinase inhibitors, which is important in drug development for several
diseases.
2.2.2 Electron Microscopy
Electron microscopy (EM) is used in this work to determine mean AuNP sizes. An elec-
tron microscope consists of an electron gun, an anode to accelerate the electrons, several
electrostatic and electromagnetic lenses to focus the electron beam, a sample holder and a
detection system. The detection of EM is performed under high vacuum conditions. It is,
depending on the measurement mode, based on elastic or inelastic scattering or diﬀraction
of the electrons by the sample.[57]
The use of an electron beam for the imaging of objects strongly increases the resolution as
compared to light microscopy. The resolution of a system is determined by the wavelength of
the probe beam, and energy-rich electrons correspond to shorter wavelengths than possible
in the visible spectrum (photons). The resolution of a transmission electron microscope
(TEM) is approximately 0.1 nm.[58] By using aberration correctors, resolution could be
improved to 50 pm in annular dark-ﬁeld scanning TEM imaging.[59]
However, several obstacles have to be overcome when using TEM for NP size determination.
As it is not an integral method, relatively few particles are examined compared to other
methods. Analysis of a statistically signiﬁcant number of particles is therefore important.
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For very small NPs, the contrast between particles and substrate (usually an amorphous
carbon ﬁlm) may be low.[60] Due to the high electron density of gold this problem is mostly
negligible for AuNPs. The resolution can be improved by measuring in dark-ﬁeld imaging
mode and even further in high-angle annular dark-ﬁeld (HAADF) mode, using a detector
operating in a preselected angular range while excluding the direct electron beam.
The appropriate choice of magniﬁcation and accelerating voltage is also crucial. Magniﬁ-
cation is especially important for statistical NP size analysis. With higher magniﬁcation,
the particle size can be determined more correctly. On the other hand, less particles per
image are available for evaluation. Higher voltage enhances contrast, but may induce severe
sample damage. A compromise has to be found for both. Typical voltages used are of in-
termediate energy (80−400 keV). To reduce sample damage by the electron beam, scanning
transmission EM (STEM) can be performed. A scanning beam is advantageous compared
to continuously exposing the entire sample to the electron beam.
Furthermore, the image analysis is an important parameter. Manual evaluation may be
defective, but for samples with low contrast, it is preferred compared to software-assisted
or fully automated analysis. Smoothing and sharpening processes of the images may come
along with loss of information and addition of artifacts.
A state-of-the art example for AuNP EM characterization was presented by Li et al., who
used aberration-corrected HAADF-STEM for the three-dimensional analysis of a Au309 clus-
ter. They could achieve atomic resolution when combined with cluster simulations.[61]
2.2.3 X-ray Diﬀractometry
X-ray diﬀractometry (XRD) is based on elastic scattering of X-rays from the electrons of
atoms of a sample. Powder diﬀraction is used to analyze the crystallographic structure and
crystallite size of a material. For very small crystallite sizes, signals in XRD are broadened,
a phenomenon described by the Scherrer equation.
XRD is used as a characterization tool for structure analysis of AuNPs. Small angle X-ray
diﬀraction (SAXRD) was used to determine the structure of Au55[(C6H5)3P]12Cl6 in crys-
tallites, showing a simple close packed arrangement of clusters correlating with an eﬀective
cluster distance of 2.3 nm.[62] Until now it was not possible to generate large single crystals
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of the Au55 cluster, therefore no single-crystal X-ray structure analysis to solve the complete
structure could be performed.[17]
Crystallization of single crystals is however possible for other AuNP species. In 2007,
Jadzinsky et al. reported of the crystallization and X-ray structure determination of a
p-mercaptobenzoic acid (p-MBA)-protected AuNP, consisting of 102 gold atoms and 44
p-MBA molecules.[63]
2.2.4 DLS and ζ Potential Measurement
In dynamic light scattering (DLS) measurements, laser light is used to determine the size
distribution proﬁle of a nanoparticle dispersion.[64] Photons are scattered by particles if
the particles are small compared to the wavelength used. For monochromatic coherent
laser light, time-dependent ﬂuctuations of the scattering intensity occur, which are induced
by the Brownian motion particles undergo in dispersion. From the intensity trace, an
autocorrelation function can be generated which typically shows exponential decay. This
decay is related to the diﬀusion coeﬃcient of the NPs. With this it is possible to calculate
the hydrodynamic radius of a sphere through the Stokes-Einstein equation.
The ζ potential of a colloidal dispersion describes the potential diﬀerence between the dis-
persion medium and the stationary layer of ﬂuid attached to the dispersed particle.[65] It is
a measure to approximate the stability of a NP dispersion. If the absolute value is higher
than 30mV, a dispersion is regarded as stable. Measurement of the ζ potential of a NP dis-
persion is conducted by applying an electrical ﬁeld during a DLS measurement and therefore
determining its electrophoretic mobility, which correlates with the ζ potential.
Advantageous of DLS and ζ potential measurements is the very fast and easy performance.
Opposed to EM, it is an integral method. A great number of particles is measured in one
measurement, providing statistically relevant data.
There is however a major drawback related to this. As the intensity of scattered light
varies with the sixth power of particle diameter, impurities such as comparatively large dust
particles are highly disturbing.
Manufacturers of DLS instruments give values around 1 nm or below as lower size detection
limits. However, this value depends strongly on factors as medium viscosity, temperature
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and monodispersity of the sample. A critical discussion of potential problems arising in size
determination of AuNPs by DLS was given by Khlebtsov et al..[66]
As one example, AuNPs with a mean gold core diameter of 2.7 nm, stabilized by a mixed
ligand shell of GSH and cysteamine, were able to be measured in DLS, resulting in a hy-
drodynamic diameter of 3.1 nm.[67]
In another study, Rotello and co-workers performed ζ potential measurements of 2 nm sized
thiol-stabilized AuNPs with mixed ligands shells of tetra(ethylene glycol) (TEG) and 1-
pentanethiol and found diﬀerences in the values depending on the ratio of ligands bound to
the particles.[68] They found a qualitative correlation of ligand shell ratio and ζ potentials.
Furthermore, DLS was used to investigate interactions of AuNPs and biomolecules, namely
the interaction of AuNP-bound protein A with the human IgG protein.[69] Here, the binding
stoichiometry could be quantiﬁed by DLS.
2.2.5 Elemental Analysis
Elemental analysis (EA) is a standard technique for the determination of elemental compo-
sition. Most typically, carbon, hydrogen and nitrogen (CHN) amounts are quantiﬁed in a
sample by combustion and detection of the resulting combustion products.
For AuNPs, EA is useful to characterize the ligand shell composition. If the structure of a
cluster and thus the theoretical elemental composition is known, EA can be used to verify
the purity of the sample. For Au55[(C6H5)3P]12Cl6 the EA result was one of the means to
determine its chemical composition.[33]
One problem that intrinsically occurs for EA of AuNPs is the high mass of the gold core
and thus the mass ratio between core and shell. This makes it diﬃcult to distinguish for
example between samples before and after a ligand exchange, if the chemical formula of the
outgoing and incoming ligands are similar. The percental changes of the AuNP species are
then small compared to the EA of the pure ligands.
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2.2.6 Nuclear Magnetic Resonance Spectroscopy
Nuclear magnetic resonance (NMR) spectroscopy is widely used in chemical analysis to
determine molecular structures. It is based on the interaction of nuclear spins of a sample
with a magnetic ﬁeld. NMR active nuclei absorb electromagnetic radiation at a characteristic
frequency. For diﬀerent local chemical environments (on an atomic scale), e. g. depending
on the functional group an atom belongs to, the chemical shielding is inﬂuenced and the
resonance frequency is slightly shifted. This chemical shift is thus characteristic and can be
used for example for structural determination of a molecule.
When ligands of a NP species are investigated by NMR spectroscopy, the proximity of
the ligand molecules to the metallic core has an eﬀect towards the resulting spectra, e. g.
line broadening may occur. This originates from the variability of diﬀerent chemical shift
environments at the surface of the NPs due to ligand mobility of the NP surface.
NMR spectroscopy can be performed in solution, giving averaged signals as the time scale
of a NMR experiment is slow compared to molecular movements. It can also be conducted
in solid state, which is typically used in polymer analysis and structure determination of
huge molecules such as membrane proteins.[70]
For AuNPs, NMR spectroscopy may yield important information about ligand dynamics.
This was shown by Schmid et al. for Au55[(C6H5)3P]12Cl6 in interaction with excess TPP
ligand,[71] and also for similar TPP-stabilized clusters with a mean diameter of 1.8 nm
by Sharma et al..[72] They found that if excess TPP (in deuterated form, d15-PPh3) was
added, ligand exchange reactions appear in which the gold(I) complex TPP-Au(I)-Cl is also
involved.
2.2.7 Infrared Spectroscopy
In infrared (IR) spectroscopy, vibrational modes of atoms or atom groups in molecules are ex-
cited and the respective absorption is detected. This covers the range from ∼400− 4000 cm-1
of the electromagnetic spectrum, typically given in wavenumbers.
As for NMR spectroscopy, IR spectroscopy in context with AuNPs is mainly used to analyze
the ligand shell. Characteristic bands from functional groups can be identiﬁed to ensure
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particle functionalization with the respective molecules. Sometimes, further information can
be gained, e. g. for thiols bound to AuNPs. Here, the S−H vibrational mode disappears
in AuNP spectra as thiols bind via the sulfur atom to the AuNP surface, as for example
shown by Brust et al..[36] Again, the problem of signal broadening arises and can hinder
the identiﬁcation of weak bands in an IR spectrum.
2.2.8 Fluorescence Spectroscopy
Fluorescence spectroscopy uses electromagnetic radiation to excite ﬂuorescent molecules.
Typically, emission spectra are recorded, but absorption can be detected as well.
As already described before, small AuNPs can be ﬂuorescent (see 2.1.2.2). Several exam-
ples for this phenomenon can be found in literature. Polymer-stabilized AuNPs with sizes
between 1.1 to 1.7 nm were found to be ﬂuorescent, with 1.1 nm sized AuNPs having the
highest quantum yield of 3%.[73]
Also, ﬂuorophores attached to AuNPs are investigated. When ﬂuorophores are in close prox-
imity to AuNPs, their ﬂuorescence is typically quenched by a Förster resonance energy trans-
fer (FRET).[74] Therefore, ﬂuorescence spectroscopy can be a valuable tool to determine
ligand release from AuNPs. This was for example shown by Seferos et al., where ﬂuores-
cein labeled DNA sequences were hybridized to AuNPs functionalized with complementary
strands.[75] DNA melting processes could then be followed by ﬂuorescence spectroscopy due
to increasing ﬂuorescence induced by released ﬂuorophore-labeled DNA strands.
2.2.9 X-ray Photoelectron Spectroscopy
In X-ray photoelectron spectroscopy (XPS), X-ray radiation is used as a surface probe to
trigger electron emission from the sample surface. As the energies of those are element
and oxidation state dependent, information about the chemical composition of the sample
surface can be derived.
A limitation of the technique is that ultrahigh vacuum conditions are required. Also, sample
degradation can occur during the measurement in the case of irradiating sensitive samples.
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As a surface analysis method, XPS can be used to characterize the ligand shell of NPs. Also,
the oxidation state of the metal core can be detected as the radiation depth is up to 10 nm
of the sample.
Techane et al. used XPS to monitor ligand exchange of 24 nm sized AuNPs that were initially
functionalized with cysteamine (HS−(CH2)2−NH2) which was then exchanged against a
long chain amine-terminated alkanethiol (HS−(CH2)11−NH2).[76] They found that ligand
exchange was complete after 4 days, while the ligand density further increased for the next
10 days.
2.2.10 Electron Paramagnetic Resonance Spectroscopy
Electron paramagnetic resonance (EPR) spectroscopy is a method to detect unpaired elec-
trons in a sample. The physical principles are the same as in NMR spectroscopy, but
the resonance frequencies of electrons are detected instead of those of nuclei. Absorption
frequency and signal ﬁne structure are compound dependent, and the signal intensity is
proportional to the species concentration.
As most stable compounds do not have unpaired electrons, EPR spectroscopy is restricted to
the analysis of radical species, paramagnetic transition metal complexes or excited molecules
in the triplet state. This restriction is on the other hand an advantage as it makes EPR
spectroscopy highly speciﬁc, even in complex systems such as in vivo analyses.[77]
Stable radicals can be used as a probe to investigate interactions with EPR inactive com-
pounds such as AuNPs. This was for example shown by Zhang et al., who used 4-Amino-
2,2,6,6-tetramethylpiperidine-1-oxyl (Amino-TEMPO) to determine the interaction with
citrate-stabilized AuNPs. They found that Amino-TEMPO is adsorbed on the AuNP sur-
face, leading to a signal decrease. In the presence of oxygen, Amino-TEMPO was oxidized
to its oxo derivative, potentially catalyzed by the AuNPs.[78]
2.3 Biological Eﬀects of Gold Nanoparticles
As the number of envisioned applications of AuNPs in biomedical applications rapidly in-
creases, the eﬀects towards biological systems need to be analyzed. This ﬁeld can be gener-
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ally divided into in vitro and in vivo investigations. Although the latter is closer to realistic
application scenarios, the former has also its value, as important basic knowledge can be
gained and some general principles of the interactions of AuNPs with living organisms may
already be found and understood in the easier accessible, cheaper and ethically better justi-
ﬁable cell experiments. Also, the analysis of in vivo experiments comprises a higher degree
of complexity due to parameters such as uptake pathway, organ distribution, retention time
and the complex interplay of numerous diﬀerent cell types. In vitro assays may enable easier
access of structure-property relationships as a lower number of parameters must be taken
into account.
This work is restricted to in vitro experiments. Two recent overviews of in vivo investigations
were given by Alkilany et al. and Li et al..[79, 80]
2.3.1 Methods
Diﬀerent methods exist to determine cytotoxicity.[6] Besides light microscopy to analyze
changes in cellular structure, staining assays are widely used. Some are based on the fact
that dying cells become leaky, such as Neutral Red, which usually accumulates in lysosomes
of healthy cells, so that reduced uptake is a sign for impaired cell viability, and Trypan Blue
that is only permeable to cells with compromised membranes.
Mitochondrial activity can be analyzed by the widely used MTT assay. Here, the dye 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) is colorimetrically quan-
tiﬁed. In living cells, it is metabolized to its blue formazan derivative, thus a correlation of
cell viability can be drawn. Other dye assays working on the same principle are MTS, WST
and XTT. As a measure, typically the half maximal inhibitory concentration (IC50) is given
as the concentration of the toxic compound that impaired cell viability by 50%.
Cytotoxic compounds may induce inﬂammation reactions within living organisms. Thus,
concentrations of inﬂammation biomarkers such as IL-1β, IL-6, and TNF-α together with
IL-8 can be quantiﬁed.
To diﬀerentiate between necrosis (sudden cell death as cellular response of acute cellular
injury) and apoptosis (programmed cell death leading to cell fragments that can be digested),
double staining with two dyes and subsequent ﬂow cytometry is often used. Annexin V is a
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staining reagent for phosphatidylserine, a membrane lipid which concentration is increased
on the extracellular side during apoptosis. Propidium iodide is a nuclear stain for impaired
membrane integrity, hence for necrosis. By diﬀerentiation between single annexin V stained
apoptotic cells and double stained necrotic cells, the cell death mechanism can be elucidated.
2.3.2 Uptake Mechanisms
Endocytosis is the generic term for several uptake mechanisms. Cells capture extracellular
molecules in vesicles consisting of plasma membrane. Depending on the size of the resulting
vesicles, endocytosis is diﬀerentiated into phagocytosis (0.1 - 10µm) and pinocytosis (up to
100 nm for micropinocytosis and up to 1000 nm for macropinocytosis). There are several
sub-mechanisms described, depending on whether cell membrane receptors are involved or
not.[81]
Concerning NPs, the kind of cellular uptake is dependent on nanomaterial intrinsic factors
such as size, shape, surface chemistry determined by charge and ligand type (hydrophilic or
hydrophobic), and potential biologically active species like receptor aﬃne functionalities.[82]
This number of determining parameters complicates a general prediction. Some recent
examples from literature will describe the diﬀerent and sometimes contradictory results.
A study about the uptake of 14, 50, and 74 nm sized AuNPs, stabilized with citric acid,
revealed size-dependent kinetics.[83] Here, 50 nm sized AuNPs were most eﬃcient in uptake.
The investigation of diﬀerently sized PEGylated AuNPs was described by Oh et al. AuNPs
from 2.4 to 89 nm were functionalized with cell penetrating peptides (CPPs), and uptake was
investigated in COS-1 cells.[84] They found that cellular uptake is directly dependent on the
surface display of the CPP whereas the ﬁnal intracellular destination is further determined
by AuNP diameter. 2.4 nm sized AuNPs were found in the nucleus. 5.5 and 8.2 nm sized
AuNPs were partially taken up by cells into the cytoplasm, while larger AuNPs with mean
diameters of 16 nm and larger were not taken up at all. This last ﬁnding signiﬁcantly diﬀers
from another report in which AuNPs of 18 nm size were endocytosed and ended in endocytic
vesicles.[11]
The endocytotic uptake of single AuNPs was investigated by atomic force spectroscopy. 4,
12, and 17 nm sized L-cysteine-stabilized AuNPs were used. Uptake forces increase with
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AuNP size, which can possibly be attributed to the increased interaction area between
AuNP and cell membrane. Endocytosis could be inhibited by treating the cell with the
cytoskeleton inhibitor cytochalasin B.[85]
Furthermore it was found by Verma et al. that even the surface structure of the ligand
shell can inﬂuence the uptake mechanism.[86] AuNPs of the same size of 4.5 nm and with a
mixed ligand shell of the same composition, but with either unordered or stripe-like ordered
ligands, were either trapped in endosomes or could pass the cell membrane without bilayer
disruption.
In biological tissue as well as in cell culture medium, particles will be wrapped in a shell of
the proteins present. For 10 - 20 nm sized FePt and CdSe/ZnS NPs stabilized by a polymer
coating, this so-called protein corona could be quantiﬁed to have a thickness of 3.3 nm.[87]
The occurrence of a protein corona around AuNPs could be shown for citrate-stabilized
AuNPs of 5 - 100 nm in interaction with typical blood proteins such as albumin and
insulin.[88] The binding constant and also the thickness of the ﬁnal protein layer depend on
the particle size, both increasing with increasing AuNP size.
Mirkin and co-workers describe a dependance of the oligonucleotide density of 13 nm sized
AuNPs and the number of proteins absorbed, thus aﬀecting the cellular uptake in a mouse
cell line (C-166) and two human cell models (HeLa and A594).[89]
2.3.3 Cytotoxicity
As a result of AuNP uptake, cytotoxicity may occur. Within the last years, several studies
were published concerning the toxicity of AuNPs. Various AuNPs were analyzed by diﬀerent
methods, which complicates a direct comparison or the statement of a general hypothesis.
The lack of systematic investigations and reports of sometimes contradictory results by
diﬀerent groups were the starting point for the DFG project in which framework this work
was conducted.
There are some recent reviews concerning the topic of nanoparticle cytotoxicity.[6, 90] The
most relevant publications with regard to the present work will be discussed here.
Surprisingly high cytotoxicity was found for Au55[(C6H5)2P(C6H4SO3Na)]12Cl6 clusters (ab-
breviated as Au1.4MS in the present work) in eleven diﬀerent cancer and healthy human
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cell lines after an incubation time of 24 h, determined by MTT assay.[8] Further, the intra-
cellular distribution was investigated by neutron activation analysis (NAA). 57.5% of the
radioactive gold isotope was located in the cytoplasmatic fraction, 42.5% was bound to the
cell nucleus. After removal of the nuclear proteins, 21.1% were found in the DNA fraction.
However, this was possibly an artifact of the sample preparation because the nuclei always
fractionate with the pellet and thus together with the AuNPs.
Connor et al. revealed the uptake of 18 nm sized citrate- or biotin-capped AuNPs in K562
leukemia cells.[11] An MTT assay after three days of incubation did not show toxicity
induced by the AuNPs up to gold atom concentrations of 250µM. The same was determined
for cysteine- and citrate-capped 4 nm sized and glucose-stabilized 12 nm sized AuNPs (up
to 25µM).
Another study reported of 13 nm sized citrate-stabilized AuNPs in human dermal ﬁbroblast
cells.[10] After incubation times of 2, 4 and 6 days, proliferation of the cells was impaired.
Moreover, it was found that the formation of actin ﬁlaments was disturbed.
2 nm sized thiol-stabilized AuNPs with either cationic ammonium or anionic carboxylate
functional end groups were analyzed for their eﬀects towards COS-1 cells, red blood cells
and E. coli bacteria cells.[91] Cells were incubated with up to 3µM AuNPs for a maximum
of 24 h and analyzed by MTT assay. E. coli cells were found to be slightly more resistant
to AuNP toxicity that was induced by the cationic AuNPs. The anionic species had no
toxic eﬀect, which was explained by less favored interaction with the negatively charged
lipid bilayer of which a cell membrane consists.
In 2009, 8 nm sized poly(vinylpyrrolidone)-stabilized AuNPs were investigated in madine
darby canine kidney cells (MDCK) and human hepatocellular carcinoma cells (HepG2)
after 24 h of exposure.[92] No cytotoxicity was found with Neutral Red uptake and colony
forming eﬃciency tests.
From these ﬁndings, no clear trend could be found yet concerning the size- or ligand-
dependent cytotoxicity of AuNPs, obviously resulting from the diﬀerent protocols, descrip-
tions of dosage and reference compounds used so far.
25
2 Basic Knowledge
2.3.4 Oxidative Stress & Reactive Oxygen Species
Oxidative stress describes a state in metabolism in which a critical concentration of reactive
oxygen species (ROS) is formed. These are the superoxide O 2 , hydrogen peroxide H2O2
and the hydroxy radical ·OH. The concentrations of cellular antioxidant defenses such as
glutathione (GSH) are depleted. In consequence, lipid membranes, proteins and DNA are
aﬀected and become oxidized which may critically disturb their vital functionalities.
A general model of NP induced oxidative stress, the determining factors and the conse-
quences in biological organisms was presented by Nel et al.. The nanomaterial factors
include material composition, electronic structure, surface bound species, surface coatings
and solubility. It is therefore not possible to predict if a certain nanomaterial will induce
oxidative stress in cells but has to be individually investigated.[13] Some studies indicate
that AuNPs may induce oxidative stress in cells.
A MRC-5 human fetal lung ﬁbroblast cell line was treated with 20 nm citrate-stabilized
AuNPs which were further passivated with fetal bovine serum (FBS).[93] The highest
AuNP concentration used was 1 nM (particle concentration) and was incubated up to
72 h. A decrease in total cell number was found. Furthermore, the generation of 8-Oxo-2'-
deoxyguanosine (8-OH-dG) could be shown. This is related to oxidative stress and genotoxi-
city (see below in section 2.3.5). The AuNPs also aﬀected genes associated with genomic
stability and DNA repair.
13 nm sized citrate-stabilized AuNPs were analyzed for their potential to produce NO in
blood serum.[94] Concentrations up to 80µM clearly induced NO release. It is speculated
that S -nitroso adducts with a thiol group, such as S -nitrosoalbumin, S -nitrosocysteine, and
S -nitrosoglutathione are the source for NO release. This conclusion was drawn from the
occurrence of a thiolate peak in XPS spectra of the AuNPs after contact with blood serum.
Cationic AuNPs with thiols of diﬀerent alkyl chain lengths were analyzed towards HeLa
cells determined by alamar blue assay.[95] The production of ROS was shown by 2'-7'-
dichlorodihydroﬂuorescein diacetate (H2DCFDA) staining. Increasing the hydrophobicity
of the particles increased their cytotoxicity and also ROS production.
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2.3.5 Genotoxicity
Oxidative stress can damage DNA and induce single-strand breaks, double-strand breaks,
oxidatively induced base damage, and other DNA lesions. This can further lead to mutage-
nesis, carcinogenesis, or other age related diseases.[96]
There are diﬀerent methods to investigate NP induced genotoxicity. One common method
is the comet assay, which is based on gel electrophoresis of a single cell after lysis. It is
a relatively simple and fast assay. One disadvantage is the lack of information about the
targets of oxidative damage.
For a more detailed investigation, single DNA base oxidation products can be quantiﬁed.
Typically, this is done by HPLC or ELISA detection for 8-OH-dG, an oxidation product of
deoxyguanosine with mutagenic and promutagenic activity.[97]
However, there are several other DNA oxidation products (lesions) with adverse eﬀects that
are more diﬃcult to detect as they are present in lower concentrations. A detection method
for identiﬁcation and quantiﬁcation of numerous lesions is GC/MS. If this is performed
together with a so-called isotope-dilution procedure for which known concentrations of the
respective, isotopically labeled lesions are added, it is possible to quantify the concentrations
of several lesions in a single measurement of one sample.[98] Despite the more elaborate
sample preparation compared to other assays, the latter method was chosen in this work to
investigate AuNP induced genotoxicity, thus enabling the detection of multiple DNA lesions
simultaneously.
An analog technique to quantify DNA damage that was also used here is liquid chroma-
tography/tandem mass spectrometry (LC/MS/MS). Similar sensitivities as compared to
results from GC coupled systems could be shown.[99] An advantage compared to GC/MS
is that the analyte does not have to be derivatized prior to the measurement.[100]
The tandem mass spectrometry measurement unit enables the selection of a certain ion
from a ﬁrst overview mass spectrometry unit, its fragmentation and subsequent analysis
of secondary fragments. This allows simultaneous detection of lesions and recording of
fragmentation patterns thereof.
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2.3.6 Ion Channels & Patch Clamp Technique
One important step to bridge the huge gap between in vitro toxicity assays and in vivo
studies is the investigation of negative eﬀects towards ion channels of cells by the patch
clamp technique.[101]
Nowadays, many new chemical compounds are abandoned early in the drug development
process because they interfere with the KV11.1 potassium ion channel (encoded by the
hERG gene and therefore abbreviated as hERG).[102] The hERG ion channel is a voltage
gated potassium channel that, together with other ion channels, regulates the heartbeat
as it mediates the rapid delayed rectiﬁer K+ current in heart (IKr). IKr is activated by
membrane depolarization and is a major determinant of the duration of action potentials in
the ventricle. Mutations in hERG leading to a complete or partial loss of channel function
are a major cause of inherited long QT syndrome (LQTS). More often, dysfunctions of
hERG that lead to LQTS are caused by a blockade of medications as an undesirable side
eﬀect. This has already led to the removal of several drugs from the market and is now
a indispensable pretest in the development of new drugs. Therefore, new drug candidates
have to be tested for a potential inhibitory eﬀect on the hERG current (Guidance ICH S7A,
S7B by the FDA). This susceptibility relates to the special structure of hERG.[103]
Distinct from other voltage gated K+ channels the S6 loop of the hERG protein lacks a
proline-X-proline motif that is proposed to insert a 'kink' in this inner helix. Therefore, the
cavity of the hERG channel is supposed to be wider compared to the related K+ channels
and thus providing more space for chemical compounds, e. g. small NPs, interacting with
putative binding sites.
With the patch clamp technique, the electrophysiology of cells, i. e. the membrane poten-
tial and channel currents of ion-channel expressing cells can be examined.[104] Undesirable
interactions of potential drugs that compromise or inhibit the channel functionality can
be analyzed. For this purpose, the patch electrode (a glass micropipette ﬁlled with an
electrolyte solution and a chlorinated silver wire) is brought in close contact to the cell
which is adherent in the medium ﬁlled cell chamber. Depending on the question that is
addressed, diﬀerent pipette-cell conﬁgurations can be realized. In a typical experiment, the
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glass capillary is placed in contact with the cell membrane. By applying a slight suction
the cell-to-capillary contact is sealed (gigaseal). By enhancing the suction the membrane
is ruptured and the electrode is in contact with the cytosol (whole cell conﬁguration). Via
this patch electrode and with a counter electrode in the cell chamber it is now possible to
apply a certain potential to the cell membrane as well as to measure the ion current through
the ion channels of the entire cell. The test compound can then be added to the cell culture
medium in the cell chamber, and inﬂuences on the channel activity can be detected. Patch
clamp is now a standard technique for new therapeutics.
In a ﬁrst example for an application of patch clamp measurements on NP incubated cells,
Parak and co-workers investigated the eﬀect of diﬀerently coated CdSe NPs with a core
diameter of 2.4 nm towards hERG expressing CHO cells.[105] They found that particles of
this size do not cause any eﬀects towards characteristic electrophysiological properties of
the cells, but a quantiﬁed cytotoxicity of CdSe NPs that could be related to the release of
Cd2+ ions.
2.4 Modiﬁcation of AuNPs for Biomedical Applications
Cytostatic drugs used nowadays in chemotherapy have several disadvantages that have to
be solved for a better treatment of patients. One huge disadvantage is the general toxicity
of most cytostatic drugs, thereby leading to severe side eﬀects during cancer therapy such as
depression of the immune system, fatigue, nausea and others. Therefore, anticancer drugs
need urgently to be improved and to be made more speciﬁc.
NPs can easily be functionalized via their ligand shell. Thus, targeting molecules can
be attached to the NP surface, leading to a speciﬁc interaction with cells having suitable
receptors. Appropriate target molecules include peptides, proteins, enzymes and antibodies,
depending on the aspired application.[40]
NPs with active targeting functionalities are classiﬁed as third generation NPs and are ca-
pable of speciﬁcally recognizing their target. Typically, they interact with receptors present
on the cell surface via peptides, proteins, aptamers and antibodies. Uptake can then occur
through receptor-mediated endocytosis.[106]
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This was for example shown for a variety of AuNPs (10, 20, 30, and 60 nm diameter,
respectively), functionalized with mixed ligand shells of PEG and two diﬀerent receptor-
mediated endocytosis-triggering peptides in HeLa cells. Eﬃcient uptake could be conﬁrmed
by induced coupled plasma-optical emission spectroscopy (ICP-OES) of the lysed cells.[107]
2.8 nm sized AuNPs functionalized with tiopronin and then further with a Tat protein-
derived peptide sequence were tested in a human ﬁbroblast cell line by TEM. Speciﬁc nuclear
targeting could successfully be performed.[108]
A TEM based study with 16 nm sized AuNPs investigated the uptake in HeLa cells de-
pending on functionalization.[109] If the AuNPs were coated with CPPs, the uptake did
no longer happen via endocytosis, or possibly the AuNPs were able for endosomal escape,
as they were not found in endosomes within cells. When they were functionalized with a
mixture of CPPs and nuclear localizing signal (NLS) peptides, it was possible to induce
nuclear targeting with these AuNPs.
2.4.1 Targeting with Bombesin
Bombesin is an oligopeptide consisting of 14 amino acids which was ﬁrst found in the skin
of a toad, Bombina bombina.[110] It shows antitumor activity as it binds to gastrin releasing
peptide receptors (GRPR). GRPR are overexpressed in a number of diﬀerent cancer cells,
such as prostate, gastrinoma and breast cancer cells.[111] It is thus an excellent marker for
early molecular events in carcinogenesis.[112]
Bombesin was already used for AuNP targeting. When 16 nm sized AuNPs were func-
tionalized with a thioctic acid-bombesin derivative, enhanced speciﬁcity towards GRPR
expressing cells could be shown in vitro, as well as in vivo in a prostate tumor bearing mice
model. Biodistribution was followed by using radiolabeled 198Au.[113]
Furthermore, Kogan and co-workers synthesized multifunctional 20 nm sized AuNPs, func-
tionalized with a bombesin analogue and an analogue of the RAF peptide as a drug
peptide.[114] They also found an enhanced activity and selectivity towards GRPR expressing
cells, the latter induced by the targeting entity bombesin.
One advantage of bombesin and its analogues compared to other targeting entities such
as antibodies is its relatively small size. This is especially important if small AuNPs are
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functionalized, as it might not be possible to attach a huge biomacromolecule to small gold
clusters for sterical reasons.
2.4.2 Labeling with Fluorophores/Aminoﬂuorescein
Besides a functionalization to induce target speciﬁcity, it is also possible to attach marker
molecules such as ﬂuorophores to AuNPs to enable visualization within organic matter. If a
ﬂuorophore is attached to a AuNP, quenching eﬀects can occur, depending on the AuNP size
and the linker length.[74] This can be used to visualize ligand desorption from the particles
which results in increasing ﬂuorescence.
2 nm sized AuNPs with thiol ligands were partially functionalized with a ﬂuorescein deriva-
tive that was bound via a TEG linker containing additional 9 CH2 groups. Here, eﬀective
quenching between ﬂuorophore and AuNPs was observed, and the particles were used to
quantify ligand release by ﬂuorescence spectroscopy.[68]
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3 Results and Discussion
3.1 Syntheses of AuNPs
Diﬀerent routes were followed to synthesize a variety of AuNP species, varying in size,
ligand shell and functionalization. The syntheses performed in this work were all based on
wet chemical synthesis, i. e. the reduction of a gold salt or complex in solution. Depending
on the synthesis conditions, diﬀerent AuNPs could be produced and further modiﬁed. For
this purpose, two main strategies were pursued: ligand exchange reactions which could be
performed in one or two phase systems, or further chemical modiﬁcation of the existing
ligand shell.
Many AuNPs described in this work are based on the Au55 cluster ﬁrst synthesized by Schmid
et al.[33] and its water soluble derivative Au1.4MS.[34] Furthermore, citrate-stabilized
AuNPs with mean diameters between 10 - 15 nm, synthesized by the Turkevitch method
[32], were often used as precursor AuNPs for further functionalization. Some other synthe-
sis strategies were also performed and are described at the respective parts.
All AuNPs were analyzed regarding two aspects: their size and monodispersity, and the
chemical composition of their ligand shell. Diﬀerent analytical tools were used for these
purposes: UV/Vis spectroscopy, electron microscopy and dynamic light scattering for size
determination; elemental analysis, IR and NMR spectroscopy for the chemical constitu-
tion. Mean diameters correspond to values determined by statistical analysis of electron
microscopy micrographs if not stated diﬀerently. The results for the diﬀerent AuNPs are
described at the respective parts.
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3.2 Size-Dependent Cytotoxicity
A variety of diﬀerently sized AuNPs between 0.8 and 15 nm, all stabilized with a TPPMS
ligand shell, was synthesized, characterized and the cytotoxicity of each species was eval-
uated. The cell experiments were conducted by Dr. Yu Pan-Bartneck at the University
Hospital Aachen (UKA), and parts of the results of these tests are described in her PhD
thesis.[12]
Au0.8MS, Au1.4MS and Au15MS were synthesized according to known protocols [19, 34,
115] (see also chapter 5 for details). The UV/Vis spectra of the three materials are shown
in ﬁg. 3.1. The spectrum of Au0.8MS shows discrete peaks in the range below 500 nm and
is consistent with a spectrum of a Au8 cluster.[19] Au1.4MS shows a smooth spectrum with
decreasing absorbance to longer wavelengths, but without discrete absorptions as small
clusters or a plasmon resonance peak as colloids. The spectrum of Au15MS shows a typical
surface plasmon band with an absorption maximum at a wavelength of 524 nm.
STEM micrographs for Au1.4MS and Au15MS are shown in ﬁg. 3.2 and show AuNPs with
a narrow size distribution (1.4± 0.2 nm and 15± 1 nm, respectively).
Figure 3.1: UV/Vis spectra of Au0.8MS, Au1.4MS and Au15MS.
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Figure 3.2: STEM micrographs of 1.4 nm (left) and 15 nm (right) sized, TPPMS-
stabilized AuNPs.
In a newly developed route, AuNPs with a mean diameter of 5.6 nm (Au5.6MS) were syn-
thesized in a two step procedure. First, dodecylamine-stabilized AuNPs were synthesized
and dispersed in dichloromethane.[37] In a two phase ligand exchange reaction, these par-
ticles were functionalized with TPPMS and transferred to the aqueous phase. The UV/Vis
spectrum, showing a distinct plasmon resonance peak at 518 nm, and a representative STEM
micrograph are shown in ﬁg. 3.3, respectively.
Figure 3.3: UV/Vis spectrum (left) and STEM micrograph (right) of Au5.6MS.
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Furthermore, the cytotoxicities of two AuNP species with sizes of 1.2 and 1.8 nm (Au1.2MS
and Au1.8MS, respectively), kindly provided by STREM Chemicals Inc, were examined as
well.
First, the stabilities of all AuNP species in cell culture medium were conﬁrmed. The
AuNP cytotoxicities were then evaluated in an MTT assay with an incubation time of
48 h. Tauredon®, a gold(I) thiomalate complex which is in clinical use as an anti-rheumatic
drug, was tested as a reference. This complex does not exist in its molecular form in solu-
tion, but forms polymeric structures. Number and nature of the species thereby depend on
parameters such as concentration, pH and nature of the cation (here Na+).[116]
The ﬁrst AuNPs tested (Au0.8MS, Au1.2MS, Au1.4MS, Au1.8MS, and Au15MS) were
tested in four diﬀerent cell lines: HeLa cervix carcinoma epithelial cells (HeLa), SK-Mel-
28 melanoma cells (SK-Mel-28), L929 mouse ﬁbroblast cells (L929), and mouse mono-
cytic/macrophage cells (J774A1). The sensitivity diﬀerence between diﬀerent growth phases
of cells, i. e. the logarithmic growth phase after 72 h of cell seeding into microtiter plates and
the stationary phase after seven days of cell culturing, was also investigated. Later, HeLa
cells in the logarithmic growth phase were used as the standard experiment conditions for
all AuNPs.
A size-dependent cytotoxicity was found for all cell lines and incubation conditions (see
ﬁg. 3.4 for the results from the logarithmic growth phase). The diﬀerent cell lines resulted
in slightly diﬀerent absolute IC50 values, but the trends were the same in all cell lines. Cells
in the logarithmic growth phase were generally more sensitive to all toxic species by a factor
of 1.5 - 3.3 compared to cells in the stationary phase.
Au1.4MS was the most toxic species with an IC50 of 46µM in HeLa cells in the logarithmic
phase. Smaller (Au0.8MS, Au1.2MS) and larger AuNPs were less toxic (Au1.8MS) or even
non-toxic (Au15MS) in the highest concentration that was applied. Au5.6MS was tested
up to a concentration of 150µM and was not toxic in this concentration. In a subsequent
experiment it was found that the IC50 of Au4.6MS, a diﬀerent batch but synthesized via the
same route as Au5.6MS, is 370µM.[118] The IC50 value for Au5.6MS is presumably in the
same order of magnitude or even higher than this value.
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Figure 3.4: IC50 values of diﬀerent AuNPs and Tauredon as reference for four diﬀerent
cell lines, determined in the logarithmic growth phase.[117]
The mononuclear reference substance, Tauredon®, had an IC50 value of 19 mM in logarith-
mically growing HeLa cells. This is a ﬁrst indicator that the cytotoxicity of AuNPs is not
induced by ionic gold species; this issue is further discussed in chapter 3.7.
The pure ligand TPPMS was also tested and resulted in an IC50 value of 600µM. For
the most toxic species, Au1.4MS, the molecular ratio of Au:TPPMS is 55:12. At the
IC50 concentration of 46µM (gold atom concentration), the TPPMS concentration thus
amounts to 10µM, being signiﬁcantly below the IC50 concentration of TPPMS itself. It
could be imaginable that the AuNPs act as a carrier for TPPMS. This would lead to
spatially accumulated TPPMS molecules and a locally increased ligand concentration,
potentially being more harmful than the free TPPMS. However, this hypothesis would not
explain the size dependence with a maximum for a medium size of 1.4 nm as it was found.
Furthermore, this could later be disproven when a mixture of Au1.4MS with additional
TPPMS was tested (see chapter 3.4.3) and showed a signiﬁcantly lower cytotoxicity than
Au1.4MS alone. The moderate cytotoxicity of TPPMS is therefore considered to be not
related to the high toxicity of Au1.4MS.
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For the size dependence of AuNP cytotoxicity a variety of potential mechanisms can be
named.
Nano-objects are in the same size range as cell components and proteins. A size-speciﬁc
interaction of AuNPs with certain important cell functionalities is conceivable. Such an
interaction might block the target entity and induce a fatal disturbance in the cellular
signaling, motility and metabolism. It is possible that AuNPs of certain sizes ﬁt better
in the blocked structures than others and that there is a maximum of interaction and a
resultant toxicity maximum for Au1.4MS. One possible target of such a size- or structure-
related interaction is DNA, as explained by the model presented by Liu et al..[9] Here, an
interaction of Au1.4MS with the phosphate groups in the major groove of the DNA double
helix backbone is hypothesized. Such an interaction could block DNA transcription and
therefore cause cell death. For a further discussion, see chapter 3.4.2.
Also, proteins might be impaired by AuNPs. It was shown for other nanomaterials (copoly-
mer particles, cerium oxide particles, quantum dots, and carbon nanotubes) that they induce
protein ﬁbrillation which is related to various diseases.[119] A similar eﬀect might be the
reason for the cytotoxicity of AuNPs.
Another potential location of activity is the cell membrane. Nanoparticles may induce
disruption of the membrane, or block certain essential functional entities. The eﬀect of
AuNPs towards HEK 293 cells, transfected with the hERG gene leading to a high expression
of potassium channels, is further discussed in chapter 3.8. But also in other cell types
without an enhanced number of ion channels in the membrane, lethal eﬀects of AuNPs are
imaginable.
It is also known that AuNPs with very small diameters are catalytically active for a range
of reactions such as oxidation and hydrogenation reactions. The size dependence here is
explained by the number of active sites, relative to the number of total gold atoms, i. e.
the smaller the particle, the more energetically favored surface atoms are present. The
toxicity of nanoparticles has been related to oxidative stress and reactive oxygen species
(ROS) before.[13] It is imaginable that the cytotoxicity of AuNPs is directly related to
the generation of ROS and that Au1.4MS is, due to its structure, the most potent ROS
generating species of the AuNPs tested (see chapters 3.4.3 and 3.5 for further discussion).
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In all scenarios the accessibility of the AuNP surface is crucial. If the eﬀect is based on
a blockade of cell functions, it seems plausible that the TPPMS shell is stripped at some
time point of the cell incubation, and that it is the bare gold core that interacts with the
target. On the other hand, the generation of ROS would very probably take place on the
gold particle surface as well. In both cases, the interaction between gold core and ligand
shell might play a role in the toxicity progress, and varying the binding strength between
gold and ligand might aﬀect the toxicity potential of a given AuNP size.
3.3 Ligand-Dependent Cytotoxicity: Phosphine vs.
Thiol
Thiols have a generally higher aﬃnity towards gold than phosphines (see chapter 2.1.4).
DFT calculations on small clusters (Au38 and Au39) resulted in a binding energy of 0.93 eV
for the Au−PH3 bond compared to 2.45 eV for Au−SCH3.[44]
Therefore, small thiol-stabilized AuNPs with a glutathione (GSH) ligand shell (Au1.1GSH)
were synthesized in a direct synthesis approach.[39] The UV/Vis spectrum and a STEM
micrograph are depicted in ﬁg. 3.5, respectively. The UV/Vis spectrum shows a simple decay
which is typical for very small AuNPs. This is conﬁrmed by the STEM analysis, resulting in
a mean particle diameter of 1.1± 0.2 nm. Note that for other batches synthesized, AuNPs
with a mean diameter of 1.5 nm were produced, therefore abbreviated as Au1.5GSH at the
respective parts.
The cytotoxicity was tested under the standardized conditions. These particles were clearly
less toxic than AuNPs of a comparable size but with the weaker binding TPPMS ligand.
They showed an IC50 value of 3131µM in HeLa cells in the logarithmic growth phase and
are therefore 68-fold less toxic than Au1.4MS.
Furthermore, a mixture of Au1.4MS and 10 eq GSH was incubated and tested. The IC50
value determined was 181µM. As thiols have a generally higher aﬃnity to gold than phos-
phines, a ligand exchange resulting in Au1.4GSH was assumed. A ﬁrst hint for a chemical
reaction was the distinct solubility behavior, as the reaction product was less soluble in
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Figure 3.5: UV/Vis spectrum (left) and STEM micrograph (right) of Au1.1GSH.
bidistilled water, but was amphoteric and well soluble in acidic and basic solution. ζ poten-
tial measurements resulted in -48mV in basic and +25mV in acidic solution and conﬁrmed
the amphoteric nature of the AuNPs. Compared to that, Au1.4MS has a ζ potential of
-42mV in H2O at pH7 due to its acidic sulfonate group.
The method of ζ potential determination is exactly valid only for larger particles than
the species investigated here. Thus, the quantitative values measured here are questionable.
However, order of magnitude and especially the positive and negative preﬁxes point towards
a ligand exchange reaction.
A 31P-NMR spectrum of washed and resuspended Au1.4GSH showed no signal, indicating
a complete ligand exchange and no residual TPPMS. The IR spectrum showed the charac-
teristic features of GSH, whereas the S-H stretching vibration at 2526 cm-1 was missing (see
ﬁg. 3.6). This indicates a binding mode of GSH towards the AuNP surface via the thiolate
function.[120]
STEM analysis revealed a slightly broadened size distribution of the AuNPs, but still a mean
diameter of 1.4 nm (see ﬁg. 3.7). The analytical investigations proved the ligand exchange
of TPPMS against GSH.
Another analyzed material was the commercially available Aurovistwhich consists of
AuNPs with a mean diameter of 1.9 nm. The exact chemical formula of the ligand shell
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Figure 3.6: IR spectra of Au1.4GSH (black) and GSH (red).
Figure 3.7: STEM micrograph (left) and histogram (right) of Au1.4GSH.
41
3 Results and Discussion
is not known for this material, but it consists of carboxylic acid containing thiols.[121] The
IC50 value was determined to 9532µM.
Small thiol-stabilized AuNPs are obviously less toxic than phosphine-stabilized ones of a
comparable size. As brieﬂy explained above, this phenomenon is in accordance with both
models of toxicity. The gold core is either too tightly wrapped into the thiol shell so that
ligand stripping is inhibited, and the gold surface is not accessible to bind to a target cell
functionality. Or the bound thiols shield the gold surface against O2 adsorption so that no
ROS can be generated and cause cell death. This can be compared to poisoning of the
gold surface by thiols, as it is known for catalytic processes using metal surfaces or NPs in
interaction with impurities of sulfur containing molecules in the feed.[122]
Further experiments that corroborate this ﬁnding are discussed in chapter 3.4.3. Another ap-
proach for a deeper understanding of the correlation between ligand−gold binding strength
and toxicity was the synthesis of diphosphine-stabilized AuNPs (see chapter 3.10). Here, the
chelating eﬀect of a ligand molecule with two phosphine groups should enhance the stability
of the bond between ligand and particle surface.
3.4 Cellular Response Reactions
3.4.1 Necrosis vs. Apoptosis
The mechanism of cell death was further investigated. HeLa cells in the logarithmic growth
phase, incubated with AuNPs, were double stained with propidium iodide and annexin V and
analyzed by ﬂow cytometry. By this method, the two main cell death pathways necrosis and
apoptosis can be diﬀerentiated. Au1.2MS and Au1.4MS were both used in their respective
double IC50 concentrations (Au1.2MS: 285µM; Au1.4MS: 90µM). Cells were incubated for
increasing incubation times (6, 12, 18, 24, 30, 39, 48 h). Untreated cells were analyzed as
negative control. As a positive control to induce apoptosis, staurosporine was used. The
percental values from ﬂow cytometry are plotted in ﬁg. 3.8.
Interestingly, the two AuNP species tested showed opposite results. Au1.2MS caused apop-
tosis to a larger extent (ﬁg. 3.8C). After 48 h, 90% of the cells were dead, whereof 60% went
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Figure 3.8: Results of ﬂow cytometry after double staining with propidium iodide
and annexin V (HeLa cells). A: untreated reference, B: staurosporine as
positive apoptosis control, C: 285µM Au1.2MS, D: 90µM Au1.4MS.[117]
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into apoptosis. On the other hand, Au1.4MS induced mainly necrosis (ﬁg. 3.8D). After 48 h,
100% of the cells were dead with 80% necrotic cells. This diﬀerence in cell death mechanism
was not obvious from the MTT assay, which is a classical end point analysis, but was only
revealed by the kinetic study design.
The two materials comprise the same chemical components as they both consist of atomic
gold cores and TPPMS ligand shells. Their main diﬀerence is a variation of 0.2 nm in
the mean diameter of particle size, accompanied by a slightly varying number of TPPMS
molecules per particle, caused by distinct synthesis routes. The number of TPPMS molecules
per Au1.2MS particle was approximated to 30. The gold core consists of approximately 39
gold atoms (estimated by calculating the volume of a 1.2 nm sized sphere, with the atomic
radius of gold of 144 pm and an atomic packing factor of 0.74 for the ccp structure). Au1.4MS
has a gold atom to ligand ratio of 55:12, thus a lower relative concentration of TPPMS.
Anyhow, for both materials the TPPMS concentration is below its critical concentration for
the IC50 concentrations of the AuNPs.
The fact that Au1.2MS and Au1.4MS induce diﬀerent kinds of cell death can be interpreted
in two ways. Depending on the exact toxicity mechanism behind, it is possible that the two
AuNP species trigger diﬀerent cell response cascades. This would for example be the case
if a size-speciﬁc blocking of a biologically essential functionality by the AuNPs is taking
place, and the two diﬀerent AuNP species hit diﬀerent points of action. On the other hand,
Au1.4MS was found to be more toxic than Au1.2MS. It is therefore possible that simply
the severity of toxicity causes a sudden necrotic cell response, whereas the slightly less toxic
Au1.2MS enables the cell to activate the apoptosis pathway.
3.4.2 Gene Regulation
With a genome-wide mRNA expression analysis (Aﬀymetrix Genechips®), the inﬂuence of
AuNPs on cellular gene expression was investigated. HeLa cells were incubated with 100µM
Au1.4MS and 1000µM Au15MS for 1, 6 and 12 h. mRNA was extracted from the cells and
reverse transcribed into cDNA. The puriﬁed cDNA was used to synthesize biotinylated
complementary RNA samples which were hybridized to the DNA array. By comparing
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the read-out values to results from untreated cells and by performing a hierarchical cluster
analysis, diﬀerences in gene regulation could be identiﬁed.
Cells incubated with Au1.4MS showed a distinct gene proﬁle compared to the reference.
After an incubation time of 1 h, some genes were already signiﬁcantly up-regulated (ﬁg. 3.9).
After 6 h and more pronounced after 12 h, Au1.4MS had induced an oxidative stress response.
35 genes showed an enhanced expression. These were mainly heat shock and stress related
genes. On the other hand, several cell cycle related genes were down-regulated. In contrast,
the non-toxic Au15MS did not induce a strong reaction towards the gene regulation for any
incubation time.
The results show that the cytotoxicity of Au1.4MS is not primarily based on a DNA interac-
tion, leading to a direct transcriptional inhibition, as some genes are up-regulated within the
time frame of the experiment. However, an interaction with DNA at a later date cannot be
excluded from these results. Also, the ﬁndings are in agreement with the fact that Au1.4MS
induces mainly necrosis.
3.4.3 Oxidative Stress
As mentioned above, the generation of ROS is an often discussed topic concerning the
toxicity of nanoparticles. To investigate if this holds true for AuNPs as well, an-
other ﬂow cytometry experiment was performed. Here, 5-(and-6)-chloromethyl-2',7'-
dichlorodihydroﬂuorescein diacetate, acetyl ester (CM-H2DCFDA) was used as a staining
reagent. This ﬂuorescein derivative has two acetate groups and shows no ﬂuorescence in its
reduced form. In the presence of ROS, CM-H2DCFDA is oxidized, the acetate groups are
cleaved and the ﬂuorescence of the reaction product is detectable (ﬁg. 3.10).
HeLa cells were incubated for 48 h with 1000µM of Au1.1GSH and Au15MS, respectively.
Au1.4MS was applied in a lower concentration of 100µM with increasing incubation times
(6, 12, 18, 24, and 48 h, respectively). Untreated cells were analyzed as negative control,
and 30min incubation with 0.3% H2O2 served as positive control for oxidative stress.
The ﬂuorescence curves (see ﬁg. 3.11) clearly show that Au1.4MS causes oxidative stress in
HeLa cells in a time-dependent manner. The non-toxic AuNPs Au1.1GSH and Au15MS
on the other hand do not induce ROS formation although applied in 10-fold higher con-
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Figure 3.9: Gene chip results. Vertically ordered rows: genes with distinct expression
proﬁles. The boxes show (in duplicate) from right to left: expression
proﬁle of control (G); after incubation with Au15MS after 1 (F), 6 (E)
and 12 h (D), and Au1.4MS after 1 (C), 6 (B) and 12 h (A), respectively,
compared with the median expression level of the gene's transcript for all
samples shown. Blue: below median; white: equal to median; red: above
median.[123]
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Figure 3.10: Reaction of CM-H2DCFDA to its ﬂuorescent derivative. This reaction
is used to indicate the presence of ROS.
Figure 3.11: Flow cytometry results, plotted as one-parameter histograms, of cells
incubated with Au1.4MS, Au15MS and Au1.1GSH and stained with
CM-H2DCFDA.
Green: untreated HeLa cells (no oxidative stress). Pink: HeLa cells
treated with 0.3% H2O2 for 30min (strong oxidative stress). Violet:
HeLa cells treated for 48 h with 1000µM Au15MS. Orange: 1000µM
Au1.1GSH. All others: HeLa cells treated with 100µM Au1.4MS for 6
(medium blue), 12 (dark blue), 18 (yellow), 24 (light blue), and 48 h
(light orange), respectively.[123]
47
3 Results and Discussion
centrations. This result is a hint that the cytotoxicity of Au1.4MS is related to oxidative
stress.
Unfortunately, this result is ambiguous as it is also possible that the detected oxidative
stress is an indirect secondary eﬀect of the necrosis that Au1.4MS deﬁnitively induces. The
diﬀerent sources for nanoparticle related oxidative stress were also discussed by Krug et al.:
the direct generation of ROS at the nanomaterial surface or a catalytic eﬀect of transition
metals, damage of mitochondria and thereby a disturbance in the respiratory chain, or an
increased ROS level induced by the activation of macrophages or neutrophiles.[5]
The eﬀect of anti-oxidants towards the cytotoxicity of Au1.4MS was investigated.
N -acetylcysteine (NAC), GSH, TPPMS and ascorbic acid were used (NAC in 3mM; GSH,
TPPMS, and ascorbic acid in 1mM concentrations). The chemical structures and IUPAC
names are shown in ﬁg. 3.12.
Figure 3.12: The four anti-oxidants tested for their inhibition potential of Au1.4MS
toxicity.
Diﬀerent incubation schemes were followed: either the HeLa cells were pre-incubated with
anti-oxidants and subsequently with 100µMAu1.4MS (with (C) or without interjacent wash-
ing (E)), or Au1.4MS was pre-treated with anti-oxidants and added immediately (F) or after
3 h (D) to cells. The eﬀects of the pure anti-oxidants was also tested (G).
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Figure 3.13: Eﬀect of diverse anti-oxidants towards cytotoxicity of Au1.4MS.
A: untreated reference. B: positive reference (100µM Au1.4MS). C: cells
pre-incubated with anti-oxidants, washed, incubated with Au1.4MS.
D: Au1.4MS pre-incubated with anti-oxidants (3 h), mixture added to
cells. E: cells pre-incubated with anti-oxidants, no washing step, incu-
bated with Au1.4MS. F: Au1.4MS pre-mixed with anti-oxidants, mixture
added to cells immediately. G: pure anti-oxidants.[123]
As can be seen in ﬁg. 3.13, NAC and GSH can protect the cells from the toxic impact of
Au1.4MS if the AuNPs are pre-incubated with the anti-oxidants (D, F) or if those are present
in the cell culture medium when the AuNPs are added (E). TPPMS has the same tendency,
but with lower eﬃcacy. A pre-incubation with subsequent washing of the cells does not
inﬂuence the toxicity of Au1.4MS (C). This points to an interaction of the anti-oxidants
with Au1.4MS, not with the cells. This interaction could be a direct ligand exchange as
shown before (3.3), or an indirect interaction by capturing and neutralizing the ROS that
are potentially generated and related to the AuNP toxicity.
Ascorbic acid on the other hand does not have a protecting eﬀect. NAC and GSH as thiols
and TPPMS as a phosphine have functional groups with high binding aﬃnities to the AuNP
surface. This is not the case for ascorbic acid, as its OH groups have only weak aﬃnity
towards gold. It is therefore likely that a direct interaction of NAC, GSH and TPPMS with
the AuNP surface is responsible for the reduced toxicity. A ligand exchange with GSH was
already shown (see 3.3). NAC will probably react in the same way with AuNPs. TPPMS
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will either build a closer packed ligand shell around the particles, or an excess of TPPMS
inﬂuences the desorption equilibrium in solution and leads thereby to a less accessible AuNP
surface. Ascorbic acid cannot attach strongly onto the AuNP surface and has therefore no
eﬀect in this experiment.
3.5 EPR Spectroscopy with AuNPs
One hypothesis concerning the toxicity mechanism of nanomaterials states that the gener-
ation of ROS plays a key role. This is related to the ability of AuNPs to catalyze oxidation
reactions (chapter 2.1.2.3). Likewise the ﬁndings about the cytotoxicity of AuNPs, their
catalytic activity is often related to size and functionalization. The former, the AuNP size,
determines the number of active surface atoms per particle, especially activated edge and
vertex atoms. The ligand shell chemistry aﬀects the accessibility and the chemical and
therefore catalytic activity of these surface atoms. Corresponding to toxicity, small AuNPs
with weakly bound ligands are potentially more active to generate toxic oxygen radicals
than larger particles or particles with inactivating, strongly bound ligands.
The ﬁndings of Turner et al. that especially Au55[(C6H5)3P]12Cl6 is more potent than other
AuNPs in the oxidation reaction of styrene to benzaldehyde enforced the hypothesis that the
strong cytotoxicity of Au1.4MS could be based on the generation of ROS.[29] The general
correlation between oxidative stress and AuNP toxicity could be shown with the substrate
CM-H2DCFDA (3.4.3), although it is here not possible to diﬀerentiate between primary
ROS generation and subsequent cell death or ﬁrstly induced necrosis and, as a secondary
eﬀect, related increase of oxidative stress in dying cells (see ﬁg 3.14).
One way to analyze the potential catalytic activity towards oxidation reactions of AuNPs
is the reaction with a stable radical substrate and the analysis by EPR spectroscopy.[78]
According to the experiments of Zhang et al., 4-Amino-2,2,6,6-tetramethylpiperidine-1-oxyl
(Amino-TEMPO), a stable radical, was used as a substrate for an indirect detection of
ROS. It can catalytically be oxidized to the also EPR active 4-Oxo-2,2,6,6-tetramethyl-1-
piperidinyloxy (Oxo-TEMPO) (reaction scheme in ﬁg. 3.15).
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Figure 3.14: Scheme depicting the possible pathways related to oxidative stress in-
duced by AuNPs, as a primary (left) or secondary (right) eﬀect in the
cell. Both pathways might include a ligand stripping step.
Figure 3.15: Oxidation reaction of Amino-TEMPO to Oxo-TEMPO.
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Figure 3.16: EPR spectra of Amino-TEMPO solutions with diﬀerent concentrations
of Au15Citrate. Light blue: Amino-TEMPO reference; blue: 5.8mM;
gray: 2.9mM; green: 1.16mM; black: 0.58mM.
Concentrated solutions of Au15Citrate, Au15MS, Au1.4MS and Au1.5GSH were saturated
with O2 or Ar, respectively. The oxidation reaction of Amino-TEMPO to Oxo-TEMPO
should be inhibited in the samples prepared under Ar atmosphere, the saturation with O2
should on the other hand facilitate the reaction. The prepared AuNP solutions were mixed
with equally treated saturated stock solutions of Amino-TEMPO at moderately basic pH,
and the amounts of detectable Amino-TEMPO were determined by EPR spectroscopy.
Interestingly, in diﬀerence to the ﬁndings of Zhang et al., in none of the experiments a
generation of Oxo-TEMPO was observed. The eﬀects under oxygen and argon atmosphere
were very similar. From the four AuNP species tested, only Au15Citrate was able to quench
the EPR signal of Amino-TEMPO (see ﬁg. 3.16).
This points to an adsorption of the Amino-TEMPO molecules onto the AuNP surface. In
this manner, the unpaired electron of the radical may interact with the electron pool of the
metallic nanoparticle, and therefore the radical character of Amino-TEMPO is lost and it
is not detectable in the EPR anymore. As can be seen in ﬁg. 3.16, the quenching potential
of Au15Citrate is concentration dependent. In the lowest concentration of approximately
0.58mM (black curve in ﬁg. 3.16), the characteristic features of the EPR spectrum of Amino-
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Figure 3.17: Sample of Au15Citrate with Amino-TEMPO, measured directly after
mixing (brown) and after 24 h (blue).
TEMPO are still visible, although already with considerably lower signal intensity. In higher
AuNP concentrations, the signal is completely quenched. Moreover it was observed that the
signal of Amino-TEMPO in a sample further decreased over longer periods of time. A sample
that was left at room temperature for 24 h and was measured again showed a further drop
in signal intensity to approximately 20% of the original intensity, indicating a continued
slow adsorption (ﬁg. 3.17).
All other AuNPs behaved diﬀerently in the experiments (ﬁg. 3.18). The Amino-TEMPO
signal was not quenched at all by Au15MS, Au1.4MS and Au1.5GSH, not even at concen-
trations of 8.2mM (Au15MS), 4.7mM (Au1.4MS) and 5.4mM (Au1.5GSH), respectively.
The results under oxygen and under argon atmosphere were identical. This ﬁnding indi-
cates that the accessibility of the AuNP surface plays a crucial role for the Amino-TEMPO
adsorption. In the case of citrate which is the weakest ligand in this set of AuNPs, Amino-
TEMPO can interact with the AuNP surface, probably via its amino function as amines are
known to act as AuNP ligands as well. Possibly, the Amino-TEMPO replaces the citrate
from the AuNP surface and becomes thereby EPR inactive. In case of TPPMS- or GSH-
stabilized AuNPs, the ligands bind more strongly to the AuNP surface and a reaction with
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Figure 3.18: EPR spectra of samples of Amino-TEMPO with diﬀerent AuNP species
(blue: Au15Citrate (2.3mM), red: Au15MS (8.2mM), orange: Au1.4MS
(4.7mM), gray: Au1.5GSH (5.4mM)).
Amino-TEMPO is inhibited. A reference experiment with pure citrate was performed to
exclude any reaction between citrate and Amino-TEMPO. Here, the Amino-TEMPO was
detectable without any quenching.
A set of experiments, under the same conditions as the previously performed ones but
with the addition of Oxo-TEMPO instead of Amino-TEMPO, was conducted. The results
were comparable to the Amino-TEMPO experiments: Au15Citrate was able to quench the
radical, the other AuNPs had no inﬂuence on the signal intensity. Obviously, the oxo
function of Oxo-TEMPO, or the tertiary amine, or both in a concerted way, may interact
with the AuNP surface of weakly stabilized AuNPs. This diﬀers from the results found
by Zhang et al., who proposed that Oxo-TEMPO interacts less strongly with AuNPs than
Amino-TEMPO and becomes therefore detectable after an oxidation reaction of Amino-
TEMPO with AuNPs.
The results from EPR spectroscopy show an interaction of Amino-TEMPO only with
Au15Citrate, probably as an adsorption, but not necessarily an oxidation reaction. As
it was found that Oxo-TEMPO is quenched by Au15Citrate as well, this question cannot
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be answered by EPR spectroscopy. The results from the experiments performed under O2
and Ar atmosphere are comparable. This points noticeably to an adsorption rather than an
oxidation reaction.
Furthermore, it is obvious that the reactivity of diﬀerent AuNPs with Amino-TEMPO does
not correlate with their cytotoxicity. This is in opposition to the hypothesis that primary
ROS generation plays a crucial role in the toxicity mechanism of Au1.4MS.
3.6 Genotoxicity Studies
The cytotoxicity of AuNPs is possibly related to the blockade and/or damage of important
cellular structures. Besides potential contact points such as the cell membrane, proteins,
enzymes or organelles like the mitochondria, another possible target of such an interaction
is DNA. Conﬂicting conclusions can be drawn from the so far discussed results. A cell frac-
tionation experiment with BLM cells, treated with Au1.4MS and subjected to subsequent
neutron activation analysis (NAA) showed a gold content of 42.5% in the nuclear fraction
with 21.1± 2.9% bound to DNA.[8] A possible interaction of Au1.4MS with the major
groove of the DNA backbone was proposed. On the other hand, the gene chip analysis (see
chapter 3.4.2) revealed predominantly up-regulation of a number of genes after AuNP incu-
bation. This controverts a full blockade of DNA transcription, i. e. the immediate inhibition
of transcription activity.
Further experiments were necessary to answer the question of AuNP induced genotoxicity.
An elegant method to determine DNA damage is the GC/MS analysis of DNA, more pre-
cisely the detection and quantiﬁcation of oxidized DNA bases.[98]
Two sets of samples were prepared by Dr. Yu Pan-Bartneck (UKA). HeLa cells were in-
cubated for 3, 24, and 72 h with three diﬀerent AuNP species, respectively: Au1.4MS,
Au15MS and Au1.1GSH. Afterwards, the DNA was extracted from the cells (see ﬁg. 3.19).
Furthermore, the same AuNPs and incubation times were applied on pure DNA which was
previously extracted from HeLa cells.
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Figure 3.19: Scheme of sample preparation for genotoxicity studies (sample set 1).
HeLa cells were incubated with AuNPs, DNA was extracted, isotopically
labeled DNA oxidation products were added, and after further treat-
ment the concentrations of DNA oxidation products were determined by
GC/MS.
The further treatment of the samples and the GC/MS measurements were conducted at the
National Institute of Standards and Technology (NIST; Gaithersburg, MD, USA), together
with Dr. Bryant Nelson and Dr. Elijah Petersen.
Deﬁned amounts of isotopically labeled derivatives of seven typical oxidation products
(lesions) of DNA bases were added to the samples prior to an enzymatic digestion of the
DNA (all lesions that were investigated are shown in ﬁg. 3.20). The samples were analyzed
by GC/MS, and the amounts of lesions could be quantiﬁed by comparing the integrals of
the gas chromatography peaks of the lesion and the respective isotopically labeled species.
In the case of oxidative damage of DNA induced by AuNPs, a signiﬁcant increase of one or
several lesion concentrations compared to the reference samples was expected. Interestingly,
in the ﬁrst set of samples (the incubated cells), the concentrations of the lesions FapyAde
and FapyGua were signiﬁcantly decreased by Au1.4MS and Au1.1GSH (ﬁg. 3.21). This was
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Figure 3.20: The DNA oxidation products (lesions) that were examined by GC/MS
in DNA samples from HeLa cells, incubated with AuNPs.
constant over all time points. The concentrations of the other lesions investigated were not
altered signiﬁcantly. Also, Au15MS had no measurable eﬀect at any time point.
These ﬁndings were surprising for two reasons: No lesion concentration was increased, as
was expected before; instead, two lesions were depleted. Furthermore, Au1.1GSH behaved
similarly as Au1.4MS, although the two AuNP species have completely diﬀerent cytotoxicity
proﬁles. A distinction of FapyAde and FapyGua from the other lesions can be explained by
the formation mechanism of these two lesions.
Generally, DNA bases are attacked by a ROS, typically the ·OH radical. The thus formed
base radical can further react in diﬀerent ways. For FapyAde and FapyGua, the second
reaction step is a one-electron reduction, either preceded or followed by a ring opening. This
one-electron reduction is unique for these two lesions and might be the impaired reaction
step.[99]
The second sample set on the other hand, the samples of DNA incubated directly with
AuNPs, did not show any signiﬁcant change, irrespective of the AuNP species or the in-
cubation time (ﬁg. 3.22). No lesion concentration was increased which would have pointed
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Figure 3.21: Lesion concentrations from the ﬁrst sample set (HeLa cells). Each lesion
point consists of four values: untreated reference (purple), cells treated
with Au1.4MS (green), Au15MS (blue), and Au1.1GSH (light blue; all
AuNPs applied in 50µM, respectively). The three graphs depict three
incubation times (3; 24; 72 h). For 72 h, 5OHUra and TG are not de-
picted because the GC/MS data were not integrable.
Results were statistically analyzed by analysis of variance (ANOVA).
P values: < 0.001: Extremely signiﬁcant ∗∗∗. 0.001 to 0.01: Very signif-
icant ∗∗. 0.01 to 0.05: Signiﬁcant ∗. >0.05: Not signiﬁcant.
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Figure 3.22: Results from second sample set (extracted DNA treated with AuNPs).
Each lesion point consists of four values: untreated reference (purple),
DNA treated with Au1.4MS (green), Au15MS (blue), and Au1.1GSH
(light blue; all AuNPs applied in 50µM, respectively). The three graphs
depict three incubation times (3; 24; 72 h). Results were statistically
analyzed as in ﬁg. 3.21.
to a catalytic oxidation eﬀect by AuNPs; also, no decrease of FapyAde and FapyGua was
found as in the case of incubated cells.
All samples should be further investigated by the more sophisticated LC/MS/MS method.
Besides a diﬀerent separating step (liquid chromatography (LC) instead of gas chromato-
graphy (GC)), in LC/MS/MS either two mass spectrometry units are connected in series, or
ion traps are included. Ions can be separated and speciﬁcally further ionized and analyzed.
Fragmentation patterns can thus be investigated in detail.
However, no clear results were received. As these measurements were performed several
months after the GC/MS investigations and the samples were stored in the freezer (T =
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−20 ◦C) in between, but exposed to air, it is very probable that the samples had been
altered during storage. The results from these measurements were therefore discarded and
not further interpreted.
From the ﬁndings of the GC/MS measurements, no direct correlation between the results
and the AuNP cytotoxicity can be found, as Au1.4MS and Au1.1GSH give similar results
despite their diﬀerent cytotoxicities. Some hypotheses regarding these surprising results can
be discussed:
The catalytic properties of AuNPs were already discussed before. As such reactions on the
AuNP surface depend on the chemical equilibrium, under certain conditions it is conceivable
that the back reaction takes place. In the case of a relatively high concentration of radicals,
the AuNPs could potentially capture these and catalyze a reaction to less reactive species.
However, a correlation between toxic eﬀects and catalytic activity of AuNPs could not been
shown in other experiments. Also, there is no reason why two out of seven investigated
lesions should preferentially be protected from oxidative damage.
Another concept is a protecting interaction of AuNPs with DNA. A preference towards
certain lesions could then stem from a stronger interaction of the AuNPs with the respective
bases; but this hypothesis does not explain why the AuNPs did not have the same eﬀect on
the second sample set of pure DNA.
The third scenario is the enhanced activity of DNA repair enzymes. This can either happen
via an activation of present enzymes through some kind of interaction of the AuNPs with
these enzymes, or as an up-regulation of transcription of certain enzymes induced by the
AuNPs. This would explain why the whole cells incubated with AuNPs showed signiﬁ-
cantly altered lesion concentrations whereas the pure DNA without repair enzymes present
and without ongoing transcription did not show the same eﬀects. Furthermore, there are
base speciﬁc DNA repair enzymes which would account for the decrease of only two of the
examined lesions.
One example of a purine speciﬁc DNA repair enzyme is encoded by the nei endonuclease
VIII-like 1 gene and therefore abbreviated as NEIL1.[124] The results from the gene chip
analysis (see chapter 3.4.2) showed no up-regulation for NEIL1. However, it is possible that
the AuNPs do not induce enhanced transcription but an enzyme activity enhancement.
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Further experiments were therefore conducted at NIST. Two sample sets were generated:
the enzyme NEIL1 was pre-incubated with Au1.4MS and then added to DNA. Here, γ-ray
irradiated calf thymus DNA (ct-DNA) with an artiﬁcially increased number of lesions was
used. In the second set, AuNPs and ct-DNA were pre-incubated and NEIL1 was added in
a second step. An excision assay was performed, i. e. the supernatants of the samples were
analyzed by GC/MS for lesion concentrations of FapyAde and FapyGua.
If NEIL1 was activated by the presence of Au1.4MS, the concentrations of FapyAde and
FapyGua should be increased in the supernatant. Interestingly, the opposite was the case.
In the ﬁrst sample set, both Fapy lesion concentrations were decreased compared to the
reference. This points towards a deactivation of NEIL1 by the AuNPs which does not occur
when the order of incubation is inversed and the reaction time between AuNPs and NEIL1
is short.
In general, a deactivation of a repair enzyme by cytotoxic AuNPs is not surprising, as ad-
verse eﬀects on biological materials are expected. Here, NEIL1 was one candidate to explain
the surprising results from the ﬁrst GC/MS experiments on cells incubated with AuNPs.
Obviously, this enzyme is not aﬀected in a stimulating way by AuNPs to enhance DNA re-
pair. As there are numerous DNA repair enzymes with diﬀerent lesion repair patterns, other
enzymes should be investigated in the same way as NEIL1 to potentially ﬁnd a candidate
which can be activated by AuNPs. Other potential enzyme candidates include NEIL3, Fpg,
Ogg1 and Nth.
3.7 The Au(I) Question
As another reference material for the cytotoxicity experiments, a gold(I) complex, the
sodium salt of chloro[diphenyl(3-sulfonatophenyl)phosphine]gold(I) (referred to as TPPMS-
Au(I)-Cl afterwards), was tested. It was found that this Au(I) species is highly cytotoxic
as well (IC50=50µM in HeLa cells in the logarithmic phase). This raised the question if
the cytotoxicity is predominantly based on the toxicity of Au(I) species and not the AuNPs
themselves. A similar mechanism is in discussion concerning the toxicity of silver nanopar-
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ticles (AgNPs).[125] AgNPs possibly serve as a source for constant Ag+ ion release which
then cause toxicity.
Furthermore, the equilibrium between AuNPs, phosphine ligands and Au(I) species was
investigated by Sharma et al.. They performed extensive NMR studies on 1.8 nm sized
TPP-stabilized AuNPs in CH2Cl2. They found that both TPP and a TPP-Au(I)-Cl species
can be released from the AuNP surface.[72] In H2O, a polar solvent, and with TPPMS the
situation might though be diﬀerent.
Hence, it was important for two reasons to investigate if there are Au(I) impurities in the
Au1.4MS material: ﬁrstly, to ﬁnd out whether the cytotoxicity of Au1.4MS was based on
Au(I) and not on a nanoparticle speciﬁc eﬀect, and secondly, to certify the purity of the
synthesized Au1.4MS in general.
By comparing the IC50 values of Au1.4MS (IC50 = 46µM) and TPPMS-Au(I)-Cl it becomes
obvious that Au1.4MS would have to be degraded completely to Au(I) species to induce such
a toxic eﬀect. This is deﬁnitely not the case, as the cell culture solutions are still colored
brown from the Au1.4MS after the incubation time, whereas TPPMS-Au(I)-Cl is colorless.
The AuNPs could also be found in TEM micrographs of incubated cells, although a size
determination was not possible due to the low contrast of the AuNPs in the biological
matrix.[12] The relation between Au1.4MS and TPPMS-Au(I)-Cl was further investigated
nevertheless to exclude any side eﬀects.
Au1.4MS is synthesized via Au1.4TPP, whose precursor is the water-insoluble chlorotri-
phenylphosphine gold(I) (TPP-Au(I)-Cl), and a subsequent two-phase ligand exchange re-
action. Therefore, no water-soluble Au(I) species should be present as an impurity remaining
from the synthesis precursor. However, as discussed above, it is possible that Au(I) impuri-
ties might be present in AuNPs. These might originate from degradation processes taking
place when AuNPs remain in solution over longer periods of time.[126]
NMR spectroscopy was used for this purpose to examine Au1.4MS. A 31P-NMR spectrum
of a concentrated solution of Au1.4MS in D2O gave signals at δ = 15.6 ppm, 33.0 ppm,
37,5 ppm, 45.7 ppm (major signal), 55.4 ppm and 58.0 ppm (ﬁg. 3.23). Not all signals could
be assigned, but obviously impurities are present. The material was further puriﬁed.
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Figure 3.23: 31P-NMR spectrum of Au1.4MS in H2O.
After column chromatography over cellulose with ethanol and H2O (4:1), the product was
measured in a mixture of deuterated methanol and D2O. Three signals remained (slightly
shifted due to diﬀerent solvent: 33.9 ppm, 45.3 ppm, 57.2 ppm), but the integrals and thus
the concentrations were aﬀected (ﬁg. 3.24). The signal at 45.3 ppm is still the signal with
highest intensity (approximately 77%), and the other two remaining signals are of minor
intensity.
TPPMS-Au(I)-Cl gives a 31P-NMR signal at 32.1 ppm in this solvent mixture. Free TPPMS
results in a signal at −6 ppm and is not visible at all. On the other hand, TPPMS in
aqueous solution is prone to oxidation, and the oxidation product of TPPMS, sodium 3-
(diphenylphosphoryl)benzenesulfonate (abbreviated as TPPMS=O), shows a 31P-NMR sig-
nal at 36.5 ppm. It shows very low cytotoxicity (IC50=4677µM). The three species are
shown in ﬁg. 3.25.
The signal at 45 ppm refers to the TPPMS ligand molecules bound to AuNPs of 1.4 nm
diameter. It is slightly broadened. One reason for this broadening is that the 12 TPPMS
molecules are weakly bound via a coordinative bond. This leads to ligand mobility on the
AuNP surface and thus structural ﬂexibility when the AuNPs are in solution, resulting in
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Figure 3.24: 31P-NMR spectrum of Au1.4MS after column chromatography, mea-
sured in deuterated methanol/D2O (1:1).
Figure 3.25: The species possibly detected in 31P-NMR spectra of Au1.4MS: the
ligand TPPMS, its oxidation product TPPMS=O and potentially
cleaved TPPMS-Au(I)-Cl.
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a broadened signal 31P-NMR spectroscopy. From this spectrum, it is not deﬁnitely deter-
minable which species causes the signal at 33.9 ppm, TPPMS=O or the Au(I) complex,
or if signals of both species overlap here. The signal at 57.2 ppm is probably caused by
small phosphine-stabilized gold clusters. A signal for free TPPMS which would be visible
at −6 ppm is not seen at all.
It is possible to purify Au1.4MS by column chromatography. The IC50 value for such puriﬁed
material was similar to non-puriﬁed Au1.4MS judged by MTT assays in HeLa cells. The
cytotoxicity therefore most likely was due to the Au1.4MS proper and not to low molecular
weight impurities.
In none of the 31P-NMR spectra of Au1.4MS, free TPPMS was detected. This was surprising
as the TPPMS molecules are weakly bound to the AuNP surface and are expected to be
in equilibrium to free TPPMS in solution. On the other hand, studies of the non-water
soluble derivative Au1.4TPP have shown that the addition of excess TPP does not lead to
the detection of free TPP in the 31P-NMR spectrum, but to a high ﬁeld shift of the signal
of Au1.4TPP.[71]
It was therefore investigated if Au1.4MS in aqueous solution shows the same eﬀect in reaction
with TPPMS. Au1.4MS was dissolved in D2O and measured in 31P-NMR. 10 eq of TPPMS
were added and another measurement was performed. This was repeated up to a total
amount of 118 eq TPPMS. As in the case of Au1.4TPP, a high ﬁeld shift of the Au1.4MS
signal was observed, and no free TPPMS was visible even in the highest amount added (see
ﬁg. 3.26).
The high ﬁeld shift of the spectra was used to perform a ﬁrst-order estimation of the equi-
librium constant for the Au1.4MS/TPPMS system. The δ values were plotted against the
concentration of additional TPPMS and approximated with a logarithmical ﬁt (ﬁg. 3.27).
From this, the amount of intrinsic free TPPMS (cdiss) was estimated, and the amount of
bound TPPMS (cass) was calculated from the original sample weight with the assumption
of 12 ligand molecules per particle. With these two values, a dissociation constant Kd of
4.76× 10-7 was calculated:
Kd =
cdiss
cass
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Figure 3.26: 31P-NMR spectra of Au1.4MS with subsequent TPPMS addition. Sig-
nals at 36.5 ppm derive from TPPMS=O.
Figure 3.27: Plot of chemical shifts δ of the 31P-NMR spectra of Au1.4MS depending
on the addition of TPPMS.
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With Kd, a Gibbs energy of ∆G0=35.5 kJ/mol was calculated:
∆G0 = −RTlnKd
The bond strength theoretically determined for PH3 by Häkkinen et al. was 0.93 eV, which
equals to 89.7 kJ/mol.[44] The value determined by 31P-NMR spectroscopy is thus signiﬁ-
cantly lower. In the theoretical calculations, solvation eﬀects were not taken into account.
Also, PH3 is only a simple model for a phosphine ligand and not directly comparable to the
bulkier and charged TPPMS.
The question remained if the detected TPPMS-Au(I)-Cl was present in the as synthesized
material, or if it was generated in solution. Thus, a sample of Au1.4MS was investigated
by solid state 31P-NMR spectroscopy. A static measurement resulted in one very broad
signal ranging from −100 ppm to 200 ppm without further signiﬁcant characteristics and
ﬁne structures (ﬁg. 3.28, bottom).
Next, it was measured under magic angle spinning (MAS) conditions at frequencies of 15
and 35 kHz (ﬁg. 3.28,middle and top spectra, red). Here, the signal became narrower, but
was still ranging from approximately −40 ppm to 120 ppm at a MAS frequency of 35 kHz.
The MAS spectra reveal that the broad peak consists of at least three overlapping signals
with an absolute maximum at δ=20ppm. 1H decoupling did not inﬂuence the spectrum
measured with a MAS frequency of 15 kHz (ﬁg. 3.28,middle spectrum, green).
Furthermore, a sample of TPPMS-Au(I)-Cl was analyzed in a reference measurement (MAS
with 15 kHz; ﬁg. 3.28,middle spectrum, blue). It gave a considerably narrower signal than
Au1.4MS, with a maximum at δ=10ppm. By superimposing the spectra of Au1.4MS and
TPPMS-Au(I)-Cl it is obvious that the signal of the Au(I) complex has the same chemical
shift as one of the three signals in the spectrum of Au1.4MS, visible as a shoulder of the
main signal.
It is not clear what causes this shoulder in the Au1.4MS spectrum. It is possible that
TPPMS-Au(I)-Cl exists as a molecular species independently besides Au1.4MS and that it
was formed as the result of a degradation reaction during the synthesis of Au1.4MS. Another
possibility is that TPPMS molecules bound to partially polarized Au surface atoms of a
AuNP have a similar electronic environment as TPPMS in TPPMS-Au(I)-Cl and therefore
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Figure 3.28: Solid state 31P-NMR spectra, static (top) and with MAS frequencies
of 15 (middle) and 35 kHz (bottom), from Au1.4MS (red), Au1.4MS
measured with 1H decoupling (green, with MAS at 15 kHz), and
TPPMS-Au(I)-Cl (blue, with MAS at 15 kHz). Stars indicate rotational
side bands in MAS measurements.
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Figure 3.29: Scheme of dialysis experiments of Au1.4MS (left) and TPPMS-Au(I)-Cl
as reference (right). The dried dialysates were analyzed by EDX analysis.
give a signal at the same chemical shift. From this data, no ﬁnal conclusion can be drawn
concerning this question. A quantiﬁcation of the three overlapping signals of the spectrum
of Au1.4MS by a line shape analysis could not be performed without considerable eﬀort and
was therefore not conducted.
To ﬁnally answer the question if signiﬁcant amounts of TPPMS-Au(I)-Cl are present in
aqueous solutions of Au1.4MS, another analysis method was chosen. A dialysis experiment
with Au1.4MS was conducted (ﬁg. 3.29).
The supernatant was dried and the resulting white residue was examined by energy disper-
sive X-ray (EDX) analysis. The EDX spectrum indicates that small amounts of TPPMS
were shed from Au1.4MS during the dialysis, but no gold could be found. The control exper-
iment with TPPMS-Au(I)-Cl showed that Au(I) (in whatever form) could readily traverse
the dialysis membrane with a molecular weight cut oﬀ radius (MWCO) of 5 kD, as a signal
for gold was found in the EDX spectrum of the white residue of this experiment.
This experiment shows that no TPPMS-Au(I)-Cl as an independent species is present in
Au1.4MS in signiﬁcant amounts. The contradictory results from the NMR investigations
may be due to chemical compounds with similar chemical environments adsorbed to AuNPs.
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3.8 Patch Clamp Experiments
In order to explore the eﬀect of smaller particles, particularly of Au1.4MS on hERG express-
ing HEK 293 cells, patch clamp experiments were performed with a variety of phosphine-
and thiol-stabilized AuNPs and ionic gold complexes, serving as reference materials. Parts
of these results were already described in the dissertation of Dr. Yu Pan-Bartneck.[12]
HEK 293 cells transfected with the hERG gene were used in a manual patch clamp set-up.
They were patched in whole-cell conﬁguration to detect the whole cell membrane potential
(ﬁg. 3.30). In the voltage protocol used the hERG channel was opened for 2 s, expressing
the typical tail current characteristics. The maximum amplitude serves as a measure for
decrease of the cell membrane voltage and therefore an inactivation of hERG.
Figure 3.30: Schematic patch clamp setup of a cell in whole-cell conﬁguration. Blue:
hERG ion channels.
First, 65µM Au1.4MS was applied to a patched cell. After a response time of approximately
2min, the hERG current amplitude decreased signiﬁcantly (ﬁg. 3.31). Compared to other
well-known molecular hERG blockers such as ﬂuvoxamin, this onset is quite slow.[127]
The eﬀect was irreversible, i. e. when the cell was perfused with extracellular buﬀer (EC)
after the Au1.4MS incubation, the amplitude remained at its low level and did not recover
to its original value.
The time scale of a typical patch clamp experiment is in the range of minutes up to a
maximum of one hour, and the ﬁrst detectable changes occur within a few minutes. The
70
3.8 Patch Clamp Experiments
(a)
(b)
Figure 3.31: Current response of a hERG expressing cell in a patch clamp experiment
during perfusion with Au1.4MS.
(a) Time response of hERG current amplitude, detected during 2× per-
fusion of 65µM Au1.4MS on a patched cell in whole-cell conﬁguration
for 10min. Arrows indicate start (S) and end (E) of perfusion.
(b) hERG current before (red) and after (black) perfusion with Au1.4MS.
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Figure 3.32: Concentration dependent response of hERG towards Au1.4MS (3.1µM,
6.5µM, 16.25µM). Arrows indicate start (S), change (C) and end (E) of
perfusion.
cytotoxicity of Au1.4MS in an in vitro cell test typically appears after a time period in the
range of hours. The eﬀect towards hERG is thus not correlated to simply induced cell death,
but is probably caused by an interaction with the ion channel.
The concentration dependent behavior of Au1.4MS was investigated. Increasing concentra-
tions of Au1.4MS were applied. The amplitude was plotted against incubation time, and the
slope became steeper for higher concentrations (ﬁg. 3.32). The lowest concentration applied
was 3.1µM. Already at this concentration (a gold atom concentration of 3.1µM equals to
a particle concentration of 56 nM), a slight decrease of amplitude was detectable.
As Au1.4MS is stabilized by TPPMS, a triphenylphosphine, an aromatic interaction between
the aromatic residues within the hERG cavity and the phenyl rings is imaginable. Therefore,
the eﬀect of the TPPMS ligand alone towards hERG was tested (ﬁg. 3.33). At concentrations
in the same magnitude that was applied with the addition of Au1.4MS (12 TPPMS molecules
per particle consisting of 55 gold atoms; i. e. when 3µM Au1.4MS are applied, the TPPMS
concentration is approximately 0.65µM), no eﬀect was detected (up to 50µM). At a higher
concentration of 100µM, the amplitude decreased within one minute.
In contrast to the blockade of Au1.4MS, this eﬀect was reversible when the cell was washed
with EC afterwards. The blockade of TPPMS therefore obviously follows a diﬀerent mech-
anism than the irreversible blocking of Au1.4MS.
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Figure 3.33: HERG response towards TPPMS in increasing concentrations (10, 50,
100, 500µM). Arrows indicate change (C) and end (E) of perfusion. The
perfusion with 10µM TPPMS was started immediately (no arrow).
Furthermore, TPPMS was also applied intracellularly by applying it in the IC medium
via the patch pipette. Here, no eﬀect was measurable up to a concentration of 1mM
TPPMS. This indicates that the reversible blocking of TPPMS is related to an extracellular
interaction. Also, the blocking of Au1.4MS is obviously not related to an interaction of
hERG with TPPMS.
One possible mechanism for the blocking by Au1.4MS is the stripping of TPPMS in contact
with the cell and an interaction of the pure gold core with the hERG channel. To prove
this hypothesis, mixtures of Au1.4MS with a surplus of TPPMS in diﬀerent concentrations
were prepared and tested. At enhanced concentrations of free TPPMS, the equilibrium in
solution between bound and dissociated TPPMS should be altered. If the accessibility of
the gold core surface is crucial for the blocking mechanism of Au1.4MS, the addition of
excess TPPMS will make the particle surface less accessible.
When a cell was perfused with a mixture of 20µM Au1.4MS (a concentration that should
induce a distinct blockade) together with 50µM TPPMS, only a slight decrease in the
hERG tail current amplitude was detected (ﬁg. 3.34). This slight decrease was a lot slower
and less steep than the usual eﬀect and in a non-signiﬁcant scale. After 10min, another
mixture with a AuNP/TPPMS ratio of 20/25µM was applied to the cell. Again, no obvious
inﬂuence towards the hERG current was detectable. Only when the TPPMS concentration
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Figure 3.34: Eﬀect of mixtures of Au1.4MS (20µM) pre-incubated with varied con-
centrations of TPPMS (50, 25, 10µM). Arrows indicate start (S) and
change (C) of perfusion.
Figure 3.35: Patch clamp measurement during TPPMS application (50µM) and sub-
sequent Au1.4MS application (20µM). Arrows indicate start (S) and
change (C) of perfusion.
was further reduced and a pre-incubated mixture of 20µM Au1.4MS with 10µM TPPMS
was applied, the typical reduction of tail current amplitude was found.
In a control experiment, the order of addition was changed (ﬁg. 3.35). The patched cell was
pre-treated with 50µM TPPMS for 10min, and then 20µM Au1.4MS was applied. Here,
the blocking could not be prevented. A direct reaction between TPPMS and Au1.4MS is
necessary to inﬂuence the ion channel blockade.
In this experiment, the response time was slightly higher compared to Au1.4MS perfused
on a fresh cell. This can be explained by the excess TPPMS in the cell chamber that was
still present when the addition of Au1.4MS was started.
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Figure 3.36: Perfusion of a patched cell with Au1.4MS (300µM) + GSH (455µM).
Arrows indicate start (S) and end (E) of perfusion.
Furthermore, a mixture of 300µM Au1.4MS with 455µM GSH (ﬁnal concentrations, respec-
tively) was applied to a cell (ﬁg. 3.36). The tail current dropped slightly (23%), but did not
decrease further. After 20min of application the cell was washed with EC and the current
amplitude recovered to its starting value. This indicates again that the surface accessibility
is crucial for the blocking interaction of Au1.4MS. After the TPPMS ligands were replaced
by GSH, the resulting species does not cause a complete, irreversible blockade of hERG as
Au1.4MS does.
Au15MS should also be tested in patch clamp experiments. When the stock solution was
diluted with EC, the AuNPs were not stable in the medium. When 10% fetal calf serum
(FCS) was added to the EC prior to dilution, the AuNPs remained stable. This solution
was tested, but no eﬀect towards the hERG amplitude was detectable.
As a reference experiment, Au1.4MS (300µM ﬁnal concentration) was given to 10% FCS
containing EC and applied to a cell (ﬁg. 3.37). First, the cell was pre-treated with EC +
10% FCS which already induced a slight decrease in tail current amplitude to a stable value.
When Au1.4MS in EC + 10% FCS was added, diﬀering from the previous experiments, this
solution did not induce the expected blockade but the current amplitude remained constant.
It is likely that FCS forms a protein corona around both AuNP species and thereby alters
the interaction of AuNPs with the ion channel. This ﬁnding is however in contrast to the
cytotoxicity investigations, where Au1.4MS was found to be toxic in the presence of FCS.
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Figure 3.37: Eﬀect of 300µMAu1.4MS in EC containing 10% FCS; the ﬁrst arrow (S)
indicates the start of FCS (10%) perfusion. The other arrows indicate
change of sample (C) to Au1.4MS + 10% FCS and back to only 10%
FCS and end (E) of perfusion.
Figure 3.38: Thiol-stabilized AuNPs in patch clamp experiments, left: 300µM
Au1.1GSH, right: 300µM Aurovist. Arrows indicate start (S) and end
(E) of perfusion.
As Au15MS is not stable in EC without FCS it was not possible to investigate the pure size
eﬀect of diﬀerently sized TPPMS-stabilized AuNPs.
Two thiol-stabilized AuNP species were also tested: Au1.1GSH and Aurovist (both in a
concentration of 300µM). No eﬀect was detectable for both materials (ﬁg. 3.38). It can be
assumed that the gold cores of the AuNPs are too strongly shielded by the respective thiol
shell so that an interaction as in the case of Au1.4MS with its weaker bound phosphine
ligands is disabled.
Obviously, the size diﬀerence of 1.1 nm respectively 1.9 nm does not play a role here, but
the ligand shell determines the activity of AuNPs towards hERG.
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Various types of ion channels are blocked by metal ions if these are applied in high mi-
cromolar and millimolar concentrations.[128] To exclude this possible pathway of gold ion
blockade by potential impurities in the AuNP solutions, diﬀerent gold salts and complexes
were investigated.
Au(III)Cl3 was not stable in the EC. The yellow solution turned grayish-blue within minutes,
indicating the formation of large AuNPs. As the EC contains glucose, this may act as a
reducing agent for Au(III). If Au(III) ions would be present as an impurity in the AuNP
solutions, it can be supposed that they would react in the same way when diluted with EC.
Au(III) was therefore not further investigated.
TPPMS-Au(I)-Cl was also examined. For 50µM or 300µM solutions of Au(I) complex, the
cells became leaky immediately after the perfusion was started. This was reproducible in
several cells. No conclusion can thus be drawn about the interaction of TPPMS-Au(I)-Cl
with the hERG channel. The very rapidly induced leaking of the cells is however a diﬀerent
response than in the case of Au1.4MS. As it was found in the dialysis experiment (see chapter
3.7), obviously no signiﬁcant amounts of Au(I) were present in a solution of Au1.4MS, as
otherwise the AuNP solution should lead to leaky cells as well.
Another gold complex that was examined was Tauredon®. In the patch clamp experiment,
no eﬀect towards hERG could be found up to a complex concentration of 50µM.
Summarized, all gold salts and complexes tested gave a diﬀerent response in the patch clamp
experiment than Au1.4MS. The eﬀect of Au1.4MS on hERG is obviously not induced by
gold ions but by the nanoparticle species itself.
As already described, the hERG ion channel has a special structure and is very prone to
channel-drug interactions, mainly because of the aromatic residues Y652 and F656 and the
possibility of aromatic interaction with a variety of compounds. Thus, another ion channel
(NaV1.5) was investigated to check whether the blocking of Au1.4MS is speciﬁc to hERG.
NaV1.5 expressing CHO-K1 cells were used. The NaV1.5 channel has a distinct gating
behavior compared to hERG, leading to a diﬀerent response curve with a negative current
amplitude in the patch clamp experiment.
When a CHO-K1 cell was perfused with 300µMAu1.4MS, a strong decrease of the amplitude
was observed (ﬁg 3.39). Blocking of Au1.4MS is therefore not speciﬁc to hERG. As the
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Figure 3.39: Patch clamp experiment with a NaV 1.5 channel expressing CHO-K1
cell exposed to 300µM Au1.4MS. The arrow indicates the start (S) of
perfusion. Note that the compared to hERG expressing cells inverted
run of the curve is caused by the distinct gating behavior of NaV 1.5
channels.
NaV1.5 channel is, in contrast to hERG, not especially sensitive towards blocking by aromatic
molecules, this result is another hint that the blocking of ion channels by Au1.4MS is not
correlated to the aromatic residues inside the hERG cavity.
The investigation of the NaV1.5 channel revealed another eﬀect: the current curve showed an
impaired channel inactivation. A similar behavior occurs when NaV1.5 cells are incubated
with diﬀerent metal ions such as La3+ and Zn2+.[128] However, as discussed above, the
blocking eﬀect of Au1.4MS is not caused by released metal ions. Such an incomplete channel
inactivation points again towards an intracellular action of Au1.4MS. What exactly leads
to this eﬀect here is not yet known.
Most so far known hERG blockers are inner cavity blockers. This means that the channel
has to be in the open state to enable the blocking species to enter from the intracellular site.
This open channel block leads to the characteristic kinetic features of hERG blockade: upon
depolarization, the onset of channel blocking occurs quite fast, within some 100ms, while
the wash-out of blockers at hyperpolarized membrane potentials is extremely slow. In the
standard voltage protocol applied before, hERG is opened for 2 s. When a diﬀerent protocol
(the so-called envelope of tails-protocol) is used, it is possible to investigate whether a
species is an open channel blocker. The length of the opening time of the intracellular gate
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is varied and the tail current is elucidated by activating depolarization pulses with increasing
durations.
When 300µM Au1.4MS were applied during an envelope of tails-experiment, the typical
blockade of hERG could unexpectedly not be detected at all anymore. If the respective cell
was further perfused with Au1.4MS and the usual voltage protocol was conducted again, the
blockade occurred as expected. This points towards an intracellular blocking mechanism,
as for an extracellular event the channel opening would be no prerequisite.
Furthermore, the hERG ion channel has obviously to be opened long enough for Au1.4MS
to interact. There are two possible explanations for this phenomenon: either the diﬀusion of
Au1.4MS (or, in more general, the blocking species) into the ion channel is very slow com-
pared to other typical blocker molecules that were successfully investigated in an envelope
of tails-experiment; or the postulated stripping of the TPPMS ligands from the gold core
occurs only in direct interaction with the opened channel and is the rate-determining step.
In cooperation with Prof. W. Wenzel from Karlsruhe Institute of Technology (KIT), the
hERG structure as well as Au1.4MS were modeled and an interaction was investigated
theoretically by Monte Carlo simulations. A classical force ﬁeld was used for electrostatics,
hydrogen bonding, Lennard-Jones potential and implicit solvent interactions in a solvent
accessible surface model. The charges of Au1.4MS were calculated by DFT calculations.
Au1.4MS was modeled with varying numbers of TPPMS ligands (12, 10, 8,... 0 molecules
per particle). The hERG channel was based on a homology model with the crystal structure
of a K+ channel of the mammalian voltage-dependent Shaker family (pdb 2A79).
At pH 7.4 the hERG channel is negatively charged, and there is a repulsive interaction for
a Au55 cluster with 12TPPMS molecules which are also negatively charged. Hypothetical
AuNP structures with less ligand molecules on the surface show increasing aﬃnity towards
hERG (ﬁg. 3.40). This ﬁts well to the experimental ﬁnding that an excess of TPPMS hinders
Au1.4MS to block hERG.
Furthermore, the calculations exclude some potential points of binding. Au1.4MS will not
ﬁt into the inner cavity and will therefore not interact with the aromatic side chains as
most hERG blockers do. Further, it cannot bind near the entrance of the K+-passage at the
bottom of the extracellular channel side.
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Figure 3.40: Simulations of hERG (depicted in blue) in interaction with Au1.4MS
with varying numbers of TPPMS ligands: (a) pure gold core with-
out TPPMS ligands; (b) gold core with 6 TPPMS ligands; (c) gold
core with 12 TPPMS ligands. Best lowest energy conformations out of
500 simulations are shown. Models were provided by W. Wenzel, KIT.
The ligand functionalization of AuNPs, similarly as in the cytotoxicity experiments, de-
termines the response of ion channel expressing cells. 1.4 nm phosphine-stabilized AuNPs
block hERG channels in an irreversible manner, whereas thiol-stabilized AuNPs of similar
sizes have no eﬀect. It can be hypothesized that Au1.4MS strips its relatively weakly bound
TPPMS ligands and a partially unprotected AuNP or the pure gold core blocks the ion
channel irreversibly.
3.9 Other Monophosphine Ligands
As the ligand shell of a nanoparticle is the ﬁrst entity the cell gets in contact with, the
functionalities of the ligand molecules might play a crucial role in the cytotoxicity.[91] This
parameter should therefore also be investigated. The phosphine ligand needs charged groups
to guarantee water solubility. In the case of TPPMS, this is one sulfonate group per ligand
molecule. The pKA value of TPPMS was not determined, but the pKA value of the respective
acid H2SO4 is −3, the pKA value of a simple alkyl sulfonic acid, methanesulfonic acid
(CH3SO3H), is still very low (−0.6), and the pKA value of benzenesulfonic acid (C6H5SO3H)
is −2.8. Therefore it can be presumed that TPPMS also has a low pKA value and is
fully dissociated in aqueous solution, which results in one negative charge in the dissolved
state.[129, 130]
A simple modiﬁcation is the use of 3,3',3-phosphinidynetris(benzenesulfonic acid) trisodium
salt (triphenylphosphine trisulfonate, TPPTS) instead of TPPMS. TPPTS is commercially
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Figure 3.41: Reaction scheme of the Pd-catalyzed coupling reaction of diphenylphos-
phine with a iodo aryl species, and the coupling products pTPPMA,
mTPPMA and TPPMCMA.
available and has three sulfonate groups, therefore a net charge of −3 in the dissociated form
in water. As the chemical composition of Au1.4MS is Au55[(C6H5)2P(C6H4SO3Na)]12Cl6,
there are 12 ligand molecules per particle, i. e. one particle has a total charge of −12 in the
fully dissociated state. There is no crystal structure of Au1.4TS available, but assuming that
Au1.4TS has a ligand number of 12 as well, the total negative charge is enlarged to −42.
The precursor cluster Au1.4TPP was functionalized with TPPTS in a two-phase ligand
exchange reaction and tested towards the four cell lines. Au1.4TS showed a very similar
cytotoxicity as Au1.4MS (IC50 = 30µM in logarithmically growing HeLa cells), so that the
increase of negative charges just by multiplying the same functional group obviously does
not strongly alter the eﬀect of the AuNPs.
Other water-soluble triphenyl phosphine derivatives were synthesized and used as ligands
for Au1.4TPP. P - andm-(aminophenyl)diphenylphosphine (pTPPMA andmTPPMA) were
synthesized according to a protocol of Hessler et al..[131] Here, p- and m-iodoaniline, re-
spectively, were coupled to diphenylphosphine in a Heck type Pd-catalyzed coupling reaction
(reaction scheme see ﬁg. 3.41).
The reaction products showed little amounts of impurities which were identiﬁed as the
respective phosphine oxide species. Diﬀerent routes that were tested to purify the phosphines
were not successful, so the raw reaction products were used for subsequent ligand exchange
reactions. Both TPPMA isomers showed only moderate solubility in H2O. The stability of
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the phosphines towards oxidation reactions was tested in a simple experiment. An NMR
sample of the respective TPPMA, dissolved in deuterated dichloromethane, was left under
ambient conditions for three days. The 31P-NMR spectrum measured after this time period
did not show any changes compared to the original spectrum. Therefore, it can be assumed
that the phosphines are stable under ligand exchange reaction conditions.
Diﬀerent routes were tried to exchange the ligands of Au1.4TPP against mTPPMA. In a
ﬁrst approach, similarly to TPPMS, a two phase reaction of Au1.4TPP in dichloromethane
and mTPPMA in H2O was tested. Due to the low solubility of mTPPMA in H2O it was
not possible to generate water soluble AuNPs by this method. As there are 12 ligands
per particle, Au1.4TPPMA might potentially be better soluble in water than the pure
ligand. This might be due to the formation of a micelle-like structure, with a nonpolar
core consisting of gold and the hydrophobic parts of TPPMA, and a polar outer surface
of 12 amine functionalities. Au1.4TPP and mTPPMA were therefore both dissolved in
dichloromethane. This mixture was stirred at room temperature for several days, dried,
and it was tried to redisperse the residue in H2O. The H2O phase remained completely
colorless, indicating that the residue was insoluble in H2O. It was not possible to generate
Au1.4TPPMA via these routes.
To enhance water solubility of the phosphine ligand, 2-amino-5-(diphenylphosphino)benzoic
acid (TPPMCMA) with one amino and one carboxylic acid function was chosen as an-
other candidate. It was synthesized analogously to TPPMA from diphenylphosphine and
2-amino-5-iodobenzoic acid in a Pd-catalyzed P-C coupling reaction. Au1.4TPPMCMA
was synthesized by a two phase ligand exchange reaction from Au1.4TPP. The H2O phase
became brown after 1.5 h so that the reaction was stopped and the product was puriﬁed
by ultracentrifugation. Water soluble AuNPs with a mean particle diameter of 1.5± 0.4 nm
were obtained. The UV/Vis spectrum showed a slightly more pronounced shoulder around
500 nm than Au1.4MS (ﬁg. 3.42), which corresponds to the few larger particles visible in the
STEM micrograph (ﬁg. 3.43).
In cell culture medium, Au1.4TPPMCMA was not stable and showed aggregation to some
extent. Therefore it was not possible to determine an IC50 value. The instability might be
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Figure 3.42: UV/Vis spectrum of Au1.4TPPMCMA.
Figure 3.43: STEM micrograph (left) and histogram (right) of Au1.4TPPMCMA.
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Figure 3.44: UV/Vis spectrum of Au1.4TPPMC.
due to the slightly basic pH of 7.4 of cell culture medium, or because of the (compared to
ultrapure water) high salt concentration.
Furthermore, 4-(diphenylphosphino)benzoic acid (TPPMC) with one carboxylic acid func-
tionality and Au1.4TPPMC particles were synthesized in the same way. The UV/Vis spec-
trum does not show signiﬁcant features as expected for AuNPs of the desired size (ﬁg. 3.44).
This was conﬁrmed by STEM analysis, as AuNPs with a mean diameter of 1.4± 0.2 nm
with only few larger particles were visible (ﬁg. 3.45).
Figure 3.45: STEM micrograph (left) and histogram (right) of Au1.4TPPMC.
The EA revealed slightly higher C and H contents than theoretically expected (table 3.1).
Dialysis of the sample improved the results a little.
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Table 3.1: Results of EA of Au1.4TPPMC.
C/% H/%
Theoretical values 17.0 1.2
Measured values prior to dialysis 26.2 2.3
After dialysis 24.2 2.3
For Au1.4TPPMC, an IC50 value of 43µMwas determined under standard conditions. These
AuNPs were also used for further functionalization (see chapters 3.11 and 3.12).
The comparison of the results from TPPMS-, TPPTS- and TPPMC-stabilized AuNPs of
1.4 nm shows that the functional groups do not have a great inﬂuence towards the cyto-
toxicity. Small, phosphine-stabilized AuNPs show relatively high toxicity irrespective which
functional groups the phosphine ligands have. It was not possible to generate stable AuNPs
with positive charges. Here, a diﬀerence in cell uptake and therefore toxicity might be possi-
ble, as the cell membrane is negatively charged and is thus generally more sensitive towards
positively charged entities.[91]
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As the binding strength between gold surface and ligand shell was found to inﬂuence the
cytotoxicity of AuNPs (see chapter 3.3), this parameter should be further investigated. Small
thiol-stabilized AuNPs were found to be less toxic than comparable phosphine-stabilized
species, or even non-toxic (see chapter 3.3). Thus, AuNPs with a ligand shell that stabilizes
with intermediate strength between monophosphines and thiols should be generated.
Other functionalities that are known to function as ligands for AuNPs, e. g. amines or
oxygen-containing groups such as carboxylates, bind even more weakly than phosphines.
Therefore, diphosphines were chosen to synthesize AuNPs with medium ligand-gold binding
strength. The aﬃnity of a molecule with two phosphine groups towards gold should be
enhanced due to a chelate eﬀect, i. e. the second phosphine of one bound molecule should
be energetically favored to bind to the particle in comparison to two single monophosphine
molecules. Some examples exist for diphosphine-stabilized small gold clusters (see 2.1.4).
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Figure 3.46: Water soluble sulfonated aryl diphosphines synthesized and investigated
as AuNP ligands.
To largely exclude any eﬀect of chemical functionalities and to cut down the eﬀect on the
binding strength of the ligand shell only, diphosphines were chosen that are as similar to
the monophosphines used as possible.
Sodium3,3',3,3 '-(ethane-1,2-diylbis(phosphinetriyl)tetrabenzenesulfonate (DPPETS),
sodium3,3',3,3 '-(propane-1,2-diylbis(phosphinetriyl)tetrabenzenesulfonate (DPPPTS)
and sodium3,3',3,3 '-(butane-1,2-diylbis(phosphinetriyl)tetrabenzenesulfonate (DPPBTS)
meet these requests as they are aryl phosphines with sulfonate groups (ﬁg. 3.46). As well
as the monophosphines used, these diphosphines are quite well examined in the ﬁeld of
catalysis, where they act as ligands for metal organic complexes of Ru, for example.[132]
The sulfonated diphosphines were synthesized from the respective aryl diphosphines by
sulfonation with fuming sulfuric acid (ﬁg. 3.47).
Figure 3.47: Reaction scheme of the sulfonation reaction of diphosphines. DPPE and
DPPETS are exemplarily shown.
In the case of DPPETS, the purity of the raw product was only approximately 67%, es-
timated by 31P-NMR. It was not possible to remove the phosphine oxide impurities by
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Figure 3.48: UV/Vis spectrum of Au1.4DPPETS.
standard puriﬁcation techniques. As a phosphine oxide should have a lower aﬃnity to bind
to gold compared to a phosphine, the product was used as such for ligand exchange reactions.
DPPPTS and DPPBTS were synthesized via slightly diﬀerent routes, leading to higher
product purities (86% for DPPPTS and 97% for DPPBTS, respectively, both determined
by 31P-NMR spectroscopy). For DPPETS and DPPBTS, the long term stability against
oxidation was tested. The NMR sample solutions were left under atmospheric conditions
for three days and then measured again. In both cases, no increase of the phosphine oxide
amount was detectable.
The ligand exchange reactions were again performed as two phase systems. In the case of
Au1.4DPPETS, the reaction mixture was stirred overnight. After this time, the aqueous
phase had become brown, thus the reaction was stopped and the product isolated. The
UV/Vis spectrum did not show a prominent shoulder (ﬁg. 3.48); however, the STEM analysis
showed several larger particles than expected and a mean diameter of 1.8± 0.3 nm (ﬁg. 3.49).
In the 31P-NMR, no signal of free DPPETS could be detected anymore. The signals were
shifted to δ=20 - 23 ppm.
The chemical analysis revealed C and H amounts much higher than expected, reproducibly
for several batches (see table 3.2).
Usually this is caused by excess ligands, but washing of the sample did not improve the
results. One explanation might be that more diphosphine molecules than expected co-
ordinated to one AuNP, possibly in a monodentate binding mode. As one phosphorus
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Figure 3.49: STEM micrograph (left) and histogram (right) of Au1.4DPPETS.
Table 3.2: Results of EA of Au1.4DPPETS. Theoretical values are calculated for
potential chemical formulas of Au55DPPETS6Cl6 (DPPETS bidentate
bound) and Au55DPPETS12Cl6 (DPPETS monodentate bound).
C/% H/%
Theoretical values (6 ligands) 11.8 0.8
Theoretical values (12 ligands) 18.0 1.2
Measured values 40.99 3.42
After 2nd washing 40.82 4.24
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atom is surrounded by only two phenyl rings and one alkyl chain, it is sterically less bulky
the TPPMS with its three phenyl groups per phosphorus, and potentially more ligands ﬁt
around one particle. Another explanation might be the occurrence of smaller gold clusters
or mononuclear gold complexes, stabilized by diphosphines. Possibly this is thermodynam-
ically favored due to steric reasons so that the AuNP cores were partially degraded by the
diphosphine excess during ligand exchange.
With another batch of AuNPs, some stability experiments concerning the ligand-AuNP
bond were performed. The chemical stability of the material was tested by the addition
of KCN to a Au1.4DPPETS solution and time-dependent UV/Vis spectroscopy. In the
presence of KCN, elemental gold is oxidized by oxygen according to the reaction shown in
scheme 3.50.
Figure 3.50: Oxidative degradation of AuNPs in the presence of KCN.
The degradation rate of the AuNPs by KCN depends on the ability of a ligand to shield the
AuNP surface.[47] Au1.4DPPETS and as a reference Au1.4MS were both analyzed for 2 h.
The intensity of absorbance at λ=430 nm was plotted against time (ﬁg. 3.51).
Interestingly, the decay is steeper in the case of Au1.4DPPETS than it is for Au1.4MS.
This greater sensitivity of Au1.4DPPETS against KCN degradation might be a hint that
DPPETS only acts as a monodentate ligand and not, as it was expected, as a bidentate one.
In that case, the behavior towards degradation can possibly again be related to the fact that
each phosphorus atom in DPPETS has only two phenyl rings and one alkyl chain. From a
steric point of view, it is conceivable that the AuNP surface is therefore better accessible
than in the case of a TPPMS-stabilized AuNP.
To investigate whether DPPETS acts as a mono- or a bidentate ligand, atom distances of
the ligand and the gold cluster were theoretically estimated. They were based on the Au55
cluster as this was the precursor species for the ligand exchange reaction. In Au55, the
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Figure 3.51: Time-dependent plot from the UV/Vis spectra of the KCN degradation
of Au1.4DPPETS (black) and Au1.4MS (red), followed at 430 nm.
distance of two vertex atoms, to which the TPPMS molecules are bound, is approximately
0.86 nm. The P−P distance in a DPPETS molecule is approximately 0.45 nm, as assessed
with the program ChemBio3D (CambridgeSoft, version 12.0). The molecule is therefore not
appropriate to bind to a Au55 cluster in the expected way. Still, one DPPETS molecule
could possibly bind to two adjacent gold atoms or even to the same gold atom. More
sophisticated calculations were not performed in that direction, but the insuﬃcient chain
length of DPPETS might be the explanation for the unexpected behavior of Au1.4DPPETS
in the KCN experiment.
As another method, diﬀerential scanning calorimetry (DSC) was applied to analyze
Au1.4DPPETS and Au1.4MS (ﬁg. 3.52). The ligands, DPPETS and TPPMS, were mea-
sured ﬁrst and showed no thermal degradation up to 400 ◦C.
The measurement of Au1.4MS showed a sharp signal at 240 ◦C which may indicate the loss
of the TPPMS shell. This is comparable to a thermogravimetric analysis of 1.5 nm sized,
TPP-stabilized AuNPs.[133] These showed a mass loss of 24.5% in a temperature range of
200 − 250 ◦C which is assigned to the organic fraction of the AuNPs.
For Au1.4DPPETS on the other hand, no sharp signal is found, but a steady decay above
320 ◦C, indicating a higher stability than Au1.4MS. Compared to the KCN degradation
experiment which focuses on the chemical stability, DSC is a method to investigate material
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(a) DPPETS (black) and TPPMS (red). (b) Au1.4DPPETS (black) and Au1.4MS (red).
Figure 3.52: DSC measurements of the ligands (a) and the AuNPs (b).
properties such as melting, vaporization and sublimation. Furthermore, it is performed with
the solid material in contrast to the KCN experiment in solution. These diﬀerences might
explain why the results from both methods are contradictory and DSC points towards a
higher stability of Au1.4DPPETS compared to Au1.4MS.
As the theoretical investigation of DPPETS as a ligand for Au55 showed that the alkyl chain
between the two phosphorus atoms might be too short, the ligands DPPPTS and DPPBTS
were used for ligand exchange reactions. The reaction times were prolonged to 4 days to
increase the yields of water soluble product.
For Au1.4DPPPTS, the ligand exchange reaction seemed to be partially successful, as a
moderately colored water phase could be obtained after one week of reaction. A chemical
analysis however showed, similar as for Au1.4DPPETS, higher C and H values than expected
(see table 3.3).
Table 3.3: Results of EA of Au1.4DPPPTS.
C/% H/%
Theoretical values 12.24 0.98
Measured values 27.41 2.73
During a further puriﬁcation by dialysis, the AuNPs aggregated. In general, the particles
showed low stability in aqueous solution, thus, no further analytics in solution were per-
formed. The low stability of DPPPTS-stabilized AuNPs might also stem from the still too
short P−P distance of the molecule, still being too short to act as a bidentate ligand. When
91
3 Results and Discussion
the diphosphines bind as monodentate ligands to the particle surface, they have a lower
steric hindrance than TPPMS and are thus weaker stabilizing ligands.
The synthesis of Au1.4DPPBTS was partially successful. As for the other two diphosphine-
stabilized AuNP species, the elemental analysis revealed a higher fraction of hydrocarbons
than the theoretical values for Au1.4DPPBTS with 6 or 12 ligand molecules (see table 3.4).
Further puriﬁcation by dialysis did not aﬀect this fact: 40mg of Au1.4DPPBTS were dis-
solved in H2O and dialyzed for three days. 15mg product were retrieved, of which the EA
showed even slightly higher amounts of C and H than prior to the dialysis. This might be
due to some aggregation that occurred during the dialysis, and parts of the released ligands
from aggregated AuNPs might have increased the ligand excess in the product.
Table 3.4: Results of EA of Au1.4DPPBTS.
C/% H/%
Theoretical values 12.65 1.05
Measured values 26.73 2.75
After dialysis 29.30 3.30
For further analytics, the non-dialyzed raw product was used. A STEM analysis showed
that the AuNPs had a mean diameter of 1.4± 0.2 nm (ﬁg. 3.53).
Figure 3.53: STEM micrograph (left) and histogram (right) of Au1.4DPPBTS.
A 31P-NMR spectrum showed only two broadened signals at 40.8 and 43.5 ppm. No signal
at −12.1 ppm from the free ligand was detected. The signal at 40.8 ppm can be assigned
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Figure 3.54: Stability test with increasing concentrations of DTT. Plotted are the
intensities at 400 nm of UV/Vis spectra from Au1.4DPPBTS (black)
and Au1.4MS (red) with the respective logarithmic ﬁt curves.
to phosphine oxide impurities, whereas the signal at 43.5 ppm indicates a phosphine−gold
interaction.
A diﬀerent experiment was performed to test the binding strength of DPPBTS to AuNPs.
The reaction with dithiothreitol (DTT) with two thiol functions as a competing ligand was
shown to be useful to induce ligand release.[134] Here, it was used to test ligand dependent
stability. Dispersions of Au1.4DPPBTS were mixed with increasing concentrations of
aqueous DTT solutions. Au1.4MS was processed in the same way. The AuNP starting
concentrations were not identical. This impedes a direct comparison. However, when the
absorbances at 400 nm are plotted against DTT concentration, the logarithmic ﬁt curve
for Au1.4MS shows a steeper decrease, indicating a higher stability of the diphosphine-
stabilized species against competing ligands (ﬁg. 3.54).
Table 3.5 summarizes all successfully performed ligand exchange reactions with Au1.4TPP.
Within this work, it was not possible to synthesize diphosphine-stabilized small AuNPs that
were long-term stable, especially in other media than H2O such as cell culture medium with
high ionic strength. One problem could be the ability of bi-functional molecules to bridge
two particles and therefore induce the occurrence of networks and aggregation of the AuNPs.
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Table 3.5: Two-phase ligand exchange reactions performed with Au1.4TPP (discussed
in chapters 3.9 and 3.10).
Particle species Ligand Starting mass/mg Yield/mg Sizea/nm
Au1.4MS TPPMS 35 10.7 1.3± 0.2
Au1.4TS TPPTS 163 15 1.4± 0.2
Au1.4TPPMCMA TPPMCMA 50 n. d.b 1.5± 0.4
Au1.4TPPMC TPPMC 50 10.7 1.4± 0.2
Au1.4DPPETS DPPETS 50 27 1.8± 0.3
Au1.4DPPBTS DPPBTS 100 144c 1.1± 0.2
a Determined by STEM. b Not determined. c Before further puriﬁcation.
Due to this lack of stability, no cell tests could be performed so far to verify the hypoth-
esis that diphosphine-stabilized AuNPs are less toxic than the respective monophosphine-
stabilized AuNPs. Within the cooperation project, there are on-going studies in this ﬁeld
to enable the synthesis of stable diphosphine-stabilized AuNPs and allow the toxicological
investigation of such compounds.[135]
To check whether the synthesized diphosphines are suitable ligands for AuNPs in general,
they were used to functionalize larger citrate-stabilized gold colloids. Diﬀerent batches of
citrate-stabilized AuNPs with slightly diﬀering mean diameters were used.
DPPETS was mixed with 13 nm sized citrate-stabilized AuNPs. The plasmon resonance
maximum in the UV/Vis spectrum shifted from 522 nm to 524 nm, indicating a diﬀerent
dielectric environment and therefore a successful ligand exchange (ﬁg. 3.55). The STEM
analysis showed that the AuNP size was not altered (13± 1.4 nm, see ﬁg. 3.56). In the 31P-
NMR spectrum of the sample, no free DPPETS around −12 ppm was detected, only one
signal at 41 ppm, indicating phosphine groups bound to gold.
From Au11Citrate with a plasmon resonance peak at 519 nm, Au11DPPPTS
(λmax=520 nm) and Au12DPPBTS (λmax=519 nm) were synthesized (ﬁg. 3.55). The STEM
analytics resulted in mean particle diameters of 11± 0.7 nm and 12± 1.2 nm for the two sam-
ples, respectively (ﬁg. 3.56).
DLS measurements were conducted to investigate the hydrodynamic radii of the AuNPs
(ﬁg. 3.57). The precursor colloids Au11Citrate showed a hydrodynamic particle size of
19.1 nm. As with DLS not only the metal core is measured but the particle including
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Figure 3.55: UV/Vis spectra of Au13DPPETS (black), Au11DPPPTS (gray) and
Au12DPPBTS (purple).
its ligand shell and the hydrate shell, it is reasonable that the value is higher than the
diameter determined from STEM micrographs.
For Au11DPPPTS and Au12DPPBTS, hydrodynamic diameters of 21.0 nm and 19.9 nm
were determined. A comparison of the DLS measurements of all species shows that the
hydrodynamic radii are slightly increased during ligand exchange. DPPPTS and DPPBTS
are both sterically bulkier than citrate. The DLS data reﬂect this as both diphosphine-
stabilized AuNPs have increased hydrodynamic radii compared to Au11Citrate. The dif-
ference between Au11DPPPTS and Au12DPPBTS is thus surprising, as DPPBTS is the
larger molecule but the resulting hydrodynamic diameters of the AuNPs are smaller. The
histogram reveals that Au11DPPPTS has a broader size distribution, therefore the here
determined diameter might be more defective than the value from Au12DPPBTS.
The stability of all three species was investigated with the KCN degradation experiment
(ﬁg. 3.58). Within the accuracy of the experiments, no signiﬁcant diﬀerences in the decay of
absorbance was observable for the diphosphine species Au13DPPETS, Au11DPPPTS and
Au12DPPBTS. In contrast to that, a batch of Au13MS showed a clearly faster reaction to-
wards KCN. Au11Citrate was degraded even faster and was almost completely decomposed
after 20min.
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Figure 3.56: STEM micrographs and histograms of Au13DPPETS (top),
Au11DPPPTS (middle) and Au12DPPBTS (bottom).
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Figure 3.57: Histograms of DLS measurements (intensity weighted) of Au11Citrate
(blue), Au11DPPPTS (gray) and Au12DPPBTS (purple).
Figure 3.58: Plots of time-dependently measured UV/Vis spectra at respective ab-
sorbance maxima during KCN degradation (0.1M).
Black: Au13DPPETS (plotted at 524 nm); gray: Au11DPPPTS
(520 nm); purple: Au12DPPBTS (520 nm); red: Au13MS (524 nm);
blue: Au11Citrate (520 nm). Note that starting intensities were not
the same for the diﬀerent AuNP solutions, and for better visualization,
the spectra were not normalized.
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Diphosphines are obviously suitable molecules as AuNP ligands in the case of colloids. They
stabilize gold colloids more strongly against chemical degradation than weaker ligands such
as monophosphines or citrate. No eﬀect was found regarding the chain length of diphosphine
ligand molecules in the case of colloids above a diameter of 10 nm. This can be explained
by the surface curvature of larger AuNPs. On a molecular level, the gold atoms to which
one diphosphine molecule binds are almost in one plane. Therefore, the binding situation
is completely diﬀerent, and the resulting strain is obviously not strongly inﬂuenced by the
chain length of the investigated diphosphines.
Because Au15MS was nontoxic in cell tests, the diphosphine-stabilized gold colloids were
not tested in cell experiments as the same result is expected here.
3.11 Labeling Au1.4 with (Lys3)-bombesin
The cytotoxicity of Au1.4MS opens possibilities for therapeutic applications. By binding a
target molecule to the AuNP, a selective toxic compound can be generated, for example for
use as a cytotoxic drug in cancer therapy.
The concept chosen was the functionalization with bombesin. Bombesin is an oligopeptide
that binds to the gastrin-releasing peptide receptor (GRPR) which is expressed mainly in
the pancreas. The structural formula is shown below (ﬁg. 3.62).
Figure 3.59: Coupling reaction scheme of a cell speciﬁc target molecule to
Au1.4TPPMC.
As Au1.4TPPMC shows almost the same toxicity as Au1.4MS (IC50=43µM, see chap-
ter 3.9), it was used as the precursor entity (ﬁg. 3.59). The carboxylic acid function enables
diﬀerent routes to bind target molecules. An EDC/sulfo-NHS coupling was chosen (ﬁg. 3.60).
When Au1.4TPPMC was functionalized with bombesin, the resulting AuNPs showed
mediocre solubility in H2O and in cell culture medium (pH7.4). They were well soluble
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Figure 3.60: EDC/sulfo-NHS coupling reaction of an amine R−NH2, indicating
bombesin or (Lys3)-bombesin, to TPPMC. The carboxylic acid function
is ﬁrst activated by EDC, reacts with sulfo-NHS to a temporarily stable
sulfo-NHS-ester, and then reacts further with the amine, generating an
amide bond.
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in acidiﬁed solutions. Acidic conditions are not applicable in cell tests though, and neither
in later in vivo applications.
However, the product was characterized. The diﬀerent solubility behavior was a ﬁrst hint
for a successful functionalization. Furthermore, the AuNPs were treated with dithiothreitol
(DTT), a dithiol with a strong binding aﬃnity towards gold and the ability to cross-link
AuNPs (ﬁg. 3.61). The aggregates were removed by centrifugation, the supernatant was
dried and analyzed by mass spectroscopy. A signal for the TPPMC-bombesin adduct at
m/z=1907.9 could be conﬁrmed.
Figure 3.61: DTT ligand exchange reaction with bombesin-functionalized AuNPs.
The supernatant was subsequently analyzed by MS.
Diﬀerent derivatives of the peptide bombesin are available that are equally eﬀective in
binding assays and clinical studies. To facilitate the coupling reaction, (Lys3)-bombesin
with a lysine residue instead of arginine on third position of the peptide structure was
chosen for further experiments (ﬁg. 3.62). The primary amine of lysine (pKB =10.5) is
more prone for a coupling reaction than the amine of the guanidinium group of arginine
(pKB =12.5).[136] The use of (Lys3)-bombesin instead of bombesin should not aﬀect the
binding aﬃnity towards GRP receptors.[111]
To enhance solubility and stability, AuNPs with a mixed ligand shell of TPPMS and TPPMC
were synthesized (Au1.4MS/MC). The optimal ratio concerning solubility and stability was
determined to be a TPPMS:TPPMC molar ratio of 7:1. This is the ratio that was initially
used for the ligand exchange reaction; the ﬁnal exact ratio that was present on the AuNPs
was not evaluated.
Characterization of Au1.4MS/MC showed typical UV/Vis spectra without speciﬁc features
(ﬁg. 3.63), identical for two synthesis batches. The STEM analytics showed AuNPs with
narrow size distribution and a mean diameter of 1.4± 0.2 nm (ﬁg. 3.64). The standard MTT
assay revealed cytotoxicity in the same magnitude as Au1.4MS (IC50=30.1µM).
100
3.11 Labeling Au1.4 with (Lys3)-bombesin
Figure 3.62: Bombesin, an oligopeptide consisting of 14 amino acids. Natural
bombesin has an arginine group at third position, which is replaced by
lysine in (Lys3)-bombesin.
The ligand shell of Au1.4MS contains 12 ligands. As TPPMC has a very similar chemical
structure to TPPMS, the same number of ligand molecules per particle can be assumed.
With a statistical ratio of 7:1 (TPPMS:TPPMC), one to two ligand molecules per AuNP
have a carboxylic acid function, suitable for the coupling of (Lys3)-bombesin. The
coupling was successfully performed, resulting in (Lys3)-bombesin-functionalized AuNPs
(Au1.4MS/MC-(Lys3)-bombesin) with approximately one or two bombesin molecules per
particle. Therefore, no cooperative eﬀect can be expected, i. e. a higher aﬃnity per par-
ticle because of an increased number of agonists to GRPR and thus binding events. On
the other hand, it is probable that the binding eﬃcacy of one single bombesin molecule
attached to one AuNP is not impaired in this surface density. The product was puriﬁed by
ultracentrifugation to ensure the absence of free bombesin molecules.
The product was well dispersible in H2O and stable in cell culture medium. It was charac-
terized by UV/Vis spectroscopy, STEM and IR spectroscopy. The UV/Vis spectrum did
not show a deﬁned peak which would be a hint of aggregates in a size range above 3 nm
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Figure 3.63: UV/Vis spectra of two batches of Au1.4MS/MC.
Figure 3.64: STEM micrograph (left) and histogram (right) of Au1.4MS/MC.
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Figure 3.65: UV/Vis spectrum of Au1.4MS/MC-(Lys3)-bombesin.
Figure 3.66: STEM micrograph (left) and histogram (right) of Au1.4MS/MC-(Lys3)-
bombesin.
(ﬁg. 3.65). The STEM analysis conﬁrmed this as no aggregates were visible, and a mean
diameter of 1.5 nm± 0.2 nm was determined (see ﬁg. 3.66).
In the IR spectrum of Au1.4MS/MC-(Lys3)-bombesin, the characteristic absorption band
for amides was clearly visible at 1643 cm-1 (ﬁg. 3.67). This band is thus probably induced
by both, the new formed amide bond between TPPMC and the amine functionality of
(Lys3)-bombesin as well as the peptide bonds within the latter.
When the product was dried and redispersed in H2O, the solubility was impaired. Therefore,
the afterwards synthesized batches were not dried and stored as solid, but kept in solution.
As such, they were stable over months.
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Figure 3.67: IR spectra of Au1.4MS/MC (black) and Au1.4MS/MC-(Lys3)-bombesin
(red). The arrow indicates the characteristic amide absorption band at
1643 cm-1.
As the analytics showed AuNPs of the desired size and the functionalization could be
proven by IR spectroscopy, cell tests were performed. The MTT assay showed that the
functionalization of 1.4 nm sized AuNPs with (Lys3)-bombesin did not alter the cytotoxi-
city (IC50=59µM).
GeneBLAzer® GRPR-NFAT-bla CHO-K1 cells, purchased from Invitrogen, were used to
analyze if the (Lys3)-bombesin attached to the AuNPs was still active. The cells contain a
β-lactamase (bla) reporter gene under control of a NFAT response element. In the case of
a receptor-agonist interaction, the production of bla is triggered. As a substrate, coumarin-
lactam-ﬂuorescein is added which shows ﬂuorescence at 520 nm from the ﬂuorescein entity.
The coumarin ﬂuorescence is transferred by a Förster resonance energy transfer (FRET)
to the ﬂuorescein entity in this adduct. Bla cleaves the lactam bridge between the two
ﬂuorophores. An interaction with GRPR therefore induces an increase of the coumarin
ﬂuorescence at 447 nm, which can be quantiﬁed by a ﬂuorescence microplate reader or
detected by ﬂuorescence microscopy of cell cultures.
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To prove the speciﬁc functionalization of Au1.4MS/MC-(Lys3)-bombesin, distinguished from
a reaction by potential residual free (Lys3)-bombesin in the sample, the supernatant from
the last ultracentrifugation step was also tested as a reference sample. This supernatant
visibly contained a low concentration of not centrifuged Au1.4MS/MC-(Lys3)-bombesin. To
exclude eﬀects from these particles, the supernatant was dialyzed prior to testing, and the
dialysis water was concentrated to a low volume and used.
The eﬀect of Au1.4MS/MC-(Lys3)-bombesin towards the GRPR containing cells was ﬁrst
analyzed visually. Under the microscope, the cytotoxicity of Au1.4MS/MC-(Lys3)-bombesin
could be conﬁrmed, whereas pure (Lys3)-bombesin did not cause cell death.
The GRPR cells were then analyzed in a ﬂuorescence reader. For Au1.4MS/MC-(Lys3)-
bombesin, increasing ﬂuorescence could be determined, indicating an interaction between
the bound (Lys3)-bombesin and the GRP receptors. Pure (Lys3)-bombesin which was tested
as reference showed the same eﬀect. Au1.4MS and the ultracentrifugation supernatant,
on the other hand, gave no ﬂuorescence signal. This proves that (Lys3)-bombesin could
successfully be coupled to Au1.4MS/MC and be puriﬁed without any impairment of the
(Lys3)-bombesin receptor aﬃnity.
A not expected phenomenon was that even at very low concentrations, there was still an
increased ﬂuorescence detectable for Au1.4MS/MC-(Lys3)-bombesin and for the (Lys3)-
bombesin reference. A possible explanation is that the bombesin is sticky and was therefore
accidentally pipetted in the dilution series in higher concentrations than intended. Although
this result is not well understood so far, the trends of all samples show the expected results
and point towards covalently to AuNPs attached (Lys3)-bombesin that is still receptor
active.
To further conﬁrm these results, the cells were investigated by ﬂuorescence microscopy by
Prof. G. Müller-Newen (UKA). Like the ﬂuorescence quantiﬁcation, the detected ﬂuores-
cence intensities in the micrographs conﬁrm the eﬀective functionalization of the AuNPs.
As can be seen in ﬁg. 3.68, Au1.4MS does not induce an enhanced coumarin ﬂuorescence
and the cells are only stained with the uncleaved substrate (the ﬂuorescence at 520 nm from
the adduct is shown in red). (Lys3)-bombesin on the other hand leads to an increased
ﬂuorescence at 447 nm, shown as yellow ﬂuorescence here. Au1.4MS/MC-(Lys3)-bombesin
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Figure 3.68: GeneBLAzer GRPR-NFAT-bla CHO-K1 cells in ﬂuorescence micro-
graphs. Cells were untreated (up left), treated with 1 nM (Lys3)-
bombesin as positive control (up right), with 1µM Au1.4MS as neg-
ative control (down left) and with 1µM Au1.4MS/MC-(Lys3)-bombesin
(down right). Au1.4MS/MC-(Lys3)-bombesin induces enhanced ﬂuores-
cence at 447 nm as indicated by the yellow color. Figures were provided
by G. Müller-Newen, UKA.
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has the same eﬀect. The (Lys3)-bombesin bound to AuNPs is still active, can bind to the
GRP receptor and trigger the release of coumarin.
In tissue consisting of healthy cells and cancerous cells expressing GRPR, interaction of
Au1.4MS/MC-(Lys3)-bombesin with cancer cells is possibly ampliﬁed and the functionalized
AuNPs will aﬀect mainly those. This would ﬁnally lead to a potential cytotoxic drug with
reduced side eﬀects.
3.12 Labeling Au1.4 with 5-Aminoﬂuorescein
It could be shown that the ligand binding strength plays a crucial role in AuNP cytotoxicity
(3.3). Furthermore, in the patch clamp experiments it became obvious that the equilibrium
of bound and free ligands has a great inﬂuence on the interaction with ion channels (3.8).
From these ﬁndings it can be assumed that the ligand shell of Au1.4MS is partially or
completely stripped at some point of the interaction with a cell.
Until now, there is no clarity about this stripping event, i. e. the time point and the spatial
circumstance and which cell organelles or molecular entities might be involved. Also, the
uptake mechanism of small AuNPs could not be veriﬁed so far. The uptake of Au15MS
via endocytosis and the fate of these AuNPs in vesicles within the cells could be shown by
TEM. Au1.4MS is however too small to be clearly visualized in the organic material.
To learn more about the interaction of Au1.4MS with a cell and its membrane and to follow
the TPPMS ligand shell, it would be helpful to have a probe that can easily be visualized.
The use of ﬂuorescence markers would allow further investigation.
The ﬂuorescence of ﬂuorophores that are bound closely to the surface of metal nanoparticles
is quenched due to resonant energy transfer. This eﬀect depends of the AuNP size and the
spacer length, determining the distance between ﬂuorophore and nanoparticle.[74] A species
consisting of a 1.4 nm gold core and a phosphine ligand shell labeled with a ﬂuorophore would
allow to follow the fate of the ligand molecules within the cell by ﬂuorescence microscopy.
In the moment of ligand stripping, the until then quenched ﬂuorophore should light up.
5-Aminoﬂuorescein was chosen for this purpose (ﬁg. 3.69). It was attached to Au1.4MS/MC
by an EDC/sulfo-NHS coupling under the same conditions as (Lys3)-bombesin (ﬁg. 3.70,
107
3 Results and Discussion
see also chapter 3.11), resulting in Au1.4MS/MC-Aminoﬂuorescein comprising the adduct
TPPMC-AF.
Figure 3.69: Chemical structure of the ﬂuorophore 5-aminoﬂuorescein.
Figure 3.70: 5-Aminoﬂuorescein, coupled to TPPMC via an amide bond.
The UV/Vis spectrum of the product showed a distinct peak at 484 nm (ﬁg. 3.71). A com-
parison to the UV/Vis spectrum of pure 5-aminoﬂuorescein revealed the origin for this peak,
as it showed high absorbance at this wavelength.
The STEM analysis showed that the particle functionalization had not altered the AuNP
size distribution much (mean diameter 1.5 nm± 0.2 nm; see ﬁg. 3.72).
An IR spectrum of the product conﬁrmed the positive functionalization, as the characteristic
bands at 1630 cm-1 and 1385 cm-1 from the spectrum of 5-aminoﬂuorescein were clearly visible
here as well (ﬁg. 3.73).
Next, the ability for monitoring the ligand binding and unbinding was evaluated.
Au1.4MS/MC-Aminoﬂuorescein was treated with DTT to release TPPMC-AF from the
AuNP surface. Fluorescence spectroscopy measurements of the stock solution before treat-
ment and of the supernatant after DTT induced aggregation were conducted.
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Figure 3.71: UV/Vis spectra of Au1.4MS/MC-Aminoﬂuorescein (black) and
5-aminoﬂuorescein (red).
Figure 3.72: STEM micrograph (left) and histogram (right) of Au1.4MS/MC-
Aminoﬂuorescein.
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Figure 3.73: IR spectra of Au1.4MS/MC-Aminoﬂuorescein (black) and
5-aminoﬂuorescein (red).
The measurements gave contradicting results. The ﬂuorescence intensity at 520 nm (ﬂuo-
rescence maximum for 5-aminoﬂuorescein) did not change strongly. After the reaction with
DTT the signal was even slightly weaker, opposed to what was expected (ﬁg. 3.74).
Possibly, AuNPs with a mean diameter of 1.4 nm are too small for eﬃcient ﬂuorescence
quenching, and the 5-aminoﬂuorescein attached to the particles already gave a full intensity
signal. Another explanation for this ﬁnding is an excess of unbound 5-aminoﬂuorescein in
the AuNP stock solution. This is however not probable, as the wash supernatants of the
sample after synthesis showed decreasing ﬂuorescence, indicating eﬃcient washing (ﬁg. 3.75).
Within the ﬁrst three washing steps, ﬂuorescence increased, probably due to subsequent
release of unspeciﬁcally bound 5-aminoﬂuorescein. In washing steps 4 and 5, the ﬂuorescence
decreases. This was interpreted as successful washing.
If the insuﬃcient quenching eﬃcacy of 1.4 nm sized AuNPs is the reason for the ﬂuorescence
spectroscopy results, a diﬀerent concept instead of using attached 5-aminoﬂuorescein has to
be applied to visualize ligand desorption.
The standard cell test was performed nonetheless, giving a similar IC50 as non-functionalized
Au1.4MS (IC50=32µM). This result suggests that the functionalization of Au1.4MS/MC
with 5-aminoﬂuorescein does not alter the interaction with cells.
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Figure 3.74: Fluorescence spectra of a Au1.4MS/MC-Aminoﬂuorescein solution be-
fore (red) and after (black) reaction with DTT.
Figure 3.75: Fluorescence spectra of the washing supernatants from the coupling
product Au1.4MS/MC-Aminoﬂuorescein.
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The biological activity of a variety of AuNPs was examined in detail. For this, diverse
water soluble AuNPs have been synthesized and characterized for subsequent cytotoxicity
investigations. Following the ﬁrst of the initially formulated parameters, AuNPs of diﬀerent
sizes up to 15 nm were synthesized. They were all functionalized with TPPMS for a ligand
independent size eﬀect determination which resulted in the identiﬁcation of Au1.4MS as the
most toxic AuNP species.
A toxicity dependence of gold−ligand binding strength was revealed by synthesis and further
analysis of GSH-stabilized AuNPs. The stronger binding thiol ligands could clearly reduce
the AuNP toxicity. This pointed towards an inﬂuence of the accessibility of the AuNP
surface.
Mechanistic aspects concerning the Au1.4MS toxicity were examined. These AuNPs mainly
induce necrosis in cells. Furthermore, they activate the expression of heat shock and stress
related genes. A ﬂuorophore dye based ﬂow cytometry analysis indicated a correlation with
oxidative stress. This could partially be conﬁrmed by the protecting eﬀect of anti-oxidants.
However, this was obviously more related to a binding reaction to the AuNPs and not
directly to an antioxidative eﬀect, as ascorbic acid without gold aﬃne functional groups had
a signiﬁcantly diﬀerent eﬀect than GSH, NAC and TPPMS.
A hypothesized correlation between cytotoxicity and catalytic activity towards oxidation
reactions could not be conﬁrmed when Amino-TEMPO was used as oxidation substrate
for EPR studies. Only non-toxic citrate-stabilized gold colloids were able to quench the
Amino-TEMPO signal whereas all other diﬀerently stabilized AuNPs (with TPPMS or GSH,
respectively) had no eﬀect on the substrate signal intensity, thus no oxidation activity.
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The experiments concerning genotoxicity of AuNPs gave unexpected results. DNA damage
was investigated by quantiﬁcation of DNA base lesions via GC/MS in the presence of iso-
topically labeled oxidation products. Here, Au1.4MS and Au1.1GSH showed a very similar
behavior despite an opposite toxicity proﬁle. Furthermore it was found that the concentra-
tions of two lesions, FapyAde and FapyGua, were decreased. This was not expected and is
still under further investigation for a deeper understanding.
A toxic eﬀect by potentially present TPPMS-Au(I)-Cl could be ruled out. Although the
Au(I) complex shows high cytotoxicity, it was proven in a dialysis experiment that only
TPPMS shows desorption of Au1.4MS to some extent, but no gold could be detected by
EDX analysis of the supernatant residue. The adsorption/desorption equilibrium of TPPMS
on Au1.4MS was analyzed by 31P-NMR spectroscopy, resulting in an equilibrium constant
of Kd=4.76× 10-7 and a free Gibbs energy of 35.5 kJ/mol.
This eﬀect plays obviously also a role in the interaction of Au1.4MS with potassium ion
channels. Patch clamp experiments identiﬁed Au1.4MS as an irreversibly acting hERG
channel blocker. No other AuNP material tested showed this eﬀect, and for Au1.4MS
it could be inhibited by the addition of FCS, GSH or TPPMS. Again, ligand stripping of
TPPMS as a crucial factor for feasible interaction was postulated and could be corroborated
by docking simulations, conducted by the Wenzel group (KIT, Karlsruhe).
In agreement to this, variation of the phosphine functionalities (TPPTS, TPPMC) did not
alter the toxicity of Au1.4MS. Obviously, the interaction strength with the AuNP surface is
the dominating factor whereas the inﬂuence of outer ligand functionalities can be neglected.
However, it was not possible to synthesize stable positively charged AuNPs of 1.4 nm size,
which may potentially show a diﬀerent cell interaction.
The eﬀort to synthesize diphosphine-stabilized 1.4 nm sized AuNPs was not successful.
This would be an interesting species with potentially intermediate binding aﬃnity between
monophosphines and thiols. Diﬀerent diphosphine-stabilized gold colloids, stabilized with
DPPETS, DPPPTS and DPPBTS, with an average size of 12 nm were successfully synthe-
sized and showed all a higher stability in a KCN degradation experiment than TPPMS-
stabilized AuNPs.
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The functionalization of Au1.4MS/MC with (Lys3)-bombesin could be realized by an
EDC/sulfo-NHS coupling reaction. The functionalization was proven by IR spectroscopy.
Cell tests showed that both the IC50 value of the AuNPs as well as the receptor aﬃnity of
(Lys3)-bombesin could be retained. This proof of concept shows high potential for a further
application in cancer therapy.
Via the same route, 5-aminoﬂuorescein functionalized AuNPs could be synthesized. Nev-
ertheless, they were not applicable for ligand visualization in cells due to unspeciﬁc ligand
desorption and therefore ﬂuorophore release already in ultrapure water.
Summarized, the biological eﬀects of diverse AuNP materials were investigated in detail.
A size- as well as a ligand-dependent toxicity were observed, with Au1.4MS as the most
toxic species. Some hypotheses concerning its mechanism could be validated, others be
disproven. The high cytotoxicity of Au1.4MS could neither be directly connected with
DNA transcription inhibition, nor with direct oxidation catalysis. A side eﬀect by Au(I)
species could also be ruled out. The understanding of toxicity behavior still requires further
mechanistic studies.
In future, it might be interesting to use sophisticated cell analytics regarding speciﬁc sub-
cellular structures and reactions to gain deeper insight into the exact mechanism of the
cytotoxicity of Au1.4MS. In vitro EPR spectroscopy is a method to visualize ROS in cells
and could therefore help to answer the questions concerning time point of action and cell
organelle(s) involved, i. e. when and where oxidative stress occurs.
The genotoxicity studies should be further conducted. The investigation of other DNA
repair enzymes besides NEIL1 could lead to the identiﬁcation of an enzyme that can be
activated by AuNPs. As the non-toxic Au1.1GSH also led to an decrease of certain DNA
lesions, this species would be an interesting candidate for potential medical applications to
enhance DNA repair.
The synthesis of diphosphine-stabilized, small AuNPs with long-term stability was found
to be challenging. However, species of this type would be interesting for cytotoxicity in-
vestigations. Variation of the reaction conditions and testing of further diphosphines could
potentially lead to success here.
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A system of phosphine-stabilized, 1.4 nm sized AuNPs with a ﬂuorophore marker that does
not readily desorb from the AuNPs would be an interesting probe for ﬂuorescence microscopy
investigations in cells. Possibly this can be achieved by varying the reaction and puriﬁcation
conditions for the synthesis of Au1.4MS/MC-Aminoﬂuorescein. Alternatively, a combina-
tion of this approach with the use of diphosphine ligands could solve this problem. The
desorption of the ligand shell is most probably a crucial step in the AuNP/cell interaction
pathway and deserves further investigation.
The functionalization of AuNPs with bombesin gave encouraging ﬁrst results. These parti-
cles are very promising candidates for further tests, potentially in vivo in a tumor model to
investigate whether the AuNPs show increased uptake in tumor cells besides healthy tissue.
The organ distribution of Au1.4MS in an in vivo rat model was already investigated. 24 h
after intravenous injection, the highest concentration (∼ 50%) was found in the liver due
to clearance eﬀects. 19.3% were present in the carcass (which refers to the entire body
of the animal without the organs and tissues that were removed). This reﬂects a uniform
distribution of Au1.4MS throughout the whole body. No speciﬁc uptake in any organs could
be observed, but signiﬁcant amounts of the injected dose (3.7%) circulated in the blood.
For a potential application of a targeted species it is interesting to notice that Au1.4MS was
not cleared completely within 24 h, in opposite to larger AuNPs of 18 nm diameter.[137]
In a more recent study, the size dependence of AuNP biodistribution was further investi-
gated. 5 diﬀerently sized, TPPMS-stabilized AuNPs were intravenously injected in rats in
low doses to exclude acute toxicity, and the distribution after 24 h was analyzed by using
radio-labeled AuNPs with 198Au. Au1.4MS was not accumulated in the liver to the same
extent as all other, larger AuNPs (51% compared to >80%). Further, Au1.4MS showed
highest percentage of retention in blood (8%) and highest clearance via urine (4.7%) of
all AuNPs tested.[138] These ﬁndings conﬁrm that Au1.4MS is well distributed in vivo and
also that slow clearance is possible, which is crucial for a potential therapeutic use.
Administration of the same library of AuNPs to rats by oral ingestion led to a generally
low absorption across intestinal membranes, showing that the administration pathway is
an important parameter, but again Au1.4MS showed highest uptake of all AuNPs tested
(0.37%).[139]
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This ﬁeld could also be further expanded by using other targeting entities, such as CPPs
or NLS peptides. There are numerous receptors on cells that are interesting target
structures.[106]
Besides the here investigated toxicity dependence on size and ligand functionalization of
spherical AuNPs, the inﬂuence of shape could be examined, as for example gold nanorods
and hollow gold nanospheres have interesting optical properties with application potential
in imaging and treatment of diseases which makes the toxicological analysis indispensable.
Apart from AuNPs, various other metal nanoparticles have valuable properties with poten-
tial applications for biomedical purposes, such as superparamagnetic FePt nanoparticles.
Synthesis of water-soluble species and systematic toxicology investigations would open the
door to new developments in diverse nanomaterial based applications.
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5.1 Chemicals and Solvents
5.1.1 Precursor Chemicals
Chemicals were available at the Institute of Inorganic Chemistry (IAC), RWTH Aachen
University, at the Cytocentrics AG, Rostock, or at the National Institute of Standards
and Technology (NIST), Gaithersburg, MD, USA, or purchased from diverse commercial
suppliers. If not stated explicitly diﬀerently, chemicals were used as received.
Table 5.1: Chemicals, solvents and suppliers.
Substance, grade/concentration Supplier
Acetic acid Riedel de Häen
Acetonitrile Merck
5-Aminoﬂuorescein Fluka
2-Amino-5-iodobenzoic acid Fluka
4-Amino-2,2,6,6-tetramethylpiperidine-1-oxyl Aldrich
(Amino-TEMPO)
Benzene, p. a. AppliChem
BF3 · OEt2 Aldrich
1,4-Bis(diphenylphosphino)butane (DPPB), 98% Aldrich
1,2-Bis(diphenylphosphino)ethane (DPPE), 99% Aldrich
Continued on next page
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Substance, grade/concentration Supplier
1,3-Bis(diphenylphosphino)propane (DPPP), 97% Aldrich
Bis(2-methoxyethyl)ether (diglyme), 99% Acros
CaCl2 Grüssing
Chlorodiphenylphosphine (Ph2PCl) Aldrich
Chloro[diphenyl(3-sulfonatophenyl)phosphine] ABCR
gold(I), sodium salt, 98%
Dichloromethane, p. a. VWR
Diethyl ether Riedel de Häen
4-(Diphenylphosphino)benzoic acid (TPPMC), 97.0% TCI Europe
Dithiothreitol (DTT) Aldrich
D2O Aldrich
Dodecylamine Sigma-Aldrich
Ethanol Grüssing
GeO2 Schuchardt
Glutathione (GSH), 98.% Fisher BioReagents
HAuCl4 · 3 H2O, ACS reagent Sigma-Aldrich
HCl, 37% KMF
H3PO4 Merck
H2SO4, 20% Riedel de Häen
H2SO4, 65% Merck
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic Sigma
acid (HEPES)
4-Iodobenzoic acid Fluka
KBr Sigma
KCN Grüssing
KOH KMF
LiAlH4 Fluka
Continued on next page
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Substance, grade/concentration Supplier
(Lys3)-Bombesin, 98% Bachem
Methanol, p. a. VWR
MgSO4 Grüssing
M -iodoaniline Fluka
NaBH4, , purum p. a. Aldrich
NaOH Geyer
N -(3-Dimethylaminopropyl)-N '-ethylcarbodiimide Fluka
(EDC)
N -Hydroxysulfosuccinimide sodium salt Fluka
(sulfo-NHS)
Palladium(II) acetate Fluka
P -iodoaniline Sigma-Aldrich
Pentane Grüssing
Petroleum ether Merck
Sodium auro(I)thiomalate hydrate (Tauredon®) Aldrich
Tetrakis(triphenylphosphine)palladium Merck
Toluene Merck
TPPTS Fluka
Triethylamine Grüssing
Triphenylphosphine (TPP), 99+% Alfa Aesar
Trisodium citrate dihydrate Fluka
H2O was obtained from an ELGA Purelab Plus water puriﬁcation system.
5.1.2 Commercially Purchased or Provided AuNPs
Au1.2MS and Au1.8MS were kindly provided by STREM Chemicals Inc.
Aurovistwas purchased from Nanoprobes.
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5.2 General Comments on Preparative Work
As phosphines are sensitive towards oxidation, most syntheses including phosphines were
performed in inert atmosphere (N2 or Argon).
All glassware, magnetic stir bars and other materials used for AuNPs were cleaned with
aqua regia and thoroughly washed with de-ionized H2O prior to usage. When AuNPs were
kept in solution over longer periods of time (in reactions or for storage), this was done under
exclusion from light to prevent light induced aggregation.
Centrifugation was performed with a Biofuge fresco centrifuge (Heraeus). Ultracentrifuga-
tion was performed at the Institute of Physical Chemistry, RWTH Aachen University, with
a Sorvall Discovery 90SE. Drying of solutions in Eppendorf tubes was performed with a
miVac DNA concentrator (Genevac). To ﬁlter AuNP solutions, Anotop ﬁlters (Millipore®,
pore diameter 20 nm) were used. For dialysis experiments, dialysis membranes made of
regenerated cellulose with a molecular weight cut-oﬀ (MWCO) of 5 kD (ZelluTrans, Roth,
V series) were used.
5.3 General Comments on Analytics
5.3.1 UV/Vis Spectroscopy
UV/Vis measurements were performed on a J & M TIDAS microspectrometer in PMMA
cuvettes for aqueous solutions and fused quartz glass cuvettes for organic solvents in a
spectral range from λ=300 - 800 nm. Low concentrated AuNP solutions were used (maximal
absorbance ≤ 1), and the respective solvent was measured as a reference. For long-term
measurements, fused quartz glass cuvettes were used and tempered to 23 ◦C.
5.3.2 Scanning Transmission Electron Microscopy (STEM)
Low concentrated AuNP solutions were used. A drop of 5µL was placed on a carbon-coated
copper grid (S160, Plano) and dried.
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A STEM FEI Tecnai G2 F20 with a High Angle Annular Dark Field (HAADF) detector
(Ernst Ruska-Centre Jülich), operated at 200 kV, or a FE-SEM Leo/Zeiss Supra 35 VP
(IAC), operated at 20 kV, were used.
Grids measured in Jülich were cleaned in a Fishione Model 1020 Plasma Cleaner with a
25% oxygen and 75% argon plasma (Ernst Ruska-Centre Jülich) before they were analysed.
The statistical analysis of the micrographs was performed with a Visual Basic tool for
CorelDraw, developed by Dr. T. Koplin (IAC, RWTH Aachen University).
5.3.3 Scanning Electron Microscopy (SEM) and Energy-Dispersive
X-Ray Spectroscopy (EDX)
For AuNP solutions, low concentrated solutions were used. A drop of 5µL was placed on a
clean silicon wafer and dried. For solids, a small part of the respective sample was ﬁxed on
a conductive adhesive carbon tab attached to a pin stub. A FE-SEM Leo/Zeiss Supra 35
VP with an integrated EDX system (Oxford, INCA Energy 200 with SiLi crystal, 133 eV,
10mm2) was used.
5.3.4 Elemental Analysis (EA)
For an elemental analysis (elements C, H, N), 3mg of a solid sample was investigated on a
Elementar Vario EL in the Institute of Organic Chemistry, RWTH Aachen University.
5.3.5 Atomic Absorption Spectroscopy (AAS)
For concentration determinations of AuNP solutions, 100µL of the respective sample was
diluted with 400µL H2O, oxidized with aqua regia and measured on a Shimadzu AA-6200.
Concentrations of AuNP solutions are therefore always given as gold atom concentrations,
if not stated diﬀerently.
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5.3.6 Electron Paramagnetic Resonance (EPR)
The EPR measurements were performed on a magnettech MiniScope MS100 EPR spec-
trometer (Forschungszentrum Jülich). They were measured with a B0 ﬁeld of 3380G, a
magnetic ﬁeld variation of 140G, a modulation of 205mG and a microwave damping of
6 dB. Concentrated solutions of AuNPs, Amino-TEMPO and Oxo-TEMPO stock solutions
were saturated with O2 or Ar by bubbling with gas for at least 10min. For the measure-
ments, solutions were ﬁlled into Blaubrand intraMARK micropipettes (50µL volume) and
closed with paramagnetic silicon paste.
5.3.7 Gas chromatography / mass spectrometry (GC/MS)
The GC/MS experiments were conducted at the NIST, Gaithersburg, MD, USA. A mass
spectrometer (Hewlett-Packard Model 5989A MS Engine) interfaced to a gas chromatograph
(Hewlett-Packard Model 5890 Series II ), equipped with an automatic injector, was used.
5.3.8 Nuclear Magnetic Resonance Spectroscopy (NMR)
5.3.8.1 Solution NMR
For organic samples, 10mg of the sample was dissolved in 700µL deuterated solvent and
measured on a Bruker Avant II 400 (400MHz) or aMercury 200B (200 MHz). The chemical
shifts are given as δ in ppm and are referenced to the respective solvent (for 1H-NMR) or
to H3PO4 as external standard (for 31P-NMR).
For AuNP solutions, highly concentrated solutions were used (for small particles, 15mg of
the respective sample was dissolved in 300µL D2O; solutions of AuNPs >5nm were concen-
trated by centrifugation). For aqueous solutions, FEP sample tube liners (Wilmad®) were
used. The number of scans and the delay time were individually ﬁtted for each experiment.
5.3.8.2 Solid State NMR
Static and magic angle spinning (MAS) solid state 31P-NMR investigations were carried out
with a Bruker AVANCE III spectrometer with a magnetic ﬁeld of 9.40T equipped with a
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standard Bruker 4.0 and 2.5mm MAS probe, respectively. The corresponding frequency
of 31P is 161.988MHz. 31P-NMR signals of Au1.4MS were recorded using a Hahn echo
sequence with pulses of 2.0µs and an interpulse delay of 100µs for the static measurements.
Rotor synchronized interpulse delays were applied under MAS conditions of 15 and 35 kHz,
respectively. A cycle delay of 5.4 s was used to ensure full recovery of the magnetization.
1H decoupling was achieved throughout a Spinal64 sequence with pulses of 5.0µs. For the
NMR measurements of TPPMS-Au(I)-Cl, a 1H decoupled (Spinal64, 5.4µs) single pulse
sequence with pulses of 3.4µs and a cycle delay of 64 s was applied. The 31P-NMR signals
are referred to H3PO4.
5.3.9 Patch Clamp Experiments
The patch clamp experiments were performed at the Cytocentrics AG, Rostock, together
with Dr. Olaf Scheel, Dr. Yu Pan-Bartneck and Frank Schiefer. The recordings were
performed on a patch clamp setup:
Patch clamp ampliﬁer: EPC-10, HEKA Elektronik ; Software: PatchMaster, HEKA Elek-
tronik, v2.15; Tube pump: ISM830, Ismatec; Bath chamber: RC-25 with platform P-3,
Warner Instruments, with glass cover slips; patch clamp pipettes: pipette resistance be-
tween 1.5 and 4MOhm. The pipette electrode was built of a chlorinated silver wire in IC.
As reference electrode a Ag/AgCl pellet electrode (Warner Instruments) was used. Patch
clamp data were recorded and analyzed using the HEKA patchmaster software. Further
analysis was performed with Microsoft Excel. The peak amplitude of the hERG tail current
was corrected by the value of the leak current determined with the -50mV pulse before the
depolarizing activation pulse giving the hERG tail current value.
5.3.10 Diﬀerential Scanning Calorimetry (DSC)
Samples of 5 - 20mg were weighted exactly and investigated on a NETZSCH DSC 204.
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5.3.11 Dynamic light scattering (DLS) and ζ potential
measurements
DLS measurements and ζ potential measurements were performed with low concentrated
solutions in 10mM or 100mM HEPES buﬀer with a pH of 8 in folded capillary cells (clear
polycarbonate) on a Malvern ZETA SIZER ZS with a laser of the wavelength λ = 632.8 nm.
5.3.12 Mass Spectrometry (MS)
The MS measurements at the IAC were performed on a Finnigan MAT95. FAB-SIMS
spectra were recorded in a glycerine/thioglycerine matrix and in a 1,4-dithioerythritol/DL-
dithiothreitol (DTE/DTT) matrix.
5.3.13 Infrared Spectroscopy (IR)
Samples were either mixed as a powder (1mg) with 200mg pre-dried KBr, or 5µL of a
concentrated AuNP solution was added to 200mg KBr and dried. This mixture was pestled
and then pressed in a molding press. The pellet was measured on a FT-IR Bruker Vertex
70 spectrometer.
The spectra were processed with the OPUS 6.5 program. A baseline correction and a CO2
correction were performed.
5.3.14 Fluorescence Spectroscopy
Low concentrated solutions were measured in PMMA cuvettes with four clear sides in a
Jasco FP-6300 ﬂuorescence spectrometer.
5.3.15 Cell Experiments
All other, not so far mentioned cell experiments described in this work were performed at
the UKA and are described in detail in the PhD thesis of Dr. Yu Pan-Bartneck.[12] To
prepare test compound solutions, the AuNP solutions of small AuNPs (<5nm) were always
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ﬁltered with an Anotop ﬁlter after redispersion. A small portion of each sample was taken
for the measurement of the concentration by AAS.
5.4 Syntheses
5.4.1 Ligands
5.4.1.1 TPPMS
To a mixture of 4.8mL 20% fuming sulfuric acid and 0.2mL 65% fuming sulfuric acid, 2.5 g
(9.5mmol) TPP were added slowly under stirring and cooling with an ice bath. After the
dissolution of the TPP, the solution was heated to 90 ◦C. After 30min, the reaction was
stopped and cooled to room temperature. The solution was poured into 200mL H2O and
neutralized with saturated NaOH. The product precipitated as ﬁne white platelets. It was
ﬁltered, recrystallized from ethanol and dried.
5.4.1.2 Diphenylphosphine (precursor)
3.1 g LiAlH4 were added to 50mL dry diethyl ether. 25mL Ph2PCl in 50mL diethyl ether
were added drop wise with a dropping funnel under stirring and cooling with an ice bath.
After complete addition, the solution was reﬂuxed for 1 h. A white suspension formed.
13mL H2O were added drop wise and the solution was reﬂuxed for further 2 h. A white
precipitate formed. It was ﬁltered, and the solid was dissolved in 60mL diethyl ether. The
solution was dried over CaCl2, then the ether was removed. The product remained as a
yellow viscous liquid.
5.4.1.3 pTPPMA, mTPPMA
1.31 g (5.95mmol) p-Iodoaniline, or m-iodoaniline respectively, and 0.61 g (5.95mmol) tri-
ethylamine were mixed in 15mL acetonitrile. The solution was degassed, and 1.11 g
(5.95mmol) diphenylphosphine were added. The solution was heated to reﬂux, and 7mg
tetrakis-(triphenylphosphine)palladium in 5mL acetonitrile and 5mL H2O were added. The
reaction was reﬂuxed for 60 h. Afterwards, the solvent was removed and the residue was
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dissolved in 5mL H2O. 5mL dichloromethane were added and the mixture was poured in
a separation funnel. The organic phase was separated and discarded, the H2O was removed
and the remaining yellowish product was dried.
5.4.1.4 TPPMCMA
3.53 g (13.4mmol) 2-Amino-5-iodobenzoic acid, 3.8mL triethylamine and 2mg (9µmol)
palladium(II) acetate were dissolved in 30mL acetonitrile. After the addition of 2mL
(11.5mmol) diphenylphosphine, the reaction mixture was reﬂuxed for 48 h. The solution
was dried and the residue was dissolved in 30mL 1M KOH. The aqueous phase was washed
with dry diethyl ether (4× 30mL) and once with 30mL petroleum ether. The aqueous
phase was cooled to 5 ◦C and acidiﬁed to a pH of 2 with 2M HCl. A yellowish precipitate
formed. It was ﬁltered, dissolved in dry diethyl ether, washed with 20mL H2O and dried
over MgSO4. After removal of the ether, the product remained as a yellow-orange solid.
5.4.1.5 TPPMC
1.96 g (7.9mmol) 4-Iodobenzoic acid, 2.3mL (16mmol) triethylamine and 2mg (9µmol) pal-
ladium(II) acetate were mixed in 24mL acetonitrile. After the addition of 1.2mL (7.9mmol)
diphenylphosphine, the reaction mixture was heated to 85 ◦C for 12 h. The color of the so-
lution changed from red to yellow-green during that time. Afterwards, the solvents were
removed and the residue was dissolved in 20mL H2O with 1.06 g (16mmol) KOH. The
solution was washed 3× with dry diethyl ether and then acidiﬁed with 5mL 2M HCl. Af-
terwards, the product was extracted from the aqueous phase with diethyl ether (3× 30mL),
the combined ether fractions were washed with 20mL H2O and dried over MgSO4. After
removal of the ether, the product remained as a yellowish powder.
5.4.1.6 DPPETS
2.0 g (5.0mmol) 1,2-bis(diphenylphosphino)ethane (DPPE) were dissolved in 25mL 20%
fuming sulfuric acid. The reaction mixture was stirred for 90 h at 0 ◦C, while the temperature
was kept constant with a cryostate. After this time, the solution was slowly neutralized
with 120mL 25% NaOH. The H2O was removed. 160mL methanol were added and the
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solution was reﬂuxed for 1 h. It was ﬁltered hot and washed in portions with 50mL of a
hot methanol/H2O mixture (4:1). The ﬁltrate was dried, then dissolved in methanol/H2O
(10:1) and stored in the refridgerator overnight to recrystallize. The solvents were removed
and the product was dried.
5.4.1.7 DPPPTS, DPPBTS
32.5mL 30% fuming sulfuric acid was cooled to 0 ◦C. 2.5 g of DPPP (6.0mmol), respectively
DPPB (5.9mmol), were dissolved in 8mL cold sulfuric acid and then added via a dropping
funnel to the fuming sulfuric acid. The dropping speed was adjusted so that a temperature
of 5 ◦C was not exceeded. After the addition, additional 10mL 30% fuming sulfuric acid
were added via the dropping funnel. The reaction mixture was stirred for 48 h at room
temperature. After this time, the solution was slowly poured into 250mL H2O while a
temperature of 10 ◦C was not exceeded. Afterwards, the pH of the solution was adjusted
to 2 with saturated NaOH. 175mL methanol were added, and the Na2SO4 formed was
removed. The ﬁltrate was dried, and the remaining solid was dissolved in H2O. The pH
was brought to 7, and 125mL methanol were added. The solid was ﬁltered and the ﬁltrate
was dried. DPPPTS remained as a light brown solid, DPPBTS as a beige solid.
5.4.2 Gold Nanoparticles
5.4.2.1 Au1.4TPP
Au1.4TPP (with the chemical structure Au55[(C6H5)3P]12Cl6) was synthesized according to
the literature.[33] Brieﬂy, 3.907 g (7.9mmol) TPP-Au(I)-Cl was dispersed in 200mL benzene
in inert atmosphere. B2H6 was generated in situ from 20 g (529mmol) NaBH4 in 100mL
diglyme and 100mL BF3 · OEt2, slowly added via a dropping funnel, and bubbled through
the Au(I) dispersion which was heated to 50 ◦C. The gas ﬂow rate and temperature were
kept constant for 40min, while the solution turned from turbid to colorless and clear to
dark brown. After the reaction, the solution was cooled to room temperature, the dark
brown solid formed was ﬁltered and washed with benzene and pentane. It was redispersed
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in dichloromethane and ﬁltered through an Anotop ﬁlter. After removal of the solvent, the
product remained as a dark brown solid.
5.4.2.2 Au1.4MS
Au1.4MS (with the chemical structure Au55[(C6H5)2P(C4H4So3Na)]12Cl6) was synthesized
according to the literature.[34] 163mg (0.01mmol) Au1.4TPP was dissolved in 10mL
dichloromethane and covered with a solution of 62mg (0.17mmol) TPPMS in 50mL H2O.
This two-phase system was stirred at room temperature to the exclusion of light for three
days. After this time, the H2O phase had become dark brown, indicating the phase transfer
by a ligand exchange reaction. The two phases were separated, the H2O was removed, the
obtained solid was washed 3× with 20mL dichloromethane and 3× with 20mL ethanol to
remove excess TPPMS, and dried. It was redispersed in H2O and ﬁltered through an Anotop
ﬁlter. After removal of the solvent, the product remained as a dark brown solid.
5.4.2.3 Au5.6MS
56mg (165 µmol) HAuCl4 · 3 H2O were dissolved in 12.5mL H2O and 12.5mL toluene.
287mg (1.5 mmol) dodecylamine in 12.5mL toluene were added. A yellowish precipitate
formed. 82.5mg (2.2mmol) NaBH4 were dissolved in 12.5mL H2O and directly added drop
wise to the reaction mixture over a period of 5min. The solution turned black. It was stirred
at room temperature for 7 h. Afterwards, the aqueous phase was separated and discarded
and the volume of the organic phase was reduced to 5mL. 60mL ethanol were added, and
the solution was kept at −25 ◦C overnight. It was warmed up to room temperature, the
black precipitate formed was centrifuged, washed with ethanol and resuspended in 1mL
dichloromethane.
The red AuNP solution was mixed with 12.8mL TPPMS in 10mL H2O and stirred for
2 h at room temperature. The organic phase was removed, and the red aqueous phase was
centrifuged (15min at 8000 rev/min). The supernatant was taken and further used.
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5.4.2.4 Au15MS
Au15Citrate was synthesized in allusion to a route known from literature.[32] The ligand
exchange reaction was performed according to the literature.[115] 17mg (40µmol) HAuCl4 ·
3 H2O were dissolved in 5mL H2O (solution I), 42mg (1.4mmol) trisodium citrate dihydrate
were dissolved in 15mL H2O (solution II). 85mL H2O were brought to boil, and solution I
and II were added consecutively under vigorous stirring. After a few minutes, a color change
from yellow over dark blue to red was visible. When the color of the solution remained
constant, the solution was heated for further 10min and then cooled to room temperature.
The size of AuNPs synthesized via this route is very sensitive towards the starting con-
centrations of the precursors and towards reaction conditions. Therefore, not all batches
synthesized gave AuNPs of exactly 15 nm. If the size of a certain batch diﬀered, it is stated
at the respective part.
To 100mL of the AuNP solution, 10mg (27µmol) TPPMS were added. The solution was
stirred for 5min at room temperature and then kept in the refrigerator overnight. In small
portions (1.5mL per tube), it was centrifuged (15min, 5 ◦C, 10000 rev/min). The super-
natants (1.4mL per tube) were discarded and the tubes were reﬁlled with H2O (1.4mL).
The centrifugation was repeated, the supernatants were again discarded, and afterwards,
the concentrated solutions (100µL per tube) were collected.
5.4.2.5 Au1.1GSH, Au1.5GSH
Au1.1GSH was synthesized in allusion to a route known from literature.[39] 100mg
(0.25mmol) HAuCl4 · 3 H2O was dissolved in 50mL methanol. 154mg (0.5mmol) glu-
tathione (GSH) were added. The solution was cooled to 0 ◦C. 12.5mL of a freshly prepared
NaBH4 solution (0.2M, 95mg, 2.5mmol) were added drop wise over 5min. The yellow-
ish solution turned dark brown. It was stirred for 30min, and the precipitate formed was
ﬁltered. It was ﬁrst washed with a mixture of H2O and methanol (1:10) and then with
methanol. The solid was resuspended in H2O and the dispersion was ﬁltered through an
Anotop ﬁlter. After removal of the solvent, the product remained as a dark brown solid.
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In diﬀerent batches, slightly diﬀerent particle sizes were obtained (1.1 -1.5 nm). The mean
diameter, determined by STEM, of the corresponding AuNPs is stated at the respective
part.
5.4.2.6 Au1.4GSH by Ligand Exchange
7mg (0.45µmol) Au1.4MS and 75.6mg (246µmol) GSH were dissolved in 0.7mL H2O and
kept 24 h at 37 ◦C. Afterwards, the solution was centrifuged (30min, 5 ◦C, 13000 rev/min)
and washed 3× with ethanol. The remaining residue was redispersed in 1mL H2O plus
50µL 10% NaOH, ﬁltered through an Anotop ﬁlter and used for a ζ potential measurement.
Another batch was not redispersed but used as a powder for IR spectroscopy.
5.4.2.7 Au1.4TS
Au1.4TS was synthesized analogously to Au1.4MS. 163mg (0.01mmol) Au1.4TPP was dis-
solved in 10mL dichloromethane and covered with a solution of 97mg (0.17mmol) TPPTS
in 50mL H2O. This two-phase system was stirred at room temperature to the exclusion of
light for ten days. After this time, the H2O phase had become dark brown, indicating the
phase transfer by a ligand exchange reaction. The two phases were separated, the H2O was
removed, the solid was washed 3× with 20mL dichloromethane and 3× with 20mL ethanol
to remove excess TPPTS, and dried. It was redispersed in H2O and ﬁltered through an
Anotop ﬁlter. After removal of the solvent, the product remained as a dark brown solid.
5.4.2.8 Au1.4TPPMCMA
50mg (3.5µmol) Au1.4TPP were dissolved in 3.5mL dichloromethane. A solution of 16.1mg
(52µmol) TPPMCMA in 10mL H2O and 300µL 2M NaOH was added. The mixture was
stirred for 1.5 h at room temperature. After this time, the aqueous phase was dark brown.
The organic phase was separated and discarded. The aqueous phase was centrifuged in
an ultracentrifuge (4 h, 20 ◦C, 50000 rev/min). The supernatant was discarded, and the
pellet at the bottom of the centrifuge tube was washed 3× with H2O by redispersion and
centrifugation under the same conditions. After the last centrifugation step the pellet was
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dried. It was redispersed in H2O and ﬁltered through an Anotop ﬁlter. After removal of the
solvent, the product remained as a dark brown solid.
5.4.2.9 Au1.4TPPMC
100mg (7µmol) Au1.4TPP were dissolved in 8mL dichloromethane. A solution of 46.1mg
(0.16mmol) TPPMC in 10mL H2O and 20mL 0.1M NaOH was added. The mixture was
stirred for 2 h at room temperature. After this time, the aqueous phase was dark brown.
The organic phase was separated and discarded. The aqueous phase was centrifuged in
an ultracentrifuge (4 h, 20 ◦C, 50000 rev/min). The supernatant was discarded, and the
pellet at the bottom of the centrifuge tube was washed 3× with H2O by redispersion and
centrifugation under the same conditions. After the last centrifugation step the pellet was
dried. It was redispersed in H2O and ﬁltered through an Anotop ﬁlter. After removal of the
solvent, the product remained as a dark brown solid.
5.4.2.10 Au1.4DPPETS
50mg (3.5µmol) Au1.4TPP were dissolved in 4mL dichloromethane. A solution of 48mg
(0.06mmol) DPPETS in 20mL H2O was added. The mixture was stirred for 15 h at room
temperature. The two phases were separated, the H2O was removed, the obtained solid was
washed with dichloromethane once and 3× with ethanol to remove excess DPPETS, and
dried. It was redispersed in H2O and ﬁltered through an Anotop ﬁlter. After removal of the
solvent, the product remained as a dark brown solid.
5.4.2.11 Au1.4DPPPTS
100mg (7µmol) Au1.4MS were dissolved in 8mL dichloromethane. A solution of 158.5mg
(0.175mmol) DPPPTS in 60mL H2O was added. The mixture was stirred for 4 days at room
temperature. The two phases were separated, the H2O was removed, the obtained solid was
washed 2× with dichloromethane and once with ethanol to remove excess DPPPTS, and
dried.
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5.4.2.12 Au1.4DPPBTS
100mg (7µmol) Au1.4MS were dissolved in 8mL dichloromethane. A solution of 160.6mg
(0.175mmol) DPPBTS in 60mL H2O was added. The mixture was stirred for 4 days at room
temperature. The two phases were separated, the H2O was removed, the obtained solid was
washed 2× with dichloromethane and once with ethanol to remove excess DPPBTS, and
dried. For a further puriﬁcation, 40mg of the product were redispersed in 4.5mL H2O and
dialyzed for 3 days (MWCO of 5 kD), while the wash water (400mL) was exchanged 3× a
day.
5.4.2.13 Au13DPPETS
As a precursor, citrate-stabilized gold colloids were synthesized as described above (see
5.4.2.4). To 25mL of this AuNP solution, 5.5mg (6.8µmol) of DPPETS were added. The
solution was stirred at room temperature for 1 h and then left in the refrigerator overnight. In
small portions (1.5mL per tube), it was centrifuged (15min, 5 ◦C, 10000 rev/min). The su-
pernatants (1.4mL per tube) were discarded and the tubes were reﬁlled with H2O (1.4mL).
The centrifugation was repeated, the supernatants were again discarded, and afterwards,
the concentrated solutions (100µL per tube) were collected.
5.4.2.14 Au11DPPPTS
As a precursor, citrate-stabilized gold colloids were synthesized as described above (see
5.4.2.4). To 30mL of this AuNP solution, 5.9mg (7.2µmol) of DPPPTS were added. The
solution was stirred at room temperature for 10min, left in the refrigerator overnight and
centrifuged under the same conditions as described above (see 5.4.2.13).
5.4.2.15 Au12DPPBTS
Au12DPPBTS was synthesized analogously to Au11DPPPTS (see 5.4.2.14) using 6.0mg
(7.2µmol) DPPBTS.
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5.4.2.16 Degradation of Diphosphine-Stab. AuNPs with KCN
The stability against KCN degradation of Au1.4MS, Au1.4DPPETS, Au11Citrate, Au13MS,
Au13DPPETS, Au11DPPPTS and Au12DPPBTS was analyzed by time-dependent UV/Vis
spectroscopy. For Au1.4MS and Au1.4DPPETS, a AuNP stock solution of 9.8mg AuNPs
in 3mL H2O was used. For larger gold colloids, highly concentrated solutions, concentrated
by centrifugation, were used.
To 1mL AuNP solution in a fused quartz glass cuvette, 0.17mL 0.1M KCN was added.
The cuvette was tempered to 23 ◦C and UV/Vis spectra were taken over a time period of
8 h (1 spectrum/min).
5.4.2.17 DTT Exchange with Au1.4DPPBTS
8mg Au1.4DPPBTS were redispersed in 10mL H2O. For each experiment, 900µL of this
stock solution were taken and mixed with 100µL of diﬀerently concentrated DTT solutions
(2.2µM - 22µM). The mixtures were heated to 60 ◦C for 5min. After cooling to room
temperature, UV/Vis spectra were taken and the absorbance at λ = 400 nm was determined.
In a reference experiment, 3mg Au1.4MS were redispersed in 10mL H2O, and samples were
prepared and measured as described above.
5.4.2.18 Au1.4MS/MC
180mg (0.01mmol) Au1.4TPP were dissolved in 12mL dichloromethane. 10.6mg (35µmol)
TPPMC and 88.7mg (243µmol) TPPMS (molar ratio TPPMC:TPPMS 1:7) were dissolved
in 25mL H2O and 25mL 0.1M NaOH. This two-phase system was stirred for 24 h. The
organic phase was separated and discarded. The H2O was removed, the obtained solid was
washed 2× with dichloromethane and once with ethanol to remove excess ligands, and the
product was dried. It was redispersed in H2O, ﬁltered through an Anotop ﬁlter and further
puriﬁed by dialysis for 24 h (MWCO of 5 kD), while the wash water (400mL) was exchanged
3×. The dialyzed solution was dried, and the product remained as a dark brown solid.
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5.4.2.19 Au1.4MS/MC-(Lys3)-bombesin
50mg (3.3µmol) Au1.4MS/MC were dissolved in 8mL H2O. 43.4mg (0.2mmol, ﬁnal con-
centration 20mM) sulfo-NHS and 77.6mg (0.5mmol, ﬁnal concentration 50mM) were dis-
solved in 2mL HEPES buﬀer (100mM, pH8), ﬁltered through an Anotop ﬁlter and added
to the AuNP solution. It was stirred for 30min at room temperature, then 5mg (3.1µmol)
(Lys3)-bombesin were added. The solution was stirred for 20 h at room temperature, trans-
ferred into Eppendorf tubes and centrifuged (30min, 5 ◦C, 13000 rev/min) to remove aggre-
gates. The supernatant was transferred into centrifugation tubes and ultracentrifuged (2 h,
20 ◦C, 50000 rev/min). The supernatant was discarded, the pellets were redispersed in H2O
and centrifuged once more. The supernatant was collected and was used as a reference after
a further dialysis step. The pellet of Au1.4MS/MC-(Lys3)-bombesin was stored as a highly
concentrated AuNP solution.
5.4.2.20 Au1.4MC-bombesin
Under similar conditions, bombesin was coupled to Au1.4MC. This product was only soluble
in acidic solvents and had a poor stability in cell culture medium (pH7.4). For cell exper-
iments, Au1.4MS/MC-(Lys3)-bombesin was therefore used. However, Au1.4MC-bombesin
was used for a DTT ligand exchange reaction (see 5.4.2.21 below).
5.4.2.21 DTT Exchange with Au1.4MC-bombesin
10mg of Au1.4MC-bombesin were redispersed in 2mL of diluted acetic acid. 2mL of acetic
DTT solution (0.5M) were added, and the mixture was heated to 60 ◦C for 5min. After-
wards, it was stirred for 1 h at room temperature. The precipitate was centrifuged, and the
supernatant was dried. The residue was analyzed by MS.
5.4.2.22 Au1.4MS/MC-Aminoﬂuorescein
The functionalization of Au1.4MS/MC with 5-Aminoﬂuorescein was conducted under sim-
ilar conditions as the coupling reaction with (Lys3)-Bombesin (5.4.2.19).
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40mg (2.6µmol) Au1.4MS/MC were dispersed in 6.4mL H2O. 34.8mg (160µmol) sulfo-
NHS and 62.1mg (400µmol) EDC were dissolved in 1.6mL HEPES buﬀer (100mM, pH8).
The two solutions were mixed and stirred for 30min at room temperature. Afterwards,
2.0mg (5.8µmol) 5-Aminoﬂuorescein was added and the solution was stirred for further
20 h. The solution was transferred to Eppendorf tubes, centrifuged and washed once with
ethanol. The product was dried in a miVac DNA concentrator. The residue was dispersed
in diluted NaOH (pH7.5) by shaking overnight. The insoluble residue was separated by
centrifugation and discarded.
5.5 Measurements with AuNPs
5.5.1 EPR Measurements
All solutions used were saturated with Ar or O2, respectively, before they were diluted
and mixed. The aqueous AuNP stock solutions were diluted in diﬀerent ratios to a total
volume of 100µL, respectively (for concentrations see table 5.2). They were then mixed
with 100µL of a 4-Amino-2,2,6,6-tetramethylpiperidine-1-oxyl (Amino-TEMPO) solution
(30µM) directly prior to the measurements. The pH was adjusted to 8-9 with 50mM
NaOH.
Table 5.2: Concentrations of AuNP solutions for EPR spectroscopy.
AuNP species conc. stock solution / mM ﬁnal conc. / mM
Au15Citrate 18.2 2.3
Au15MS 32.7 8.2
Au1.4MS 18.6 4.7
Au1.5GSH 21.6 5.4
5.5.2 GC/MS Measurements
DNA samples were prepared by Dr. Yu Pan-Bartneck (UKA). Au1.4MS, Au1.1GSH, and
Au15MS (50µM, respectively; Au1.4MS was also applied in 20µM) were used to incubate
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HeLa cells (incubation times 3 h, 24 h, 72 h), followed by subsequent DNA extraction (sam-
ple set 1). As a positive control, cells were also treated with 0.3% H2O2 for 30min.
Furthermore, DNA was isolated from untreated HeLa cells and the pure DNA was incu-
bated (incubation times 3 h, 24 h, 72 h) with Au1.4MS, Au1.1GSH, and Au15MS (50µM,
respectively) as well (sample set 2).
Further treatment of the samples and GC/MS measurements were performed at the NIST,
Gaithersburg, MD, USA, together with Dr. Bryant Nelson and Dr. Elijah Petersen. All
DNA pellets were washed several times (2× 70% ethanol, 1× 100% ethanol). Then the
exact DNA concentrations were determined with a NanoDrop spectrometer. 50µg DNA
was taken of each sample (except for the few samples that contained less DNA). Isotopi-
cally labeled internal standards (FapyAde, FapyGua, 8OHGua, 5OHCyt, 5OHUra, TG, and
5OH5MeHyd) were added. After that, the DNA was enzymatically digested by Endo III/Nth
and Fpg enzymes. The samples were freeze dried, and bis(trimethylsilyl)triﬂuoroacetamide
(BSTFA) was added to derivatize the DNA bases to their silyl ester analogues. GC/MS
measurements were performed. For the data analysis, the signals were integrated manu-
ally with the MSD Productivity ChemStation (Agilent) and further processed for statistical
analysis with GraphPad Prism.
5.5.3 NMR and EDX Experiments
5.5.3.1 Au1.4MS + TPPMS
15mg (0.95µmol) Au1.4MS were dissolved in 300µL D2O and the 1H and 31P-NMR spectra
were measured (400MHz). 3.2mg (8.7µmol, 9.8 eq) TPPMS were dissolved in 60µL D2O
and added. The NMR measurements were repeated. Successively, more TPPMS was added
(see table 5.3), and the NMR measurements were repeated after each addition.
The δ values of the 31P-NMR spectra were plotted against the concentration of additionally
added TPPMS. A logarithmic ﬁt was performed with Microsoft Excel. The ﬁrst measure-
ment value was neglected as the added concentration of TPPMS was in the same regime
as the calculated concentration of intrinsically present TPPMS (which is not taken into
account in the ﬁt). Therefore, this ﬁrst measurement point is not feasible for a ﬁt.
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Table 5.3: TPPMS amounts for 31P-NMR analysis.
Measurement No. m (TPPMS) / mg eq (TPPMS) δ / ppm
1 0 0 44.95
2 3.2 9.8 42.95
3 3.2 19.6 30.56
4 3.2 29.4 25.98
5 3.2 39.2 21.98
6 6.4 58.8 19.70
7 6.4 78.4 18.38
8 6.4 98.0 15.44
9 6.4 117.6 16.56
The δ value for pure Au1.4MS (measurement no. 1) was used to approximate the amount of
dissociated TPPMS ligands in a Au1.4MS solution (cdiss).
5.5.3.2 Solid State NMR of Au1.4MS
Fine powdered samples of Au1.4MS and TPPMS-Au(I)-Cl were diluted with GeO2 in a ratio
of approximately 1 : 5 and mounted in a 4.0 and 2.5 mm ZrO2 rotor.
5.5.3.3 Dialysis and EDX of Au1.4MS
6mg (0.38µmol) Au1.4MS were dissolved in 6mL H2O and ﬁlled in a dialysis membrane
(MWCO of 5 kD). The membrane was put in a beaker ﬁlled with 400mL H2O and the
AuNP solution was dialyzed under slow stirring at room temperature for 2 h. Afterwards
the supernatant was reduced to dryness and the remaining residue was examined by EDX
analysis. In the control experiment, 12.4mg (0.38µmol) TPPMS-Au(I)-Cl was dialyzed
under the same conditions and the dialysate was examined.
For the EDX investigation, the solid samples were ﬁxed on a conductive adhesive carbon
tab attached to a pin stub.
5.5.4 Patch Clamp Experiments
HEK 293 cells, stably transfected with the hERG ion channel gene, or CHO-K1 cells trans-
fected with the gene encoding the sodium ion channel NaV1.5, were used. These cells were
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stored in liquid nitrogen and were ready-to-use directly after thawing without any culti-
vation. After thawing, the cells were resuspended in extracellular buﬀer and kept in the
Cytocentrics Cell Reservoir as a cell suspension at a density of 2.0millions/mL in extracel-
lular buﬀer at room temperature and were used for 4 h after thawing.
The extracellular buﬀer (EC) was used for thawing the cells, the storage in the Cell Reser-
voir and the preparation of the working concentrations of the test and reference compounds.
The extracellular buﬀer consists of: 140mM NaCl, 2.5mM KCl, 2mM MgCl2, 2mM CaCl2,
10mM HEPES, 10mM glucose, 15mM sucrose. The buﬀer was adjusted to a pH of 7.4± 0.1;
osmolality 320± 5mOsmol/kg. The buﬀer was stored at 4 ◦C and heated up to room tem-
perature prior to usage. The intracellular buﬀer (IC) consists of: 100mM K-gluconate,
20mM KCl, 1mM CaCl2, 1mM MgCl2, 10mM HEPES, 11mM EGTA-KOH, 4mM ATP-
Mg2+, 3mM phosphocreatine-Na2-H2O, 9mM sucrose. The buﬀer was adjusted to a pH of
7.2± 0.1; osmolality 295± 5mOsmol/kg. Aliquots were stored at −20 ◦C. Prior to usage
an aliquot IC was thawed and used no longer than for 4 h.
The diﬀerent AuNPs were dissolved in H2O as stock solutions and diluted with EC in
the concentrations needed for the experiments directly prior to the experiments. When
Au1.4MS was pre-incubated with TPPMS or GSH, both compounds were diluted in EC to
the respective concentrations, mixed and kept at 37 ◦C for 3 h.
For patch clamp recordings, cells were seeded in the bath chamber ﬁlled with EC. After
approx. 5min in which the cells attached to the cover slips the seal process was started.
After gigaseal formation the membrane patch under the tip of the glass pipette was opened
by a short suction pulse to gain electrical access from the pipette electrode to the cytosol
(whole cell conﬁguration). Then the cell was lifted from the cover slip with the pipette
and positioned close to the perfusion entry of the bath chamber and perfusion with EC was
started. To activate hERG currents the voltage protocol was repeated every 10 s. The hERG
currents were then recorded for 10min upon EC perfusion to assure that stable recording
conditions were established. Only cells with tail current amplitude of more than 400 pA were
used. After the control phase the test compounds were applied. Application time was in
general 10min per concentration. Recordings in which the whole cell membrane resistance
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decreased below 500MOhm without recovery (leaky) were stopped and not taken into the
analysis from here. All measurements were done at room temperature.
The typical pulse protocol that was applied was: 0.2 s, -80mV; 0.2 s, -50mV; 2 s, +40mV;
2 s, -50mV; 0.2 s, -80mV.
5.5.5 Cell Experiments
All other cell experiments were performed by Dr. Yu Pan-Bartneck at the UKA and are
described elsewhere.[12]
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6 Abbreviations
AAS Atomic absorption spectroscopy
AF 5-Aminoﬂuorescein
Amino-TEMPO 4-Amino-2,2,6,6-tetramethylpiperidine-1-oxyl
ANOVA Analysis of variance
ATP Adenosine-5'-triphosphate
AuNPs Gold nanoparticles
BINAP 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl
bla β-lactamase
BLM Human melanoma cell line
ccp cubic close-packed
cDNA complementary DNA
CHO-K1 Chinese hamster ovary cell line
ct-DNA calf thymus DNA
CM-H2DCFDA 5-(and-6)-chloromethyl-2',7'-dichlorodihydro-
ﬂuorescein diacetate, acetyl ester
COS-1 Cell line (CV-1 (simian) in Origin, and carrying
the SV40 genetic material)
CPP Cell penetrating peptide
DFT Density functional theory
DNA Deoxyribonucleic acid
DLS Dynamic light scattering
DPPB 1,2-Bis(diphenylphosphino)butane
DPPBTS 1,2-Bis(diphenylphosphino)butane tetrasulfonate
DPPE 1,2-Bis(diphenylphosphino)ethane
DPPETS 1,2-Bis(diphenylphosphino)ethane tetrasulfonate
Continued on next page
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6 Abbreviations
DPPP 1,2-Bis(diphenylphosphino)propane
DPPPTS 1,2-Bis(diphenylphosphino)propane tetrasulfonate
DSC Diﬀerential scanning calorimetry
DTE Dithioerythritol
DTT Dithiothreitol
EA Elemental analysis
EC Extracellular buﬀer
EDC 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide
EDX Energy-dispersive x-ray spectroscopy
EGTA Ethylene glycol tetraacetic acid
ELISA Enzyme-linked immunosorbent assay
EM Electron microscopy
EPR Electron paramagnetic resonance
eq Equivalents
FBS Fetal bovine serum
FCS Fetal calf serum
FEP Fluorinated ethylene propylene
FRET Förster resonance energy transfer
GC/MS Gas chromatography / mass spectrometry
GRPR Gastrin releasing peptide receptor
GSH Glutathione
HAADF High angle annular dark ﬁeld
HEK 293 Human embryonic kidney cell line
HeLa HeLa cervix carcinoma epithelial cell line
HEPES 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid
HepG2 Hepatocellular carcinoma cell line
hERG Human ether-à-go-go related gene
HPLC High-performance liquid chromatography
IAC Institute of Inorganic Chemistry
(RWTH Aachen University)
IC Intracellular buﬀer
ICP-OES Induced coupled plasma-optical emission spectroscopy
Continued on next page
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IC50 half maximal inhibitory concentration
IR Infrared
IUPAC International Union of Pure and Applied Chemistry
J774A1 Mouse monocytic/macrophage cell line
KIT Karlsruhe Institute of Technology
L929 L929 mouse ﬁbroblast cell line
LC/MS/MS Liquid chromatography /
tandem mass spectrometry
Lys Lysine
MAS Magic angle spinning
MDCK Madine darby canine, kidney cell line
mRNA Messenger ribonucleic acid
MS Mass spectrometry
MTT Dimethyl thiazolyl diphenyl tetrazolium salt
MWCO Molecular weight cut oﬀ radius
NAA Neutron activation analysis
NAC N -acetylcysteine
NEIL1 Enzyme encoded by nei endonuclease VIII-like 1
gene
NIST Natinal Institute of Standards and Technology
NLS Nuclear localizing signal
NMR Nuclear magnetic resonance
NP nanoparticle
8-OH-dG 8-Oxo-2'-deoxyguanosine
Oxo-TEMPO 4-Oxo-2,2,6,6-tetramethyl-1-piperidinyloxy
PEG Poly(ethylene glycol)
PMMA Poly(methyl methacrylate)
PVP Poly(vinylpyrrolidone)
ROS Reactive oxygen species
RWTH Rheinisch-Westfälische Technische Hochschule
SAM Self-assembled monolayer
SK-Mel-28 SK-Mel-28 melanoma cell line
Continued on next page
145
6 Abbreviations
STEM Scanning transmission electron microscopy
Sulfo-NHS N-Hydroxysuccinimide sulfonate
Tat Trans-activator of transcription
TEG Tetra(ethylene glycol)
TEM Transmission electron microscopy
TPP Triphenylphosphine
TPPMA Triphenylphosphine monoamine
TPPMC Triphenylphosphine monocarboxylate
TPPMCMA Triphenylphosphine monocarboxylate monoamine
TPPMS Triphenylphosphine monosulfonate
TPPMS=O Sodium 3-(diphenylphosphoryl)benzenesulfonate
TPPTS Triphenylphosphine trisulfonate
UKA University Hospital Aachen
UV/Vis Ultraviolett/Visible
XPS X-ray photoelectron spectroscopy
XRD X-ray diﬀractometry
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